Characterization of the Genome of Equine Herpesvirus 1 Subtype 2 by Cullinane, Ann A
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
CHARACTERIZATION OF THE GENOME OF 
EQUINE HERPESVIRUS 1 SUBTYPE 2
by
Ann A. Cullinane
A Thesis presented for the Degree of 
Doctor of Philosophy
in
The Faculty of Science 
at the University of Glasgow
Institute of Virology October, 1986 
Church Street,
Glasgow,
ProQuest Number: 10991905
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10991905
Published by ProQuest LLO (2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
PAGE
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS 
SUMMARY 
ABBREVIATIONS
CHAPTER 1: INTRODUCTION: 1-AY
THE FAMILY HERPESVIRIDAE 1
General Description 1
Classification 2
Sub-classification of Herpesviruses on the 
Basis of Biological Properties 3
Sub-classification of Herpesviruses on the 
Basis of Genome Structure 4
Structure of Herpes Simplex Virus DNA 5
Group A 9
Group B 9
Group C 10
Group D 12
Group E 13
Other Genome Structures 14
THE PATHOGENESIS OF EQUINE HERPESVIRUSES 15
Introduction 15
Abortion caused by EHV-1 16
Respiratory Disease Caused by EHV-1 20
EHV-1 Neurological Syndrome 21
Neonatal Foal Disease caused by EHV-1 24
Coital Exanthema caused by EHV-1 25
The Differentiation of two Subtypes
of EHV-1 25
Latency of EHV-1 30
THE MOLECULAR BIOLOGY OF EHV-1 SUBTYPE 1 33
The Structure of EHV-1 33
The Genome of EHV-1 Subtype 1 35
Lytic Infection with EHV-1 37
Initial stages of Infection 38
Effect of Virus Infection on Host
Macromolecular Synthesis 39
Replication of Viral DNA 40
Transcription 41
Protein Synthesis 42
Virus Associated Enzymes 44
Assembly of EHV-1 Virions 46
Oncogenic Transformation by EHV-1 46
CHAPTER 2: MATERIALS AND METHODS 48-75
MATERIALS 48
Cells 48
Viruses 48
Tissue Culture Media and Solutions 48
Other Solutions used for Tissue Culture 49
Tissue Culture Ware 50
Chemicals and Enzymes 50
DNA 51
Miscellaneous Materials 52
Commonly Used Solutions and Buffers 53
METHODS 54
Growth of Cells 54
Production of Virus Stocks 54
Virus Titration 55
Plaque Purification of Virus 55
Preparation of EHV-1 DNA 56
Electron Microscopy of EHV-1 Subtype 2 DNA 58
Restriction Endonuclease Digestion of DNA 59
Agarose Gel Electrophoresis 59
Isolation of Restriction Fragments 60
Nick Translation of DNA 61
Radiolabelling of M13 Probes 61
Transfer of DNA to Nitrocellulose 62
Hybridization 63
Autoradiography 64
Cloning of EHV-1 Subtype 2 DNA 64
Ligation of EHV DNA into Plasmids 64
Transfection of Bacteria with Recombinant 
Plasmids 65
Analysis of Recombinant DNA Clones 66
Large-Scale Isolation of Plasmid DNA 67
The Preparation of Single-Stranded 
Template DNA for the Determination of DNA 
Sequences 68
DNA Sequencing Reactions 71
Preparation of DNA Sequencing Gels 72
Sequencing Gel Artefacts 74
Interpretation and Analysis of Sequencing
Data 74
CHAPTER 3: STUDIES ON THE STRUCTURE OF
THE EHV-1 SUBTYPE 2 GENOME 76-94
RESULTS 76
Introduction 76
Virus Growth and DNA Preparation 76
Electron Microscopy of EHV-1 DNA
Restriction Enzyme Patterns of EHV-1 DNA
Molecular Weights of Restriction Digest 
Fragments of EHV-1 Subtype 2 DNA
Hybridization Studies of EHV-1 Subtype 2 
DNA using Probes Isolated from Virion DNA
77
80
81
82
Cloning of the EHV-1 Subtype 2 Genome 
and Use of Clones in Mapping Studies
Hybridization Studies Using Cloned DNA
Restriction Endonuclease Double Digest 
Experiments
Derivation of the Restriction Endonuclease 
Map for the S Region of the EHV-1 
Subtype 2 Genome
Derivation of the Restriction Endonuclease 
Map for the L Segment of the EHV-1 
Subtype 2 Genome
DISCUSSION
84
85
85
86
89
93
CHAPTER 4; STUDIES ON THE LOCATION 
OF HOMOLOGOUS SEQUENCES IN THE 
GENOMES OF THE TWO SUBTYPES OF 
EHV-1 AND HSV-1
RESULTS
Introduction
95—108
95
95
The Location of Highly Conserved Genes
on the EHV-1 Subtype 2 Genome 96
Regions of Homology in the Genomes of the
Two Subtypes of EHV-1 97
Homologous Regions of EHV-1 and HSV-1
Genomes 98
DISCUSSION 101
CHAPTER 5; THE DNA SEQUENCE ANALYSIS
OF AN EHV-1 SUBTYPE 2 FRAGMENT CONTAINING
THE JUNCTION BETWEEN U_ AND TR„ 109-123
INTRODUCTION 109
RESULTS AND DISCUSSION 110
DNA Sequence Analysis 110
Location of the U^/TRg 112
ORFl 113
0RF2 114
0RF3 “ 116
0RF4 117
Reiterated Sequences 118
Comparison of Gene Arrangement in EHV-1
Subtype 2, HSV-1 and VZV 120
CHAPTER 6: GENERAL DISCUSSION 124-142
APPLICATION OF MOLECULAR ANALYSIS TO THE 
UNDERSTANDING AND CONTROL OF EHV-1
DISEASE IN THE HORSE 124
eeeeeences
TO ELEANOR, 
my best friend and mother.
ACKNOWLEDGEMENTS
I would like to acknowledge the generous sponsorship 
of the Horserace Betting Levy Board and to thank the 
following:-
Professor John H. Subak-Sharpe for giving me the 
opportunity to work in an Institute with such an excellent 
international reputation, and for his interest in, and 
overall supervision of this work.
Dr. Andrew J. Davison for his scientific guidance 
throughout this work and his valuable criticism of the 
manuscript. His speedy cooperation during the latter 
stages of preparing the manuscript was greatly appreciated.
Dr. Fraser J. Rixon for invaluable help with electron 
microscopy.
Mr. Jim Scott for assistance with sequencing gels.
Dr. Valerie Preston for always having the time to 
advise me on even the most trivial technical problems.
Dr. Howard Marsden and his wife, Moira for their 
hospitality and exceptional kindness towards me during the 
initial stages of writing this manuscript.
The members of the service department of the 
Institute of Virology for furnishing supplies of media, 
clean glassware and chemicals.
The many members of the Institute of Virology who were 
kindly and encouraging.
Mr. Martin Crawshay of the Horserace Betting Levy 
Board for his interest in my work and for his generosity 
with his time and advice.
Mr. John Fuller for doing such a fine Job on the 
figures and for always being so patient and calm.
Mr. Mark Lee who despite being very busy obliged me by 
taking the photographs.
My father for his- interest in my work and invaluable 
encouragement and support throughout the years.
Lastly, words cannot express the depth of the gratitude 
I feel towards my mother. She worked unceasingly 
throughout the summer typing this manuscript, proofreading 
and checking references. It was she who loyally supported 
me in every crisis and inspired me with the determination 
to continue. Without her constant love, interest and 
encouragement this work would never have reached 
completion.
During this work the author was supported by a 
Horserace Betting Levy Board Veterinary Research 
Scholarship. Unless otherwise specified, all the 
results reported were obtained by the author's own efforts.
SUMMARY
Equine herpesvirus type—1 (EHV-1), a member of the
Alphaherpesvirinae. is a major cause of abortion and 
respiratory disease in horses worldwide. It is also 
associated with a neurological syndrome, neonatal foal 
disease and more rarely, coital exanthema. Collectively, 
these diseases represent a significant economic loss to the 
thoroughbred industry each year. Two antigenically and 
genetically distinct subtypes of EHV-1 exist. They can be 
unequivocally differentiated by restriction endonuclease 
analysis of their DMAs. Molecular epizootiological studies 
in America and Australia indicate that both subtypes of 
EHV-1 are respiratory pathogens with the potential to cause 
abortion, but only subtype 1 has been associated with 
abortion storms and the neurological form of the disease. 
Most of the molecular data published concern the subtype 1 
virus.
At the onset of this project the genome of EHV-1 
subtype 2 was totally uncharacterized. This was probably 
due in part to the original misconception that it was 
identical to EHV-1 subtype 1 and in part to the relative 
difficulty of growing this virus to a high titre in tissue 
culture. The purpose of this work was to determine whether 
the two subtypes of EHV-1 shared a common genome structure, 
to construct the first restriction endonuclease maps for 
EHV-1 subtype 2 and to investigate the homology between 
this virus and other members of the Alphaherpesvirinae by 
molecular hybridization and DNA sequence analysis.
Electron microscopy of EHV-1 subtype 2 DNA which had
been denatured and self-annealed indicated that a sequence 
of llkbp approximately at one genome terminus is repeated 
in inverse orientation at one internal site. The inverted 
repeats were shown to be separated by a unique sequence of 
approximately 13kbp. The presence of repeated sequence 
within the EHV-1 subtype 2 genome was confirmed by 
hybridization studies using DNA probes isolated from virion 
DNA. A library of plasmid clones containing Eaifl HI 
fragments representing approximately 75% of the genome was 
prepared, and the clones were then used to derive ESJB HI 
and Ecü RI restriction endonuclease maps for EHV-1 subtype 
2 DNA. The results show that the EHV-1 subtype 2 genome 
consists of two segments, L (lllkbp) and S (35kbp). The S 
component consists of a unique sequence (U^ ,; 9,6kpb - 
16kbp) flanked by inverted repeats (TRg and IR^ ,; 9.5kbp - 
12.7kbp). Published data indicate that the EHV-1 subtype 1 
genome has a similar structure. However, the maps for the 
two subtypes are quite different. Eco RI and EaiD HI cleave 
within the TR^/IR^, and so it was not possible to determine 
whether Ug inverts relative to the L region, as it does in 
subtype 1.
HSV-1 DNA fragments containing coding sequences for 
genes which have been shown previously to be well-conserved 
in the alphaherpesviruses were hybridized to EHV-1 subtype 
2 DNA. Thus, the regions of the EHV-1 subtype 2 genome 
homologous to probes for the HSV-1 genes encoding the 
ribonucleotide reductase, the major capsid protein, the 
major DNA-binding protein and the immediate early protein 
V^^IE175 were identified. Cloned DNA fragments of EHV-1
subtype 2 were used in comparative hybridization 
experiments to further determine the extent and 
distribution of homologous sequences in the genomes of both 
subtypes of EHV-1 and HSV-1. Regions of detectable 
homology are arranged colinearly along the genomes 
suggesting that the three viruses share a common gene 
arrangement. These results imply that it should be 
possible to predict the locations of most EHV-1 subtype 2 
genes on the basis of our existing knowledge of HSV-1 gene 
location and function.
Published data indicate that the S segment is the 
least related region in the genomes of several members of 
the Alphaherpesvirinae and that the TRg/Ug and IRg/Ug 
junctions have altered in location, relative to adjacent 
genes, during evolution. To elucidate the nature of the 
genes near the EHV-1 subtype 2 TRg/Ug junction, the DNA 
sequence of a 4.57kbp Eam HI fragment was determined using 
the Sanger chain terminating dideoxynucleotide method. The 
junction was located within a lOObp region by using several 
M13 clones in a hybridization study, indicating that 
TRg/IRg and are approximately lO.Qkbp and 13.1kbp in 
size respectively. The G+C content of the TR^ portion of 
the fragment is approximately 17% greater that that of the 
Ug portion. An 8bp sequence is tandemly repeated within 
the TRg. Analysis of the sequence showed that Bam HI 1 
contains two complete open reading frames and the parts of 
two others. The amino acid sequences of predicted EHV-1 
subtype 2 proteins were compared with those coded by the S 
segments of VZV and HSV-1. Homologues of the four EHV-1
genes were detected in both HSV-1 and VZV. The EHV-1 genes 
and the TR_/U^ junction have an arrangement intermediate 
between that of their HSV-1 and VZV counterparts. One of 
the EHV-1 subtype 2 genes apparently encodes a 
glycoprotein.
ABEEEVIAIIQNS
A adenine-containing moiety or alanine
ACV acyclovir
Ala alanine
Arg arginine
Asn asparagine
Asp aspartate
ATP adenosine triphosphate
BHK baby hamster kidney cells
BHV-1 bovine herpesvirus type 1
BHV-2 bovine herpesvirus type 2
BHV-4 bovine herpesvirus type 4
BMV bovine mammilitis virus
bp base pairs
C cytosine-containing moiety or cysteine
CCV channel catfish virus
CMV cytomegalovirus
c.p.e. cytopathic effect
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DNase deoxyribonuclease
E glutamate
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EHV-2
EHV-3
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G+C content
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GPCMV
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HCMV
His
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HSV-1
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HVPan
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HVS
I
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H e
K
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KB
bovine embryo tracheal cells 
Epstein-Barr virus
ethylenediamine tetra-acetic acid 
equine herpesvirus type 1 
equine herpesvirus type 2 
equine herpesvirus type 3 
phenylalanine
guanine-containing moiety or glycine
moles per cent deoxyguanosine plus 
deoxycytidine moieties
glutamine
glutamate
glycine
guinea pig cytomegalovirus 
histidine
human cytomegalovirus 
histidine
herpes simplex virus
herpes simplex virus type 1
herpes simplex virus type 2
herpesvirus pan
herpesvirus papio
herpesvirus saimiri
isoleucine
immediate early
isoleucine
lysine
kilobases
human carcinoma cells
kbp
L
Leu
Lys
M
MCP
MDBP
MDV
Met
min
m. 0.1.
ulRNA
N
n
NBL-6
NP40
oz
P
PAA
Phe
PK(15>
Pro
PRV
Q
R
RNase 
r . p. m. 
RK13 
S
kilobase pairs
leucine
leucine
lysine
methionine
major capsid protein 
major DNA-binding protein 
Marek's disease virus 
methionine 
minutes
multiplicity of infection 
messenger RNA 
asparagine 
nucleotides
equine dermal cell line
Nonidet P40
ounces
proline
phosphonoacetic acid
phenylalanine
pig kidney cell line
proline
pseudorabies virus 
glutamine
purine or arginine 
ribonuclease 
revolutions per minute 
rabbit kidney cell line 
serine
SDS
sec
Ser
SHELUT 
SV4 0 
T
TK
Thr
Trp
ts
Tyr
UV
V
Val
vol/vol 
VZV 
vrt / vol
V
V
sodium dodecyl sulphate
seconds
serine
SV40-transformed sheep lung fibroblasts 
simian virus 40
thymidine-containing moiety or threonine
thymidine kinase
threonine
tryptophan
temperature-sensitive
tyrosine
ultraviolet
valine
valine
volume/volume 
varicella-zoster virus 
weight/volume 
tryptophane 
tyrosine
Abbreviations for media and solutions are given in the 
Materials
CHAPTER 1
i n t r o d u c t i o n :
— 1 —
THE FAMILY HERPESVIRIDAE
Ge ne ral .Desarlptlan
Herpesviruses are highly disseminated throughout the 
world. Approximately eighty members of the family 
Herpesviridae are currently recognized (Roizman, 1982), and 
these have been isolated from a wide range of hosts 
including fish (e.g. channel catfish virus, Volf and 
Darlington, 1971), reptiles (e.g. green iguana virus,
Zeigel and Clark, 1972), birds (e.g. pigeon herpesvirus 1; 
Cornwell gi ab. , 1970) and many mammaIs including monkeys,
apes and man (Nahmias, 1972; Barahona gi âJL* » 1974).
There are five human herpesviruses, herpes simplex virus 
type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),
varicella-zoster virus (VZV), Epstein-Barr virus (EBV) and 
human cytomegalovirus (HCMV). Herpesviruses cause several 
economically important diseases in domestic animals. For 
example, pseudorabies virus (PRV) causes Aujeszky's disease 
in swine, bovine herpesvirus 1 (BHV-1) is the aetiological
agent of infectious bovine rhinotracheitis and equine 
herpesvirus 1 (EHV-1) is a major cause of abortion and
respiratory disease in horses.
Clinical manifestations of herpesvirus infection range 
from inapparent infection, to localized disease and to 
fatal systemic illness. Some herpesviruses are associated 
with neoplastic disease in their natural host. For 
example, Lucke virus causes renal adenocarcinoma in the 
frog (Graven, 1971), Mareks disease virus (MDV) induces
— 2 —
transformation of lymphoblastoid cells in chickens 
(Churchill and Biggs, 1968) and EBV is clearly involved in 
Burkitt's lymphoma in humans (Epstein et 
al.. 1964; Klein, 1979). Herpesviruses are able to
persist in a latent form after primary infection, and then 
may reactivate to cause additional, and often recurrent, 
episodes of disease during the lifetime of the host.
Members of the family Herpesviridae have been 
classified on the basis of morphology and cytopathology 
(Matthews, 1979, 1982). The herpesvirion comprises four
major structural elements; the core, capsid, tegument and 
envelope. The nucleocapsid consists of an internal DNA- 
containing core surrounded by an icosahedral capsid. The 
amorphous material arranged around the nucleocapsid is 
known as the tegument, and the entire structure is 
surrounded by a lipid envelope containing glycoproteins 
(Vildy g± aJL- , 1960; Roizman and Furlong, 1974).
Despite these morphological similarities herpesviruses 
show an immense diversity of biological properties and do 
not lend themselves readily to subclassification. However, 
attempts have been made to subdivide the family 
Herpesviridae on the basis of biological properties 
(Barahona gji ,1974; Honess and Watson, 1977; Roizman 
ei aJL. , 1981) and, to a limited degree on the basis of
genome structure (Roizman al. , 1981; Roizman, 1982).
-  3 -
Subclasslfication of Herp&svlru££S_QH_t.li£_Ea£lS-Ql-
Subclassification on the basis of host range, 
cytopathology, duration of reproductive cycle and 
characteristics of latent infection has led to the 
definition of three subfamilies: the Alphaherpesvirinae .
Betaherpesvirinae and Gammaherpesvlrlnae (Roizman gi al., 
1981; Roizman, 1982; Honess, 1984).
The Alphaherpesvirinae have a variable host range :
L n  vitro. Their reproductive cycle is 
relatively short and they spread rapidly in tissue culture 
with mass destruction of infected cells. Clinically, these 
viruses can cause serious generalized disease in the 
newborn or immunocompromised adult. The more typical 
syndrome is a mild infection of the skin, genitalia, or 
respiratory tract. Latency, usually in the neurons of the 
ganglia, is a common sequela to primary infection (Vildy gi 
al. , 1982). Members of this group include HSV-1, HSV-2,
VZV, PRV, EHV-1 and bovine herpesvirus type 2 (BHV-2).
The Betaherpesvirinae or cytomegaloviruses are 
species-specific In vivo and in vitro (Vright, 1973).
Even in these cells they have a relatively long 
reproductive cycle. Infected cells often become enlarged 
(cytomegalia) and persistently infected cell cultures are 
readily established. In normal adults infection is usually 
subclinical but generalized disease may occur in neonates 
or immunocompromised adults. Transplacental transmission 
of many of these viruses may result in congenital
-  4 -
malformations. Sites of persistence include secretory 
glands, lymphoreticular cells, kidneys and other tissues. 
Members of the Betaherpesvirinae include human 
cytomegalovirus (HCMV) and equine herpesvirus 2 (EHV-2).
The Gammaherpesvirinae are specific either for B 
lymphocytes (e.g. EBV, belonging to the «y ^  subgroup) or T 
lymphocytes (e.g. Herpesvirus saimiri (HVS), belonging to 
the 2 subgroup). Several of these viruses cause 
lymphoproliferative diseases. All members of this 
subfamily are able to replicate in lymphoblastoid cells in 
vitro and some are able to grow in epithelial cells and 
fibroblasts. Latent virus is commonly detected in host 
lymphoid tissue.
SubcLasslfication■of Herpesviruses on_ the Basis of Genome
Despite the generally convincing concordance of 
biological characteristics displayed by members of each 
subfamily, it must be noted that this is a subjective 
classification based on an assessment of a multitude of 
complex properties. In some cases the assignment of a 
virus to a particular group is equivocal. Bovine 
herpesvirus 4 (BHV-4) has a long replicative cycle, is 
enveloped primarily by budding on smooth cytoplasmic 
membranes of Golgi body elements and gives rise to the 
formation of cytoplasmic inclusions. On this basis it was 
classified as a cytomegalovirus (Storz ei ai-, 1984). 
However, the BHV-4 genome is 144kbp in size and has 
polyrepetitive DNA segments at both termini. This bears 
closer resemblance to the genome of the lymphotropic virus
-  5 “
HVS, a member of the than to the
cytomegaloviruses (Ehlers g±. al- . 1985). Furthermore, the
recently identified thymidine kinase induced by BHV-4 (Kit 
g.t a l-  , 1985) provides another similarity between HVS and
BHV-4 absent from HCMV, Such anomalies have stimulated 
subclassification by criteria other than biological 
properties.
Subclassification on the basis of genome structure 
depends on the arrangement within the genome of reiterated 
DNA sequences of at least lOObp (Roizman, 1982). Although 
the majority of herpesviruses can be classified according 
to biological properties, only a minority have been 
characterized sufficiently to group them by this criterion. 
The human pathogen, HSV-1, is the type species of the 
Herpesviridae (Fenner, 1976), and was also the first 
herpesvirus whose genome structure was analysed in detail. 
Thus, an account of the types of herpesvirus genome 
structure will be preceded by a description of the HSV-1 
genome, with occasional reference to HSV-2.
Stnug.tuiie-_Ql_He.Epe.s DNA
The genome of HSV-1, like that of all herpesviruses 
studied to date consists of a linear, double-stranded DNA 
molecule (Ben-Porat and Kaplan, 1962; Russell and 
Crawford, 1963; Becker g±. al. , 1968). The molecular
weight of HSV DNA is approximately 1 x 10^ as determined by 
electron microscopy, sedimentation velocity and restriction 
endonuclease analyses (Becker gt a l .  , 1968; Kieff gt a l .  ,
1971; Vilkie, 1973; Grafstrom gt a l .  , 1974; Wadsworth gt
al. , 1975; Clements gt al* » 1976; Vilkie, 1976; Skare 
and Summers, 1977). The genome has a nucleotide 
composition of 67% G+C (Russell and Crawford, 1963; Kieff 
gt a l * , 1971). HSV DNA sediments homogeneously on a
neutral sucrose gradient but heterogeneously on an alkaline 
gradient (Kieff gt a l * , 1971). This alkali sensitivity of
the DNA has been ascribed by some to single strand 
interruptions (Frenkel and Roizman, 1972a; Vilkie 1973; 
Ecker and Hyman, 1981) and by others to covalently bound 
ribonucleotides (Hirsch and Vonka, 1974; Muller gt a l . , 
1979).
The outstanding paper in the elucidation of the 
structural organisation of the HSV-1 genome was undoubtedly 
that of Sheldrick and Berthelot (1974). Using electron 
microscopy, they demonstrated that single strands of HSV-1 
DNA could fold back on themselves to form dumb-bell shaped 
structures (C2) consisting of two single-stranded circles 
joined by an extensive and highly homologous double­
stranded region. A diagrammatic representation of a C2 
molecule is shown in Figure 1.1a. For this structure to 
arise from a linear precursor, two sets of inverted 
repetitions must be present in the genome. The presence 
of "tails" in the duplex region of several C2 molecules and 
the scrutiny of molecules consisting of a single circle and 
duplex suggested that the genome termini resided near the 
middle of the duplex. Annealing of HSV-1 DNA treated with 
exonuclease III resulted in circular duplex molecules, 
indicating the presence of a directly, repeated sequence at 
the genome termini. These three important observations, as
Figure 1.1
a. The dumbell shaped structure (C2) observed by 
electron microscopy of self-annealed HSV DNA 
Sheldrick and Berthelot, 1974). TR^ = b + a, IR^
= b' + a', TRg = c + a, IRg = c' + a' ,
b. Structural arrangement of the HSV-1 genome comprising 
two unique sequences and Ug bounded by
inverted repetitions TR^, IR^, TRg, and IRg.
Sequence a represents the terminal repetition.
c. The four permutations of sequence arrangement of HSV- 
1 DMA. The four arrangements have been designated
P , 1^ , Ig and Ig^ (Roizman g.t al- , 1979) depending on
the orientation of the and Ug. Restriction maps 
of HSV DMA are conventionally displayed in the P 
arrangement. Both and Ug are found in two 
orientations which occur with equal frequency. As a 
consequence of this inversion a restriction enzyme 
which cleaves only in the U^ and Ug will generate 
four quarter molar fragments (a+b, c+b, a+d and c+d), 
and the genome termini will form half molar fragments,
b.
TRl Ul irl irs Us trs
a b
a b
b à c ca
b a c ca
a+b
c+b
•s
a+d
c+d
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well as others, were used to propose the following model 
for the genome structure of HSV. In summary, the DNA 
molecule consists of a long unique sequence (U^) bracketed 
by inverted repeat sequences (IR^ and TR^), linked to a 
short unique sequence (U^ ,) flanked by a_ second pair of 
inverted repeat sequences (IRg and TRg), This arrangement 
is shown in Figure 1.1b. Consideration of this model 
suggested that inter- or intra-molecular recombination 
could result in inversion of the L (TR^ + + IR^> and 8
(TRg + Ug + IRg) components to generate four isomeric forms 
of virion DNA (Sheldrick and Berthelot, 1974). This 
possibility was confirmed by partial dénaturation mapping 
(Delius and Clements, 1976). Restriction endonuclease 
analysis confirmed the genome structure and demonstrated 
that the four isomers are of equal abundance in virion DNA 
(Hayward o t  gJL. , 1975; Clements êi , 1976; Vilkie and
Cortini, 1976). Gel electrophoresis of HSV-1 DNA digested 
completely with certain restriction endonucleases resulted 
in the visualisation of 0.5M and 0.25M fragments. The size 
of the fragments generated by an enzyme which cleaves only 
in the unique sequences depends on the orientation of those 
sequences. Figure 1.1c illustrates four 0.25M fragments 
spanning the L-S junction a+b, c+b, a+d and c+d. As a 
consequence of inversion these are generated by digestion 
with a hypothetical enzyme which cleaves in the U_ and the 
U^. Similarly four 0.5M fragments are generated from the 
termini. The four genome arrangements of HSV have been 
designated P (prototype), I (L inverted), (S inverted)
&iid Ig^ (L and S inverted) (Roizman at , 1979).
— 8 —
Sheldrick and Berthelot, (1974) proposed that TR^/IR^
and TR_/IR_ were identical, but further electron o o
microscopic analysis showed that the two sets of inverted
repeats differ in size and in partial dénaturation profile
(Wadsworth et. ai-, 1975; Delius and Clements, 1976). This
was confirmed by the observation that certain restriction
endonucleases cleave only within one set of inverted
repeats (Hayward ei aJL- » 1975; Clements ei aT. , 1976;
Vilkie and Cortini, 1976). TR /IR are subdefined as a'c'o o
and ca in Figure 1.1b and TR^/IR^ as ab and b'a' (Wadsworth 
et a l ' , 1975). The a sequence is present as a direct
repeat at the genome termini and in inverse orientation at 
the L-S junction. A variable number of a sequences is 
present at the L-S joint and L terminus (Wilkie 1976;
Wilkie e.t a l .  , 1977; Wagner and Summers, 1978). The size
of the HSV-1 a sequence was estimated to be 400 to 600bp by 
electron microscopy (Grafstrom ei a l . , 1975; Wadsworth ei
a l - , 1976; Kudler and Hyman 1979) and 265bp by restriction
endonuclease mapping (Wagner and Summers, 1978). Davison 
and Wilkie (1981) determined the nucleotide sequence of the 
a sequence of HSV-1 and HSV-2 and found they had 
approximate sizes of 400bp and 250bp, respectively.
However, heterogeneity of size is characteristic of the 
HSV-1 a sequence and appears to be due to variability in 
the copy number of a tandemly reiterated G+C-rich sequence 
within the a sequence (Wagner and Summers, 1978; Davison 
and Wilkie, 1981). The a sequence has been reported to 
play a major role in the inversion of the L and S 
components (Mocarski and Roizman, 1982) and in
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encapsicïation of DNA (Stow et al.. , 1983).
HSV-2 has a G+C content of 69% (Goodheart et al.,
1968; Kieff et al., 1971, Halliburton, 1972), and
approximately 50% of its genome is homologous to HSV-1 DNA 
(Kieff si al.» 1972). The HSV-2 genome structure is the
same as that of HSV-1 (Hayward si al.» 1975; Skare si al.,
1975; Cortini and Vilkie, 1978) and the two viruses have a 
col inear gene arrangement (Esparaza et al. , 1976, Davison
and Vilkie, 1983). The substantial differences between the 
HSV-1 and HSV-2 restriction endonuclease maps is of 
diagnostic value in determining the subtype of an HSV 
isolate (Lonsdale, 1979).
This genome type has a single direct repeat at each 
terminus. The group is exemplified by the channel catfish 
herpesvirus (CCV), the genome of which is illustrated in 
Figure 1.2 (Chousterman e±. al. , 1979).
As in Group A, group B genomes are characterized by 
terminal redundancy. The two groups differ in that 
redundant regions in the latter are composed of multiple 
reiterations of one set of sequences (Figure 1.2). 
Structural analysis of the genomes of three oncogenic 
kerpesviruses of nonhuman primates, HVS, herpesvirus ateles 
and herpesvirus aotus type 2 has shown that they belong to 
this group (Bornkamm al. , 1976; Fleckenstein gi al. ,
1978; Fuchs et al., 1985). In each case the genome
consists of a unique A+T-rich llOkbp sequence flanked by
Figure 1.2
Saqjj.e.iisLe._Ani:aiig:êjBe.iii.&_lii_He.i:pe.s.vinu.£_jQNAs
Herpesviruses can be sub-classified into different 
groups on the basis of their genome structure. The groups 
A, B, C, D and E are represented by chanel catfish 
herpesvirus (CCV), herpesvirus saimiri (HVS) , Epstein-Barr 
virus (EBV), pseudorabies virus (PRV) and herpes simplex 
virus (HSV) respectively. While most of the herpesvirus 
DNAs studied to date fall into one of these groups this is 
not true of a number of the cytomegaloviruses such as 
guinea pig cytomegalovirus (GPCMV) and equine 
cytomegalovirus (EHV-2).
In this schematic diagram the horizontal lines 
represent unique sequences. Where appropriate the 
observed orientations of the and Ug are indicated by 
arrowheads. Repeat sequences larger than Ikbp in length, 
other than terminal reiterations, are shown as dot-filled 
rectangles. The arrows above these rectangles indicate 
the orientation of the repeat sequences. The vertical 
lines and letters a^ and b^ signify multiple tandem repeat 
sequences. The letters a, b, c have also been used to 
denote the orientation of repeat sequences and their 
complements a' , b' , c' . The use of these letters does not 
imply homology between different herpesviruses. Numbers 
above the lines represent molecular weight (x 10^). The 
numbers above the vertical lines refer to a unit length of 
the reiterated sequence.
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repetitive G+C-rich sequences. Restriction endonuclease 
cleavage patterns of the terminal repeats of HSV and 
herpesvirus ateles indicate that these regions are composed 
of identical tandemly repeated sequences of approximately 
1. 4kbp and l.Skbp, respectively (Bornkamm s.iL âh. , 1976;
Fleckenstein aiL. , 1978; Fleckenstein and Desrosiers,
1982). The reiterations of herpesvirus aotus are more 
variable. Analyses with restriction enzymes indicates the 
existence of two types of unit, one 2.Ikbp and one 2.3kbp 
in size, which share at least 1.3kbp of identical DNA 
sequence. The repeat units are arranged in tandem and 
appear to be random in order (Fuchs e.t. al. , 1985). HVS,
herpesvirus ateles and herpesvirus aotus type 2 all show 
genomic size heterogeneity due to variability in the number 
of reiterated H-units (Bornkamm e.t a l .  , 1976; Fleckenstein
a t  a l .  , 1978; Fuchs a t  a l .  , 1985). Isopycnic
centrifugation of intact DNA demonstrated that a population 
of any of these three viruses contains a minority of 
defective genomes comprising reiterations of the terminal 
repeat unit. Their lack of infectivity corresponds to 
their low genetic complexity (Bornkamm a t  a l  1976; 
Fleckenstein a t  a l . , 1978; Fuchs a t  a l - . 1985).
Bovine cytomegalovirus is the first non-primate herpes 
virus reported to possess a genome structure similar to 
those of the viruses discussed above (Ehlers a t  a l . , 1985).
Tandemly repeated DNA sequences are present at both genome 
termini and amount to 20 to 25% of the 144kbp genome.
iii) SnQup-.C
This group is exemplified by EBV, which has tandemly
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reiterated sequences in direct orientation at the genomic 
termini and a different set of internal tandem reiterations 
(Figure 1.2). Three primate p-lymphotropic viruses, EBV, 
herpesvirus papio (HVPapio) and herpesvirus pan (HVPan), 
exhibit this type of genome structure (Dambaugh et aJL. ,
1980; Heller and Kieff, 1981; Heller ei al., 1981,
1982a). Of the three, the genome of EBV is the best 
characterized. The DNA is approximately 180kbp in size and 
consists of two regions of unique sequences and Ug 
separated by a direct internal repeat region, IRl. As in 
group B, both ends of the DNA contain a variable number of 
direct, tandem repeats (TR). The TR is 500bp and there are 
usually 4 - 8  copies per terminus. The internal 
reiteration, IRl, is 3,071bp in size and variable in copy 
number (Given and Kieff, 1979; Cheung and Kieff, 1982). 
Other features of the EBV genome include two partially 
homologous sequences designated DL and DR, near the left 
and right ends of (Raab-Traub e±. al- , 1980) . D^ ^
contains 11 to 14 repeats of a 124bp sequence designated 
IR2. DR contains approximately 30 reiterations of a 
related 103bp sequence designated IR4 (Dambaugh and Kieff, 
1982). Another repeat sequence, IR3, composed of only 
three nucleotide triplet elements is located between IR2 
and IR4 (Heller g.t. ah. , 1982b). The determination of the
complete DNA sequence of the B95-8 strain of EBV revealed 
the existence of other repetitive sequences scattered 
throughout the genome (Baer al* » 1984).
HVPapio and HVPan DNA are approximately 40% homologous 
to EBV DNA (Falk ejk aT. , 1976; Gerber et al. , 1976) and
- 12 -
the size and organization of their DNA is similar to that 
of EBV (Heller and Kieff, 1981; Heller gt. gJL. , 1982a).
There is extensive homology among the IBs of the three 
viruses and the duplicated DL and DR regions are conserved. 
No homology is detected, however, among the TRs (Heller and 
Kieff, 1981; Heller at. al. , 1982a).
iv) Group D
The genomes of group D herpesviruses such as PRV, EHV- 
1 subtype 1, EHV-3 and BHV-1 consist of two regions, L and 
S. The unique sequence of S (Ug) is bracketed by inverted 
repeat sequences (IRg and TRg). The S component inverts 
relative to the L component which consists of a unique 
sequence in a fixed orientation. The genome structure of 
PRV is shown in Figure 1.2. Electron microscopic 
examination of self-annealed single-stranded PRV DNA 
(Stevely, 1977; Ben-Porat ei a l*  , 1979), EHV-1 subtype 1
DNA (Ruyechan e± a l . , 1982), EHV-3 DNA (Atherton at a l . ,
1982) and VZV DNA (Ecker and Hyman, 1982) revealed 
structures consisting of single-stranded loops joined to a 
double-stranded region which terminates in a long single­
stranded tail. This is consistent with the repetition of 
DNA sequences at one terminus in inverse orientation within 
the genome. Evidence for the existence of two isomeric 
forms of these virus genomes comes from the existence of 
four 0.5M restriction digest fragments and the presence of 
three terminal fragments, two in 0.5M amounts, in some 
restriction digests. The S region inverts and yields two 
terminal fragments, whereas the L region produces only one
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terminal fragment as it is in a fixed orientation (Dumas 
al. , 1981; Henry ei. a l .  , 1981; Vhalley ei a l .  , 1981;
Atherton s i  a l . » 1982; Sullivan s i  a l . » 1984).
Restriction endonuclease maps were derived by enzyme and 
Southern hybridization analyses for the genome structure of 
EHV-1, subtype 1 (Vhalley s i  a l . , 1981; Henry s i  a l . ,
1981), EHV-3 (Sullivan s i  a l . , 1984), PRV (Powell, 1979),
VZV (Dumas s i  a l .  , 1981) and BHV-1 (Mayfield s i  a l .  , 1983).
Interestingly, unlike any other PRV strains that have been 
studied, the Norden vaccine strain has a Group E genome 
structure similar to that of HSV. Both the Ug and U^  ^
regions of the genome invert giving rise to four isomeric 
forms. This is most likely due to the fact that a DNA 
sequence found normally only at the end of U^ is also 
present in the inverted form next to the internal IRg of 
the Norden genome (Lomniczi et al., 1984). DNA sequence
analysis of the L-S joint and genome termini of VZV 
revealed that U^ is flanked by an inverted repeat of 
88.5bp, and hybridization studies indicated that 5% of VZV 
DNA molecules have an inverted L component (Davison, 1984). 
Thus, whereas the VZV genome could be regarded as a member 
of Group E described below, the size of the VZV IR^/TR^ is 
less than the minimum 100 nucleotides considered for 
classification purposes (Roizman, 1982).
This group is exemplified by the HSV genome, the 
structure of which has been discussed in some detail above. 
Electron microscopic studies, partial dénaturation mapping 
(Kilpatrick and Huang, 1977) and restriction endonuclease
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digestion and Southern hybridization analyses of cloned 
fragments of HCMV DNA (Spector gt. aJL« » 1982) showed that it
has a similar structure to HSV DNA, BHV-2 was the first 
non-human herpesvirus to be shown to be closely related to 
HSV. The antigenic relationship of these viruses was 
demonstrated by complement fixation, immunofluorescence and 
immunodiffusion tests while DNA-DNA hybridization analyses 
showed that they share about 14% sequence homology (Sterz 
et al., 1973/74). These findings stimulated interest in
BHV-2 DNA. Analysis of the genome structure demonstrated 
that, although smaller, BHV-2 DNA has a similar sequence 
arrangement to HSV (Buchman and Roizman 1978a,b). Group E 
also includes MDV (Fukuchi gi al., 1984) and herpesvirus
aotus types 1 and 3 (Ebeling gi &!_. , 1983a).
The genome structures of a number of 
cytomegaloviruses are not readily classified into any of 
the groups discussed above. The genomes of murine CMV 
(Mercer gt. a i-»  1983; Ebeling gt. a l - ,  1983b), guinea-pig 
CMV (Gao and Isom, 1984) and rat CMV (Meijer gt. a l-  » 1986) 
consist of a long unique sequence without invertible 
components or extensive repeated sequences (Figure 1.2). 
Preliminary data on the genome of EHV-2 DNA indicates that 
it contains inverted repeats at one terminus. At the other 
terminus there is a sequence which is directly repeated 
within the genome (Figure 1.2), There is no evidence to 
suggest that the EHV-2 genome exists in more than one 
isomeric form (O'Callaghan gt al. , 1984).
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THE PATHOGENESIS OF EQUINE HERPESVIRMSEg
Three antigenically distinct types of equine 
herpesvirus have long been recognized. These are equine 
herpesvirus type 1 (EHV-1), also known as equine abortion 
virus or equine rhinopneumonitis virus, equine herpesvirus 
type 2 (EHV-2) or equine cytomegalovirus (ECMV) and equine 
herpesvirus type 3 (EHV-3) or equine coital exanthema 
virus. There is now conclusive evidence that viruses 
currently classified as EHV-1 consist of two genetically 
and antigenically distinct subtypes. It has been suggested 
that one of these subtypes be renamed equine herpesvirus 
type 4 (EHV-4) (Studdert et al. , 1981), and it seems
probable that this change in nomenclature will be 
implemented by the Herpesvirus Study Group of the 
International Committee for the Nomenclature of Viruses.
The equine herpesviruses have recently been the subject of 
a number of comprehensive review articles (O'Callaghan et 
&1. , 1978; O'Callaghan gt at. , 1983; Campbell and
Studdert, 1983; Allen and Bryans, 1986). Viruses 
classified at present as EHV-1 cause considerable financial 
loss to the horse industry each year. They are a major 
cause of respiratory disease and abortion in horse 
populations throughout the world and are also associated 
with neonatal foal disease, neurological disease and coital 
exanthema (Kemen, 1975; O'Callaghan g t  a t . ,  1983). EHV-2, 
an antigenically heterogeneous group of viruses (Plummer 
ê.t a t-»  1969, 1973; Erasmus, 1970; Mumford and Thompson,
1978) is widely disseminated throughout the horse
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population. The virus has been isolated from a variety of 
equine tissues (Kono and Kobayash, 1964; Kemeny and 
Pearson, 1970; Studdert, 1974) but has not yet been 
implicated conclusively in any disease syndrome (Studdert, 
1974; Gleeson and Studdert, 1977; Burrell, 1985). Horses 
appear to be infected early in life, become persistent 
carriers and shed virus constantly (Studdert, 1974). EHV-3 
is the aetiological agent of a progenital disease known as 
equine coital exanthema. Systemic signs are uncommon. 
Lesions, which appear initially as papules and progress 
rapidly to pustules and ulcers, are usually confined to the 
penile and vulvar mucosa (Bryans and Allen, 1973;
Studdert, 1974) but may occur around the lips and nose 
(Krogsrud and Onstad, 1971). Breeding must cease for the 
duration of the disease.
Abortion Caused by EHV-1
Equine abortion of putative viral aetiology was first 
recorded in Kentucky in 1932, and the transmissibility of 
the filterable agent and pathological lesions of the 
aborted foetus were described soon afterwards (Dimock and 
Edwards, 1932, 1933, 1936; Dimock, 1940). In 1941,
JManninger and Csontos reported that pregnant mares 
inoculated with filtered material from aborted foetuses 
suffered a mild upper respiratory tract disease which was 
transmitted to in-contact animals. Their conclusion, that 
abortion is a sequel to respiratory tract infection, was 
confirmed by numerous other studies (Salyi, 1942;
Manninger, 1949; Hansen and Holst, 1950). In Kentucky,
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two viruses isolated from the respiratory tract, Army 183 
(Jones et al., 1948) and the Grayson I strain were shown to
induce similar pathological lesions to the Kentucky—A 
strain of equine abortion virus (Dimock and Edwards, 1933) 
on inoculation of Syrian hamsters (Doll et ad., 1953) or
equine foetuses (Doll and Kinter, 1954). In 1957, Doll ejt 
al. suggested that the agent previously described as equine 
abortion virus be regarded primarily as a respiratory virus 
of horses and be designated as equine rhinopneumonitis 
virus. Later electron miscroscopy identified the causal 
agent of equine rhinopneumonitis as a herpesvirus, and 
since that investigation it has been known as equine 
herpesvirus type 1 (Plummer and Vaterson, 1963).
EHV-1 is a major cause of both sporadic and epizootic 
abortion in horse populations throughout the world. In 
Kentucky, EHV-1 was shown to be responsible for an annual 
loss of 0.4 to 2.6% of foetuses (Bryans, 1981), and in the 
absence of equine arteritis virus (Mumford, 1985a), EHV-1 
is virtually the only known cause of epidemic abortion in 
mares in these islands at present. It is widely accepted 
that abortion occurs subsequent to a respiratory tract 
infection which may be subclinical or so mild as to go 
unnoticed by the mare's handlers. The incubation period is 
extremely variable under natural conditions, and 
experimental inoculation of pregnant mares by the 
intranasal, subcutaneous, intravenous or intramuscular 
route resulted in an incubation period varying from 14 to 
120 days (Doll and Bryans, 1962). A transient viraemia 
occurring after infection with abortigenic EHV-1 has been
Figure 1.3
EH¥-1. -Abarti an
Necropsy of an aborted foetus showing some of the 
classical lesions of EHV-1 infection;
Ca) splenomegaly with prominent lymph follicles, excess 
pleural fluid and Jaundice.
(b> necrotic foci in the liver.
The photographs were a kind gift of Dr. C. Vhitwell, 
The Equine Research Centre, Newmarket.
EHV-1 Abortion
Figure 1 3a
Figure 1 3 b
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well documented (Bryans, 1969; Bryans and Prlckett, 1969; 
Burrows and Goodridge, 1973; Gleeson and Coggins, 1980), 
but Infectious virus has not been detected in circulating 
leukocytes beyond the first 24 days after infection 
(Bryans, 1969). The period between natural respiratory 
infection and expulsion of the foetus ranges from 14 to 90 
days (Doll and Bryans, 1962), and the location of the virus 
for much of this period is unknown. An extra-foetal 
location is suggested as direct inoculation into the foetus 
or chorioallantoic sac results in abortion within 9 days.
The majority of abortions occur between the 8th and 
11th months of gestation (Doll and Bryans, 1963b). The 
mare usually aborts without premonitory signs, the foetal 
membranes are not retained, and the subsequent fertility of 
the mare is unaffected (Dimock, 1940), The pathological 
lesions depend on the age of the foetus (Prickett, 1970) 
and probably the degree of development of the foetal immune 
system. Foetuses aborted prior to the sixth month of 
gestation are severely autolyzed, and foetuses aborted 
between the seventh month and full term present the 
classical lesions described originally by Dimock gi aX- , 
(1942, 1947). The most prominent gross lesions are
jaundice, petechiation of mucous membranes, necrotic foci 
in the liver, splenomegaly with prominent lymph follicles, 
excess pleural fluid and marked oedema of the lungs. Some 
of these lesions are shown in Figure 1.3. The principal 
microscopic lesions are focal necrosis of spleen and liver, 
bronchiolitis and pneumonitis. Foetuses aborted during the 
6th or 7th months of gestation tend to show a mixture of
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general autolysis and local tissue reaction.
The cellular and humoral immune responses, to EHV-1 
are poorly understood. Mares with high levels of virus 
neutralizing antibody are susceptible to either natural or 
experimental reinfection of the respiratory mucosa, and may 
abort (Doll, 1961; Doll and Bryans, 1963b; Bryans, 1969). 
Bryans (1969) suggested that the reinfecting virus escapes 
neutralization by becoming situated intracellularly in 
leukocytes. However, the same study in Kentucky showed 
that mares with a serum virus neutralizing antibody titre 
of 2.0 or higher withstood challenge with EHV-1 by the 
natural route. This immunity to infection was not 
maintained when virus was inoculated parenterally. The
ability of EHV-1 to induce abortion in the presence of a 
high serum neutralizing antibody titre suggests that cell 
mediated immunity may play an important role in protection. 
Gerber ei aX. (1977) demonstrated that the cell-mediated 
immune response of mares in the latter stages of pregnancy 
was suppressed. However, although this is the stage in 
gestation when 95% of EHV-1 abortions occur, Dutta and 
Campbell (1977) found no significant difference in the 
stimulating index of lymphocytes from mares which suffered 
EHV-1 abortion and those which foaled normally. While the 
immune response elicited by abortion is more protective 
than that stimulated by EHV-1 respiratory disease it tends 
to be variable (Doll, 1961). Most mares do not abort as a 
result of EHV-1 infection more than once in their lifetime 
but animals have been known to abort in consecutive 
pregnancies (Doll and Bryans, 1962) or after an interval of
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2 years or longer (Doll, 1961).
Respiratory Disease Caused by EHV-1
Several European studies which suggested that equine 
abortion virus was a pneumotropic virus (Manninger and 
Csontos, 1941; Manninger, 1949; Hansen and Holst, 1950) 
prompted Doll gt gX. (1954) to investigate the pathogenesis 
of EHV-1 in young horses. On experimental inoculation of 
weanling horses, the virus caused mild respiratory catarrh, 
fever and leukopenia. Serological surveys indicated that 
EHV-1 was the aetiological agent of an annual epizootic 
rhinitis in young horses in Kentucky. EHV-1 has since been 
shown to be the major cause of acute upper respiratory 
tract disease in young horses worldwide (Studdert, 1974). 
Clinical disease is most prevalent in horses under 2 years 
of age, and infection of perinatal foals may lead to a 
fatal bronchopneumonia (Bryans, 1969). The common clinical 
manifestations of EHV-1 respiratory infection in a 
susceptible animal are anorexia, fever, serous nasal 
discharge (Figure 1.4), coughing, enlarged intermandibular 
and parapharyngeal lymph nodes and congestion of the 
conjunctivae (Doll gt al. , 1954; Coggins, 1979). Coughing
is a less prominent feature of the disease than with 
influenza while the nasal discharge tends to be more 
copious (Powell, 1975). While recovery is usually 
uneventful the disease is sometimes complicated by 
secondary bacterial infection (Figure, 1.4) often with 
streptococci of Lancefield group C (Studdert, 1974).
Once maternal antibodies have waned, usually at 3-4 
months of age (Bagust et a_l. , 1972), the immune response
Figure 1.4 
EHV-1 Respiratory Disease
a. Horse with serous nasal discharge typical of acute 
virus infection of the upper respiratory tract.
b. Purulent discharge indicative of secondary bacterial 
infection.
Photographs were a kind gift of Dr. D, Onions, Glasgow 
Veterinary School.
EHV-1 Respiratory Disease
Figure 14a
£
Figure T4b
—• 21 —
elicited by respiratory infection with EHV-1 is short-lived 
and horses may be reinfected every 3 or 4 months (Doll,
1961; Doll and Bryans, 1963b), Consecutive infections do 
appear to induce some measure of protection, however, as 
clinical signs of the disease are seldom seen in the older 
animal. It is thought that mild and subclinical infections 
and the resulting inappetance may play a role in the "poor 
performance" syndrome in racehorses (Mumford and Rossdale, 
1980; Strickland, 1986; Powell, 1986). The virus is 
highly contagious, and when a susceptible population is 
exposed disease spread may be very rapid. Such a situation 
occurs commonly at weaning when young stressed animals are 
often grouped together in close proximity for the first 
time (Doll and Bryans, 1963b), In young horses in 
training, serial infections of different animals can cause 
a yard to lose an entire racing season. In 30 training 
stables in 6 areas of England surveyed from 1971-1976, only 
2 were completely free of respiratory disease for 12 
months. EHV-1 was involved in approximately 45% of 
outbreaks of respiratory disease investigated in this 
survey (Powell gi al,, 1978).
The first definitive account of EHV-1 neurological 
disease was by Saxegaard (1966), who isolated the virus 
from the tissues of two adult male horses which had shown 
serious nervous symptoms. Since then this syndrome has 
been recorded worldwide in horses of all ages and both 
sexes (Dinter and Klingeborne, 1976; Collins, 1972;
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Greenwood and Simpson, 1980; Bartra gi al.. , 1982) and the
disease has been induced experimentally (Jackson gt aJL* , 
1977; Mumford and Edington, 1980), Three years ago an 
outbreak of EHV-1 neurological disease among the Lippizaner 
horses in Fiber, Austria received international media 
coverage. The syndrome has been associated both with 
abortion and outbreaks of respiratory disease. The 
clinical signs vary with the severity of the case, and may 
include inco-ordination, ataxia, weakness, incontinence and 
posterior paralysis. Severe cases become laterally 
recumbent and either die or necessitate euthanasia. The 
prognosis for non-recumbent animals is usually favourable 
and although a period of months may be required for a 
complete return to normal, recovered horses have won races 
(Little and Thorsen, 1976).
Gross lesions tend to be minimal at necropsy, while 
the histopathological changes vary with the severity of the 
disease. A vasculitis of the smaller arteries and veins of 
the central nervous system with associated malacia is 
common to all cases. The vasculitis is characterized by 
necrosis of the endothelium, often with concomitant 
thrombosis. The cellular response to endothelial necrosis 
is manifested as a perivascular cuffing of inflammatory 
cells; initially neutrophils and later, lymphocytes 
(Jackson gfc. slL. , 1977). Other lesions range from minimal
gliosis and neuronal degeneration associated with foci of 
malacia in the brain and spinal cord (Jackson and Kendrick,
1971) to severe disseminated meningoencephalitis (Charlton 
et ai*, 1976). While virus has been recovered from a
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variety of organs at necropsy, including the brain and 
spinal cord (Saxegaard, 1966; Mumford and Edington, 1980), 
efforts to isolate virus are not always successful (Platt 
at ai., 1980).
Unlike many other herpesviruses, such as HSV, BHV-1 
and PRV, EHV-1 does not appear to be neurotropic (Jackson 
a t  a i . , 1977). There is no evidence that the virus infects
neuronal cells and the neurological signs evident in the 
affected animal appear to be a consequence of ischaemia, 
malacia and inflammation of nervous tissue subsequent to a 
disruption in the cerebrospinal blood supply. EHV-1 
antigen has been demonstrated in the vascular endothelial 
cells (Patel gt ai. , 1982; Edington gt ai. , 1986) thus
supporting the observation made by Dinter and Klingeborn 
(1976) that EHV-1 paralysis may be an immune complex 
mediated disease. Experimental EHV-1 infection of ponies 
resulted in a hypocomplementemia, a characteristic of 
several virus diseases where immune complexes play a role 
in the pathogenesis (Snyder gt a i . , 1981). The suggestion
that the pathogenesis of the neurological syndrome was 
immunologically based prompted Greenwood and Simson (1980) 
to attempt corticosteroid therapy on affected cases in 
Newmarket. Treatment was unfortunately initiated too late 
in the outbreak to assess its efficacy. Recently HSV-1 IgM 
immune complexes were detected by immunofluorescence in the 
brain of a human patient with herpes encephalitis, 
Histopathologically, perivascular cuffing composed mostly 
of T lymphocytes were prominent in various parts of the 
brain. It was suggested that the immune complexes played a
— 2if —-
role in the development of the pathology by attracting 
these lymphocytes through the activation of a complement 
pathway (Hayashi ei. &1, , 1986).
Neonatal Eoal Disease Caused by EHV-1
Outbreaks of neonatal foal disease associated with 
EHV-1 have been described in Kentucky (Bryans at at. » 1977)
and in Australia (Dixon at a t . , 1978; Hartley and Dixon,
1979). Bryans a t  a t . * (1977) isolated EHV-1 from three of
nine foals which died in the second week of life. Most of 
these foals were normal at birth but succumbed after a few 
days to respiratory distress, weakness and diarrhoea. An 
interstitial pneumonitis and hypoplasia of the spleen and 
thymus was observed at necropsy. The authors suggested that 
this depletion and/or degeneration of lymphocytes in spleen 
and thymus caused by EHV-1 may have increased the 
susceptibility of the foals to lethal bacterial infections. 
Dixon ei aX. (1978) reported the occurrence of primary 
uncomplicated perinatal EHV-1 infection. A number of foals 
were unable to stand or suckle without assistance and died 
with varying degrees of respiratory distress within 24 
hours of birth. Other foals were normal at birth and no 
clinical signs were observed until 18 to 24 hours later, 
when severe signs of respiratory distress commenced. At 
necropsy the lungs were enlarged, firm and plum purple in 
colour. Splenomegaly with prominent lymphoid follicles was 
apparent, but some of the classical lesions associated with 
EHV-1 abortion, such as Jaundice, focal liver lesions and 
excess pleural fluids, were absent. EHV-1 was isolated 
from all foals examined.
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EHV-1 is the aetiological agent of a form of coital 
exanthema similar to, but less severe than, that caused by 
EHV-3. This appears to be a relatively rare manifestation 
of EHV-1 infection and is of little economic importance 
(Bryans and Allen, 1973: O'Callaghan aX. , 1983),
The Di fferentiaXXan_oX_TMa_SuhXyp&s_qf_EHV-X
For more than a quarter of a century evidence has 
accumulated to indicate the existence of two distinct 
subtypes of EHV-1 differing in antigenicity, tissue culture 
characteristics, epizootiology, pathogenicity and molecular 
biology. EHV-1 subtype 1 is commonly referred to as the 
abortigenic subtype while subtype 2 is known as the 
respiratory subtype. However, EHV-1 subtype 1 and subtype 
2 are not necessarily equivalent to foetal and respiratory 
isolates. Both subtypes have the potential to cause 
respiratory disease and abortion.
All isolates of EHV-1 are regarded as belonging to the 
same serotype as they are neutralized to some extent by 
convalescent sera or by antisera prepared in laboratory 
animals (Burrows and Goodridge, 1973). However, as early 
as 1959, Shimizu aX. reported that the virus could be
divided into two subtypes on the basis of cross­
neutralization tests. This was subsequently confirmed by 
other workers (Matumoto at aX>, 1965; Mayr at âX-* 1965;
Borgen and Ludwig, 1974). Burrows and Goodridge (1973), in 
a study of 17 isolates of foetal or respiratory origin, 
demonstrated far greater antigenic differences between the
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two groups than between different isolates recovered from 
the same site. Polyspecific serum has been used to 
differentiate strains of each subtype in plaque reduction 
and kinetic neutralization tests and in enzyme-linked 
immunosorbent assays (Turtinen, 1983). The latter 
technique measures both neutralizing and non-neutralizing 
antibodies and was found to be somewhat less sensitive than 
the other techniques in discriminating between the two 
subtypes. Yeargan et aJL. (1985) produced EHV-1 monoclonal 
antibodies, several of which demonstrate subtype 
specificity. These specific monoclonal reagents allow 
subtype identification within 3 hours after the isolation 
of virus in tissue culture.
Serological surveys have indicated a worldwide 
dissemination of EHV-1 (Matumoto ei aX* » 1965). However,
while the respiratory form of the disease is common in all 
horse populations EHV-1 abortion has a far higher incidence 
in the United States and parts of Europe than it does in 
Australia, South Africa, Japan and Great Britain (Platt 
1973; Powell 1975; Burrows and Goodridge, 1979; Coggins, 
1979; Mumford and Rossdale, 1980). EHV-1 abortion in 
Britain and Ireland tended, for many years, to be sporadic 
and associated with imported animals (Farrelly, 1966; 
Burrows, 1968). The relative rarity of EHV-1 abortion in 
Ireland, where rhinopneumonitis occurs annually in young 
stock, led Farrelly to suggest, as early as 1966, that 
there were two strains of EHV-1: an aborting strain which
could cross the placenta and a non-aborting strain which 
failed to pass this barrier. EHV-1 has been isolated, in
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Australia, from horses suffering from respiratory disease 
since 1962 (Duxbury and Oxer, 1968; Bagust and Pascoe,
1968; Studdert ê.t aX. , 1970), but no case of EHV-1
abortion was recorded until 1977, when it is thought that 
an abortigenic subtype 1 virus was introduced into the 
country for the first time (Sabine, 1980; Sabine o±. aX.,
1983). Retrospective analysis of the sole EHV-1 isolate 
obtained from an aborted foetus prior to 1977 (Peet êt aX«, 
1978) showed it to be a respiratory subtype or subtype 2 
isolate (Sabine aX.> 1983), thus supporting the view
that the previously endemic respiratory subtype 
occasionally caused abortion.
The geographical variation in the clinical 
manifestations of EHV-1, and the apparent existence of 
strains of virus differing in virulence, instigated a study 
of the growth characteristics of EHV-1 isolates by Burrows 
and Goodridge (1973). In general, foetal isolates grew 
more quickly in cell culture, had a wider host cell range 
and were more cytopathic than respiratory isolates. 
Comparisons were made both in cell monolayers and organ 
cultures of susceptible tissues. Studdert and Blackney 
(1979) compared the plaque size and host cell range of 
several Australian foetal and respiratory isolates. Their 
results supported those of Burrows and Goodridge (1973), 
and indicated that bovine embryo tracheal (EBTr) cells are 
useful for differentiating the two subtypes. All but one 
of 11 foetal isolates grew on EBTr cells, but none of the 7 
respiratory isolates tested grew in this cell line. 
Respiratory isolates also produced larger plaques than
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foetal isolates. Growth characteristics of the two groups 
of isolates in vitro correlated well with those iii vivo. 
After inoculation into partly immune horses, viruses 
recovered from aborted foetuses were more infectious, grew 
better in the nasopharynx, were more likely to be found in 
the buffy coat of the blood, were excreted in greater 
quantities and elicited a better neutralizing antibody 
response than the respiratory isolates (Burrows and 
Goodridge, 1973, 1975). Patel aX* (1982) showed by
immunofluorescence studies in experimentally infected foals 
that a subtype 2 respiratory isolate was confined to the 
respiratory tract epithelium, macrophages and regional 
lymph nodes. Both paresis and foetal subtype 1 isolates 
also replicated in the epithelium of the small intestine, 
but only the paresis isolate infected blood vessel 
endothelial cells. Only subtype 1 isolates initiated a 
viraemia. Further studies in mice demonstrated that 
subtype 1 isolates, unlike subtype 2 isolates, infected the 
brain following intracerebral inoculation (Patel and 
Edington, 1983).
Sabine ei aX* (1981) first demonstrated conclusively 
that there were two subtypes of EHV-1 by restriction 
endonuclease analysis of virus DNA. Virus isolates within 
each subtype have similar restriction endonuclease profiles 
which are entirely different from those of viruses of the 
other subtype. While anomalies frequently arose in all the 
differentiation studies discussed above, the 
electrophoretic pattern of restriction digest fragments 
provides a definitive way of classifying a viral isolate
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into either subtype. It has been suggested that viruses 
with a respiratory subtype or subtype 2 electropherotype be 
renamed EHV-4 (Studdert gt. , 1981). Both subtypes are
respiratory pathogens, but only viruses which have a 
subtype 1 electropherotype are commonly associated with 
abortion. The use of restriction endonuclease analysis in 
epizootiological studies of EHV-1 in Kentucky (Allen ai. 
aX. , 1983a) and Australia (Studdert, 1983) indicate that
subtype 2 virus, like subtype 1, causes epizootics of 
respiratory disease in young horses, but is rarely the 
cause of abortion and does not appear to be associated with 
abortion storms or the neurological syndrome. It was 
thought, initially, that both subtypes of EHV-1 were 
similar to those of HSV in that no two epidemiologically 
unrelated viruses had identical restriction endonuclease 
fingerprints (Studdert gt aX., 1981). However, on
examination of a larger number of field isolates this 
proved not to be the case. The abortigenic subtype, or 
subtype 1, of EHV-1 demonstrates remarkable genetic 
homogeneity for a herpesvirus (Allen e± aX.» 1985). Two
electropherotypes were responsible for greater than 90% of 
176 epizootically unrelated outbreaks of abortion, over a 
24 year period in Kentucky, excluding those which were 
vaccine-related (Allen gt aX*i 1983a). In contrast, DNA 
fingerprints of the respiratory subtype show greater 
heterogeneity than those of the abortigenic (Allen ei aX., 
1983a; Allen and Bryans, 1986).
Kinetic analysis of DNA-DNA reassociation suggests 
that the two subtypes of EHV-1 share only 17% of their
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genome nucleotide sequence (Allen and Turtinen, 1982).
Thus, they are more distantly related than HSV-1 and HSV-2, 
which demonstrate a genetic homology of 50% (Kieff et aX.,
1972).
One of the major problems associated with the majority 
of infections by herpesvirus including HSV (Baringer and 
Swoveland, 1973; Stevens, 1975; Vildy e± a X -, 1982), BHV-
1 (Snowden, 1964, 1965; Pastoret g±. aX* » 1984), PRV
(Gutekunst, 1979; Beran ei aX«, 1980) and feline
herpesvirus 1 (FHV-1) (Herrman gi aX. > 1984) is their
ability to establish latency. Latent virus may reactivate, 
usually under stress, at any time during the life of the 
host, and not only cause clinical disease but also serve as 
a potential source of infection for the animal's cohorts. 
Much circumstantial evidence for the persistence of EHV-1 
and its reactivation following a variety of stress 
situations has been accumulated. Erasmus (1966) isolated 
EHV-1 from groups of horses after inoculation with an 
attenuated African horse sickness virus vaccine while 
Burrows and Goodridge (1984) noted increases in EHV-1 
complement fixing antibody following influenza vaccination. 
In a self-contained pony herd at the Animal Virus Research 
Institute in Pirbright, virus was recovered from ponies 
shortly after castration, rehousing, weaning of offspring 
and in the terminal stages of grass sickness. No clinical 
abnormalities were detected in these animals but a number 
of ponies developed four-fold or greater increases in EHV-1
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neutralizing antibody (Burrows and Goodridge, 1978, 1979).
Edington aX fflX. » (1985) recently presented the first
experimental evidence that EHV-1 can exist in the latent 
form and be reactivated following immunosuppression with 
dexamethasone and prednisolone. Three months after 
experimental infection EHV-1 was recovered from six ponies 
in a group of eight within two weeks of corticosteroid 
treatment. While five of these ponies were viraemic only 
three shed virus in nasal secretions arguing in favour of 
reactivation rather than secondary reinfection. No 
clinical signs of respiratory disease were detected after 
virus reactivation and two animals failed to show a 
significant increase in complement fixing antibody 
suggesting that reactivation may go undiagnosed at both the 
clinical and laboratory level (Mumford, 1985b).
The sensory ganglia have been shown to be a site of 
latent infection for HSV in man (Bastian gt sJL. , 1972; 
Baringer and Swoveland, 1973; Baringer, 1974), in mice 
(Stevens and Cook, 1971; Cook and Stevens, 1973, 1976) and
in rabbits (Stevens gt. aX> , 1972) , for BHV-1 in cattle
(Homan and Easterday, 1980) for PRV in pigs (Beran g±. aX. ,
1980) and FHV-1 in cats (Gaskell gi aX., 1985) by isolation
of infectious virus in explant and co-cultivation studies. 
Attempts to demonstrate EHV-1 in the trigeminal ganglia and 
other tissues using these techniques have, with one 
exception, failed (Burrows and Goodridge, 1984; Allen and 
Bryans, 1986). The site of EHV-1 latency remains to be 
identified. In the acutely infected animal EHV-1 subtype 1 
can be isolated from leukocytes for two to three weeks
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after infection by cocultivation onto permissive cell 
monolayers (Bryans, 1969). EHV-1 can only be isolated from 
viable undisrupted leukocytes indicating that the virus may 
be present in a noninfective or subvirion form (Gleeson and 
Coggins, 1980; Scott et g_l. , 1983). It has been suggested
that this cell-associated viraemia represents a latent 
infection of the white blood cells by EHV-1 (Gleeson and 
Coggins, 1980).
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The two subtypes of EHV-1 are morphologically 
indistinguishable from each other and similar to all 
members of the Herpesvirinae. Virions are approximately 
150 - 170nm in size and are composed of four major 
subvirion components: the envelope, tegument, capsid and
core (Plummer and Vaterson, 1963; Abodeely et al.,, 1970;
Darlington and Moss, 1968; O'Callaghan and Randall, 1976). 
An electron micrograph of an EHV-1 subtype 2 virion is 
shown in Figure 1.5.
The lipoprotein envelope is a triple-layered 
membranous structure that surrounds the nucleocapsid. It 
is derived from the nuclear membrane of the infected cell 
(Darlington and James, 1966; Darlington and Moss, 1968;
O'Callaghan and Randall, 1976; O'Callaghan gt. aX. , 1978). 
Virus envelope glycoproteins play an important role in the 
adsorption and penetration of virus into cells, cell fusion 
and spread of virus from cell to cell and egress of progeny 
virus (Manservigi gi. aX* , 1977; Sarmiento gt aX. , 1979; 
Noble gX aX‘ » 1983; Buckmaster gt a.X. , 1984). Thus, they
are important determinants of viral pathogenicity. They 
elicit both a humoral and a cell-mediated immune response 
in the host (Powell gX aX., 1974; Papp-Vid and Derbyshire,
1978, 1979; Norrild gX aX-, 1979; Bishop gX aX., 1983,
1984). Their identification and characterization is thus 
of primary importance to the elucidation of viral 
pathogenesis and prophylaxsis of disease. Six major and
Figure 1.5
Electron micrograph of an BHV-1 subtype 2 virion 
Magnification = 145,000X
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six minor glycoproteins have been identified in the 
envelope of both subtypes of EHV-1 (Turtinen and Allen,
1982; Turtinen, 1983; Allen and Bryans, 1986). The six 
major glycoproteins are between 240,000 and 40,000 in
18
molecular weight, and are designated VGP 2, 10, 13,' 14, and
A
22a based on the original nomenclature of O'Callaghan and
Randall, (1976). Equivalent species are found in both 
subtypes (Turtinen, 1983; Allen and Bryans, 1986).
The amorphous area between the envelope and the
nucleocapsid is known as the tegument (Roizman and Furlong, 
1974). Variation in size of this region is thought to be 
responsible for the differences in overall virion size 
noted among EHV-1 populations (O'Callaghan ei aX. , 1983).
Several EHV-1 proteins have been tentatively assigned to 
this region (O'Callaghan gt aX- • 1983; Turtinen, 1983;
Allen and Bryans, 1986). However, little is known about 
the detailed composition of the EHV-1 tegument.
EHV-1 capsids are approximately lOOnm in diameter 
(Abodeely gt aX-, 1970) and a comparative electron
microscopy study by Vernon gt aX. (1974) demonstrated that 
there were no significant structural differences between 
HSV-1 and EHV-1 capsids. The HSV-1 capsid is composed of 
162 morphological subunits called capsomeres, arranged to 
form an icosadeltahedron which exhibits 2-, 3- and 5- fold 
symmetry (Vildy gt sX*» 1960). The fully assembled EHV-1
nucleocapsid is made up of six major proteins, one of which 
a phosphoprotein with a molecular weight of 148,000 
constitutes approximately 68% of total capsid protein
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(Perdue gt. al., 1974, 1975, 1976; 0'Callaghan et. al. ,
1977, 1978).
The core contains the EHV-1 DNA molecule and 
associated proteins and is located centrally within the 
capsid. It is an electron dense toroidal structure 
occasionally containing a less dense centre (Perdue gt aX*, 
1975; O'Callaghan and Randall, 1976). This centre 
consists of a bar structure around which the DNA is spooled 
or wound in strands with a regular spacing (Furlong at aX-, 
1972; O'Callaghan and Randall 1976; O'Callaghan a t  al. .
1978, 1983).
Early studies which found that EHV-1 inclusions 
stained Feulgen-positive indicated that the virus contained 
DNA (Randall and Bracken, 1957; Gentry and Randall, 1960). 
Further evidence for this was obtained from the 
autoradiographic study of hepatic cell nuclei isolated from 
EHV-1 infected hamsters labelled with tritiated thymidine 
(Gentry a t  aX-, 1962). Chemical analysis of virus purified
from the plasma of infected haunters indicated that the DNA 
has a G+C content of approximately 56% (Darlington and 
Randall, 1963). A detailed study by Soehner a t  aX- (1965) 
of the buoyant density and melting temperature of EHV-1 DNA 
showed that the G+C content is 57%. Like HSV-1 DNA 
(Frenkel and Roizman, 1972a) EHV-1 DNA fragments upon 
treatment with alkali (O 'Callaghan a t  aX- » 1983).
A combination of techniques such as electron 
microscopy, restriction endonuclease digestion, end
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labelling and Southern blot hybridization have been used to 
demonstrate that EHV-1 subtype 1 has a genome structure 
characteristic of a Group D herpesvirus (Figure 1.2).
Thus, it comprises two covalently linked segments 
designated L (long) and S (short). The S segment consists 
of a unique region bracketed by inverted repeat
sequences (TRg,IRg). Electron microscopic studies showed 
that when single stranded EHV-1 DNA is allowed to self­
anneal the inverted repeat sequences (TR^,IR^) hybridize to 
form a double-stranded region which is contiguous at one 
end with a single stranded loop (Ug) and at the other with 
a long single stranded tail (L) (Ruyechan ei slL- , 1982).
The presence in virion DNA of two equimolar isomers of the
EHV-1 genome differing in the orientation of Ug is
indicated by the existence in certain restriction
endonuclease digests of three terminal fragments and 0.5M
fragments which share significant homology (Henry ei aJL. , 
1981; Vhalley gi al., 1981).
Henry et al. (1981) investigated the genome structure 
of the Kentucky A strain of EHV-1 subtype 1, Their 
findings indicated that the L and S segments have molecular 
weights of 71.6 x 10^ and 20.4 x 10^, respectively. The 
average molecular weight of Ug on electron microscopic 
examination was found to be 6.4 x 10^ (Ruyechan ei al*, 
1982). Vhalley e± al. (1981) analysed the genome structure 
of an Australian isolate of EHV-1 subtype 1 (isolate HVS 
25), and reported molecular weights of 74 x 10^ and 26 x 
10® for the L and S segments, respectively. The molecular 
weight of was estimated as at least 7.9 x 10^. The DNA
Figure 1.6
The Genome Structure of EHV-1. Subtype
A. The Bam HI cleavage map of isolate HVS-25 of EHV-1, 
subtype 1, derived by Vhalley ei aJL. , (1981).
B. The Bam HI cleavage map of the Kentucky A strain of 
EHV-1, subtype 1, derived by Henry ei al., (1981),
C. The revised Bam HI cleavage map of the Kentucky A 
strain (Baumann ei al., 1986),
The two hatched boxes represent the repeat regions. Both 
orientations of the S region are shown.
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was not examined by electron microscopy, The latter values 
are used for comparative analysis in this thesis.
Eco RI, Bgl II, Xba I and Earn HI cleavage maps were 
derived for the Kentucky A strain by Henry ei al. (1981), 
and Ec q  RI, Eg.1 II and EaiD HI maps of isolate HVS-25 were 
derived by Vhalley et al. (1981). The original maps for 
the Kentucky A strain (Henry ei al-, 1981) suggested a
difference in the arrangement of fragments of the of 
these two viruses. However, a later modification of the 
Kentucky A maps consisting of the inversion of DNA 
sequences between 0.2 and 0.7 map units, showed that the 
Kentucky strain has an arrangement of restriction —
endonuclease sites similar to HVS-25 (Baumann ei al, ,
1986). This is illustrated in Figure 1.6.
Lytic Infection Vlth EHV-1.
The replicative cycle of EHV-1 subtype 1 has been 
studied in mouse fibroblast (L-M) cells and in the young 
Syrian hamster. The latter was used for 20 years for 
propagation of EHV-1. In this animal EHV-1 causes a 
consistently reproducible lethal hepatitis and virus is 
released into the blood in large amounts. All animals die 
approximately 12 hours post inoculation, and more than 95% 
of the hepatic parenchymal cells show a typical 
intranuclear inclusion (Bracken and Randall, 1957; Gentry 
and Randall, 1960; Gentry e± aX. , 1960; O'Callaghan at.
, 1972). The maximum virus titer is obtained from
monolayers of L-M cells 18-24 hours postinfection, and 95% 
of the virus is released from the cell (O'Callaghan at at. , 
1968a, 1978, 1983).
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Herpesviruses attach to specific unidentified 
receptors on the cell surface. The mechanism of virus 
entry into the cell has not been fully elucidated, but it 
is generally accepted that it is mediated by fusion of the 
virus envelope with the cell membrane (Morgan et aT,,
1968) . This is supported by evidence that envelope 
glycoproteins play a role in adsorption and penetration of 
HSV-1 (Sarmiento g± aX.> 1979; Little ai âX-, 1981) and
that HSV-1 envelope Fc receptors could be detected in the 
cell surface membrane immediately after penetration and in 
the absence of viral gene expression (Para si aX., 1980).
However, virus entry by fusion has not been definitively 
established and several early electron microscopic studies 
indicate that HSV is taken up by phagocytosis (Holmes and 
Watson, 1963; Hummeler si aX., 1969; Dales and
Silverberg, 1969). Abodeely si. aX* (1970), studied the 
entry of EHV-1 subtype 1 particles into L-M cells by 
electron microscopy. The virus entered the cell by 
viropexis within 5 min postinfection. The particles were 
engulfed by pseudopodia phagocytized and remained in 
intracytoplasmic vacuoles for up to two hours 
postinfection. The mechanisms by which parental virus DNA 
is uncoated and translocated into the nucleus is unknown. 
However, release of virus DNA into the nucleoplasm is 
obviously dependent on a viral function as viral capsids 
accumulate at the nuclear pores of cells infected at the 
nonpermissive temperature with the HSV-1 temperature-
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sensitive mutant tsB7. These capsids do not release DNA 
for at least 6 hours postinfection, unless the cells are 
shifted to the permissive temperature, in which case DNA 
release occurs within 30 min (Batterson e± al., 1983).
Shutoff of host macromolecular metabolism is a
recognised feature of herpesvirus infections (Roizman and
Roane, 1964; Sydiskis and Roizman, 1966; Gergely si al.,
1971; Rakusanova e.t al. , 1971), but the mechanisms
involved are poorly understood, EHV-1 infection causes
significant alterations in host nucleic acid and protein
synthesis. Inhibition of host DNA synthesis commences
early in infection of L-M cells and is eventually
suppressed by 95% (Randall and Walker, 1963; O'Callaghan
ei a l .  , 1968a). Also, pulse labelling with radioactive
uridine demonstrated a dramatic inhibition of cellular RNA
synthesis in L-M cells (O'Callaghan si a l .  , 1968b) and in
human carcinoma cells (KB) (Lawrence, 1971) commencing
early after infection with EHV-1 subtype 1. O'Callaghan si
a l .  (1968a) measured protein synthesis in EHV-1 infected L-
14M cells by incorporation of C C]leucine into the protein
fraction. Cell replication ceased a few hours after
infection, but total protein synthesis continued at a
linear rate. The authors suggested that EHV-1 infected
cells undergo a smooth transition from the synthesis of
host protein to viral protein. However, Lawrence (1971)
14using pulse labelling with C CD valine in KB cells found 
the rate of total protein synthesis decreased between 5 and 
6 hours after infection and decreased progressively for the
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remainder of the infectious cycle. Recent studies on the 
regulation of EHV-1 polypeptides using SDS-polyacrylamide 
gel electrophoresis indicated that a gradual but 
progressive decline in cellular protein synthesis occurs 
during the course of infection (Caughman a t  a l .  , 1985).
E a p liQ a tiQ n _ Q l_ V lr a l  DNA
The kinetics of viral DNA synthesis in EHV-l-infected 
L-M cells were examined by measuring the incorporation of 
labelled thymidine and deoxycytidine (O'Callaghan a t  a l .  , 
1968a,b). EHV-1 DNA synthesis began at 4-6 hours 
postinfection, increased rapidly and reached a peak at 12- 
14 hours. The rate of EHV-1 DNA synthesis decreased after 
14 hours postinfection and by 16-18 hours was reduced to 
less than one-third of the maximal rate. Studies of EHV-1 
infected Syrian hamsters demonstrated a similar virus 
growth curve. A short latent period was followed by a 
sharp increase in virus titre. DNA synthesis began at 3-4 
hours postinfection and continued to increase until 8 hours 
postinfection, after which synthesis decreased until the 
animals died at 12-14 hours postinfection (O'Callaghan ei 
a l .  , 1972).
Electron microscopic studies, pulse labelling 
experiments and restriction endonuclease analysis of 
replicating DNA suggest that herpesvirus replication 
involves circularization of the linear input DNA and the 
formation of head-to-tail concatamers probably by a rolling 
circle mechanism (Jean and Ben-Porat, 1976; Ben-Porat e t  
a l .  , 1976; Jacob and Roizman, 1977; Jacob e t  a l .  , 1979;
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Ben-Porat and Rixon, 1979). Sequences essential for HSV-1 
amplification in permissive cells have been analysed in 
detail. One origin of replication is present twice in the 
genome, in IRg/URg (Stow, 1982; Mocarski and Roizman 1982; 
Stow and McMonagle, 1983), and the second is located in 
the centre of between the genes encoding the major DRA- 
binding protein and DNA polymerase (Locker al. , 1982;
Spaete and Frenkel, 1982; Veller e.±. a l .  , 1985). No such
information is available on the locations of the EHV-1 
origins of replication.
Transcription
No EHV-1 RNA is synthesised in the presence of oL - 
amanitin, a potent inhibitor of RNA polymerase II (Kemp êt 
a l .  , 1975), EHV-1 transcription was first investigated by
Huang e i  a l .  (1971) who used DNA-RNA hybridization to 
demonstrate that virus-specific RNA synthesis commenced at 
2-4 hours postinfection and continued until 12-14 hours 
postinfection. Hybridization competition experiments 
indicated that the virus-specific RNA species transcribed 
early in infection were a subset of RNA transcribed at 
late times. Temporal regulation of RNA transcription has 
been described in detail in other herpesviruses 
particularly HSV-1 (Rakusanova e.1 al. , 1971; Frenkel and 
Roizman, 1972b; Vagner, 1972; Swanstrom and Vagner,
1974).
The transcription of the HSV genome is sequentially 
ordered, and three major groups of viral mRNA immediate- 
early (IE) or c< , early (E) or (1 and late (L) or *y have 
been identified (Frenkel and Roizman, 1972b; Swanstrom and
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Vagner, 1974; Kozak and Roizman 1974; Clements ei ai* , 
1977). The synthesis of HSV IE mRNA occurs in the presence 
of protein synthesis inhibitors (Kozak and Roizman, 1974),
The gene for a virion polypeptide synthesised late in 
infection which specifically activates transcription from 
IE genes has been mapped (Campbell ei al., 1984) and its
DNA sequence determined (Dalrymple ei al., 1986). IE gene
products are required for the transcription of both E and L 
genes (Vatson and Clements, 1978; Preston 1979, 1981;
Everett, 1984; O'Hare and Hayward, 1985). Analysis of 
the effects of metabolic inhibitors on EHV-1 polypeptide 
synthesis indicates that viral gene expression is 
temporally regulated in a manner similar to that of HSV 
(Caughman e.i al. , 1985).
Honess and Roizman (1974, 1975) used amino-acid
analogues and inhibitors of protein synthesis to 
demonstrate the existence of three classes of HSV 
polypeptides OC ,P a n d ^ . These correlate in general to the 
three temporal classes of viral transcripts, IE, E and L, 
discussed above. The synthesis o ±  oC polypeptides, the 
earliest polypeptides made, is maximal between 3 and 4 
hours postinfection and requires no prior protein 
synthesis. The function of one or more cL polypeptides is 
required for synthesis of |3 polypeptides, which is maximal 
at between 5 and 7 hours postinfection. The (3 
polypeptides inhibit OC polypeptide synthesis. One or more p 
polypeptides is required for the onset of synthesis of the y
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group which in turn inhibit the production of p 
polypeptides (Honess and Roizman, 1974, 1975; Kozak and
Roizman, 1974; Roizman at al*, 1974). Analysis of 
polypeptides produced by HSV-1 ta. mutants suggests that 
this initial account of the cascade synthesis of HSV 
polypeptides was an oversimplification (Marsden a t  a l . , 
1976). Although the IE viral polypeptide V^^IE 175 and 
possibly V^^IE 110 mediate the synthesis of non-IE viral 
polypeptides (Vatson and Clements, 1978, 1980; Preston
1979, 1981; Everett, 1984; O'Hare and Hayward, 1985),
the requirement does not appear to be absolute (Pereira a t  
a l .  , 1977; Locker a t  a l .  , 1982). Two groups of p
polypeptides which differ in the kinetics of their 
synthesis have been identified (Pereira a t  a l . , 1977).
This is also true of the group which is subdivided 
into two subgroups *y  ^ and ^ 2 ' *7 1 polypeptides such as
glycoprotein B are made in the absence of DNA synthesis, 
but in substantially lesser amounts than in a normal 
productive infection. ^  ^ proteins have an absolute 
requirement for DNA synthesis (Conley a t  a l . , 1981; Volf
and Roizman, 1978).
Caughman a t  a l .  (1985) demonstrated that EHV-1 
polypeptide synthesis is a coordinately regulated and 
sequentially ordered process similar to that of HSV—1.
Four IE, 17 E and 12 L polypeptides were identified. The 
kinetics of synthesis of at least 3 of the E polypeptides 
appear to be linked to viral DNA replication.
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yir-U.S__AaSQClated Enzymes
Several changes in enzymatic activity are associated
with infection by EHV-1 subtype 1. A virus coded thymidine
kinase (TK) has been identified and characterized (Allen et
al. t 1978b, 1979; McGowan at at- , 1979). The existence of
this enzyme was first suggested by the inhibition of EHV-1
replication in both L-M cells and in the Syrian hamster by
arabinosylthymine (ara-T), a thymidine analogue which is
selectively phosphorylated by herpesvirus TKs (Aswell at
al. , 1977). Increased TK activity was observed in the
presence of sufficient TTP to inhibit host cell TK after
infection of four different cell types with EHV-1. This
was also observed in liver homogenates from EHV-l-infected
hamsters (Allen a t  a l . , 1978b), Neutralization of the
novel TK activity occurred on preincubation of the cells
with antiserum against EHV-l-infected cells (Allen a t  a l . ,
1978b). Moreover, biochemical transformation of TK-
negative cells to the TK-positive phenotype with EHV-1
subtype 1 was demonstrated (Allen a t  a l . , 1978b). The
purified EHV-l-induced TK was shown to be more closely
related to that of PRV than to that of HSV by its lack of
ability to phosphorylate deoxycytidine. However, EHV-1 TK
resistance to
resembled the HSV-coded enzyme in its^feedback inhibition 
by TTP and dCTP and its ability to use a variety of 
nucleoside triphosphates as phosphate donors (Allen at al., 
1979). Purified TK, from EHV-1 transformed TK-negative 
mouse cells, was identical to the TK purified from these 
cells on lytic infection with EHV-1 with respect to its 
phosphate donor specificity, molecular weight.
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electrophoretic mobility, substrate specificity and 
antigenicity (McGowan al., 1979),
EHV—1 DMA polymerase has been purified from the nuclei 
of infected hamster livers and characterized (Allen SLt a i-  , 
1977a), The main features which distinguish it from the 
host enzyme are immunological specificity, high salt 
requirement for maximal activity and sensitivity to 
phosphonoacetic acid (Kemp si a l . , 1975; Allen si a l . ,
1977a). EHV-1 DMA polymerase shows no immunological cross 
reactivity with, and is far more sensitive to 
phosphonoacetic acid, than the enzyme coded by HSV-1 
(Honess and Watson, 1977; Allen ei al., 1977a). HSV-1
ribonucleotide reductase is composed of two non identical 
virus-coded subunits (Langelier and Buttin, 1981; Cohen s± 
al.I 1985; Frame si a l . , 1985; Bachetti at a l . , 1986).
The resistance of EHV-1 replication to hydroxyurea and TTP 
concentrations sufficent to completely block host cellular 
DMA synthesis suggests that EHV-1 also specifies 
ribonucleotide reductase (Cohen si al., 1975 Allen si al.,
1978a). Significant alterations in ribonucleotide 
reductase activity in EHV-1 infected cells have also been 
observed (Cohen si al., 1977).
A protein kinase was identified by Randall si al. 
(1972) in the virions of EHV-1. There is also some 
evidence for the existence of an EHV—1—induced 
deoxyribonuclease although the results of much of this work 
are confused by the contamination of virus stocks with 
Mycnplasma homlnis (Stock and Gentry., 1969).
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Assembly of EHV-1 Virions.
Capsids are assembled and the DNA packaged in the 
nucleus of the infected cell. Three major species of EHV-1 
nucleocapsid have been isolated and characterized (Perdue 
fi.t al* » 1974, 1975, 1976; O'Callaghan and Randall, 1976;
O*Callaghan si al., 1977, 1978). They are classified on
the basis of their densities as Light (L), Intermediate (I) 
and Heavy (H) (Perdue si al., 1975). It was deduced from
pulse chase experiments that the I capsids are precursors 
of the H capsids and that the L capsids are defective by­
products of virus assembly (Perdue et al., 1976).
Only the mature, core-containing H capsids are enveloped 
(O'Callaghan and Randall, 1976; O'Callaghan si a l.»  1977). 
Envelopment occurs at the nuclear membrane either by 
budding or invagination of the nuclear membrane (Darlington 
and Moss, 1968; O'Callaghan and Randall, 1976;
O'Callaghan si al. , 1977).
EHV-1 subtype 1, EHV-2 and EHV-3 have been shown to 
have oncogenic potential in tissue culture and in 
laboratory animals. Transformed and tumour cell lines have 
been established (Robinson si a l.»  1980a,b; Dauenhauer si 
a l . » 1982; Staczek si a l . , 1984). EHV-1 subtype 1
preparations enriched for defective interfering (DI) 
particles, or UV-irradiated virus, can oncogenically 
transform permissive primary hamster cells (Robinson si 
a l . , 1980a,b,c). Infection with the former results in the
coestablishment of oncogenically transformed and 
persistently infected cell populations (Robinson ei al .r
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1980c; Dauenhauer e± al., 1982). Infection of
nonpermissive, primary BALB/c mouse embryo cell cultures 
with infectious EHV-1 or transfection of these cells with 
EHV-1 DNA also resulted in oncogenic transformation 
(O'Callaghan gt. ai. * 1983). EHV-1 transformed and tumour
cells of all three systems contain integrated EHV-1 DNA 
sequences, express viral antigens and are oncogenic in 
laboratory animals (Robinson and O'Callaghan 1983;
O'Callaghan et al. , 1983).
There is no evidence that any of the equine 
herpesviruses are associated with oncogenesis in the horse
CHAPTER 2
MATERIALS AND METHODS
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MAIEEIALS
Rabbit kidney cells, (RK13), and pig kidney, [PK<15>3, 
both established cell lines, were obtained from Flow 
Laboratories, Irvine, Scotland. Equine dermal cells <NBL— 
6), a finite cell line, were also purchased from Flow 
Laboratories. An SV40—transformed cell line derived from 
sheep lung fibroblasts (SHELUT) was a generous gift of Dr.
J. Macnab, Institute of Virology, Glasgow, U.K. (Macnab, 
1972).
yiruggg
Several primary EHV-1 isolates were kindly supplied by 
Dr. J. Mumford, The Animal Health Trust, Newmarket, U.K. 
These included the two viruses used throughout these 
studies: Vol939 which was isolated from an aborted foetus,
and 1942, an isolate from a young horse suffering from 
upper respiratory tract disease.
Tissue Culture Media and Solutions
PK(15), RK13 and NBL-6 cells were grown in Earle's Minimum 
Essential Medium (Flow) supplemented with 0.2% sodium 
bicarbonate, 1% non-essential amino acids, 1% glutamine,
100 units/ml penicillin, lOOmg/ml streptomycin and 10% 
foetal calf serum.
SHELUT cells were grown in Glasgow's Modified BHK 
Medium (Flow) (Busby et al., 1964) supplemented with 0.2%
sodium bicarbonate, 1% glutamine, 100 units/ml penicillin,
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lOOmg/ml streptomycin and 10% newborn calf serum.
Qther_Solutions_Used for ..Tissue Culture
Agar
Giemsa strain
3.8% sea plaque agar.
1.5% (vol/vol) suspension of Giemsa 
in glycerol, heated to 56° for 
90-120 min and diluted with an equal 
volume of methanol.
Phosphate-buffered 
Saline (PBS)
170mM NaCI; 3.4mM KCI ; ImM NaH^PO^;
2mM KHgPO^; 0.7mM CaCl^;
0.5mM MgCl^; in distilled water, 
pH 7.2.
PBS/Cidex 50% (vol/vol) PBS plus 50% (vol/vol) 
Cidex.
Trypsin
Versene
Trypsin/Versene
0.25% wt/vol Difco trypsin in 140mM 
NaCl; 30mM KCI; 0.28mM Na^HPO^;
Img per ml dextrose; 0.0015% wt/vol 
phenol red; 25mM Tris-HCl, pH7.4;
100 units/ml penicillin and 100 ug/ml 
streptomycin.
6mM EDTA in PBS containing 0.0015% wt/ 
vol phenol red.
1 volume of trypsin solution plus 4 
volumes of versene solution.
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Plastic roller bottles, flasks and petri dishes were 
purchased from Flow Laboratories, Irvine, Scotland.
Unless otherwise stated, all chemicals were of Analar 
grade and obtained from B.D.H. Chemicals Ltd., Poole,
Dorset, U.K.
Agarose (type II), bovine serum albumin (5% solution (wt/vol) 
in 0.7g/litre NaCl), cytochrome c, deoxyribonuclease I, 
ethidium bromide, lysozyme, polyvinylpyrollidone, 
ribonuclease A and yeast KNA were purchased from the Sigma 
London Chemical Co. Ltd., Kingston-upon-Thames, Surrey,
U. K.
TEMED (N,N,N',N'-tetra-ethylenediamine) was purchased from 
Bio-Rad Laboratories Inc., Richmond, California, U.S.A.
Formamide was purchased from, Fluorochem, Glossop,
Derbyshire, U.K.
Parlodion was purchased from Mallinkcrodt, Rochester, New 
York, U.S.A.
Dextran sulphate, Ficoll 400 and Percoll were purchased 
from Pharmacia Fine Chemicals, Uppsala, Sweden.
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Sea plaque agarose was purchased from FMC Corporation, 
Marine Colloids Division, Rockland, U.S.A.
Dimethyl sulphoxide (DMSO) was purchased from Aldrich 
Chemical Co. Ltd., Gillingham, Dorset, U.K.
Ampicillin was purchased from Beecham Research 
Laboratories, Brentford, Middlesex, U.K.
32
Radiochemicals, C<s6- P] -dCTP, -dGTP, -dATP and -TTP 
<3000Ci/mmole) were purchased from Amersham International, 
Bucks. U.K.
Caesium chloride, calf intestinal phosphatase, T4 DNA 
ligase, coli DNA polymerase I and Klenow DNA polymerase 
were purchased from the Boehringer Corporation (London) 
Ltd., Lewes, East Sussex, U.K.
Bam HI, Eco RI and other restriction endonucleases were 
purchased either from Boehringer Corporation (London) Ltd., 
Lewes, East Sussex or from Bethesda Research Laboratories 
(BRL), Inc., Cambridge, U.K.
Vacker reagent was purchased from Vacker Chemical Company, 
Munich, West Germany.
DNA
Calf thymus DNA was obtained from Sigma (London) Chemical
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Company, Kingston-upon-Thames, London, U.K.
(j)X174 RFI DNA was purchased from New England Biolabs,
Beverly, Massachussetts, U.S.A.
pUC9 DNA and M13mpl8 RF DNA were purchased from Bethesda 
Research Laboratories, Inc., Cambridge, U.K.
HSV-1 DNA was generously supplied by Dr. N. Stow.
Kpn I fragments of HSV-1 DNA cloned in pAT153 were a kind 
gift of Dr. A.J. Davison.
MisG&llaneous.Materials
Nitrocellulose membrane filters - Schleicher and Schull, 
Dassel, West Germany.
X-Omat and XSl film - Kodak Ltd., London.
Fix (Amfix) - May and Baker Ltd., Dagenham, Essex, U.K.
Filter papers — Whatman, Ltd. , Maidstone, Kent, U.K.
Membrane Filters (0.4pm and 0.22pm pore size) - Millipore 
(U.K.) Ltd., London.
All deoxynucleoside and dideoxynucleoside triphosphates were 
purchased from Pharmacia, P L Biochemicals, Hounslow, 
Middlesex, U.K.
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CoiBfflonly Used Solutions and Buffers
E buffer 0.036M Trizma; 0.036M NaH^PO^; O.OOIM EDTA,
pH 7.8.
TBE buffer 0.089M Trizma; 0.089M boric acid; 0.0025M
EDTA.
TE O.OIM Tris-HCl pH 8.0; O.OOIM EDTA.
NTE O.OIM Tris-HCl, pH 7.4; O.IM NaCl; O.OOIM
EDTA.
SSC 0.15M NaCl; 0.015M sodium citrate, pH 7.5.
TM buffer O.IM Tris-HCl, pH 8.0; O.IM MgCl^.
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METHODS 
SriQiriLh-Qi Cells
RK13, PK(15), NBL—6 and SHELUT cells were grown in 
slowly rotating 80 oz bottles in 100ml of the appropriate 
medium at 37°C in an atmosphere of 5% CO^. When the 
monolayers were confluent, the medium was decanted, the 
cells washed twice with trypsin-versene and rotated until 
they detached from the bottle surface. Roller bottles were
r?
usually seeded at approximately 3 x 10 cells/ bottle and 
50mm Petri dishes at 1 x 10^ cells/dish in 4ml of medium.
Stocks of cells were stored by freezing at-140°C in 
the appropriate medium containing either 20% glycerol or 
10% dimethyl sulphoxide.
Production of Virus Stocks
Roller bottles of slightly sub-confluent monolayers 
were infected with virus at a m.o.i. of 0.003. Virus was 
added in 20ml of medium per bottle and allowed to adsorb 
for 60 min at 37°C. At the end of the adsorption period, 
30ml of medium were added to each bottle, and the infected 
cells were incubated at 31°C for 3-6 days. When the cell 
monolayer showed 100% c.p.e., the cells were shaken into 
the medium and pelleted at 1,500 r.p.m. for 5 min at 4°C in 
an MSE Coolspin centrifuge. The clarified supernatant was 
centrifuged at 12,000 r.p.m. for 2 hours in a Sorvall GSA 
rotor and the resultant virus pellet resuspended in the 
appropriate medium. Virus stock was stored in sterile 
vials at -70°C.
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Sonicated virus stock was diluted serially at 
tenfold dilutions in the appropriate medium. Drained 
confluent monolayers of cells in 50mm Petri dishes were 
inoculated with lOOpl of virus suspension at the required 
dilution. Each dilution was assayed in duplicate. Virus 
was adsorbed for 60 rain at 37°C, the plates being agitated 
periodically to prevent dehydration of the cell sheet.
After adsorption the medium was aspirated, and the 
monolayers overlaid with 4ml of medium containing 0.75% 
(wt/vol) sea plaque agarose. The plates were then 
incubated at 37°C until plaques were clearly visible (5-7 
days). The monolayers were fixed for at least 6 hours with 
Cidex/PBS, stained with Giemsa, and the plaques counted.
Virus was titrated on the appropriate cell monolayers, 
and plaques allowed to develop under an agarose overlay.
The plates were then overlaid with agarose containing 
0.016% (wt/vol) neutral red chloride, and well separated 
virus plaques were picked with a Pasteur pipette using a 
Wild M7A stereoscopic dissecting microscope. The infected 
cells were transferred to 1ml of medium and sonicated.
Cell monolayers inoculated with tenfold dilutions of this 
virus were incubated at 37°C until plaques developed which 
were suitable for picking. The virus was plaque purified 
three times in this way before 50% of the progeny of a 
plaque were used to inoculate a 50mm plate of cells to 
prepare a primary virus stock. The stock was used to 
inoculate several flasks of cells. Virus harvested from
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the infected monolayers in the flasks was titrated and used 
to infect 80 oz roller bottles for production of working 
stocks of virus.
Ereparatlan_qf_EHy%l_nSA
The required number of roller bottles of confluent 
cells were infected with the appropriate subtype of EHV-1 
at a m. o.i. of 0.003 as described above. They were 
incubated at 31°C until extensive c.p.e. was evident and 
the majority of cells had detached from the bottle surface 
<2-6 days, depending on the virus subtype used). The 
infected cell medium was centrifuged at 5,000 r.p.m. for 5 
min to pellet the cells, and the supernatent was 
centrifuged at 12,000 r.p.m. for 2 hours in a Sorvall GSA 6 
X 200ml rotor. The pellet was resuspended in 5ml PBS, 
sonicated and centrifuged at 11,000 r.p.m. in a Sorvall 
SS34 rotor for 5 min to spin down cellular debris. Virus 
was then pelleted by centrifugation at 18,000 r.p.m. in a 
Sorvall SS34 rotor for 1 hour, resuspended in 0.5ml 5mM 
Tris, 0.1% bovine serum albumin, sonicated and layered onto 
a Percoll gradient. The Percoll gradient solution was 
prepared by the method of Pertoft described in the 
manufacturer's instructions for the purification of HSV. 
Centrifugation was for 30 min at 40,000 r.p.m. in a Beckman 
Ti50 rotor at 4°C. The virus banded about one third the 
way down the self-generated gradient. The fraction 
containing the virus was collected in a 2ml syringe, by 
inserting the needle through the side of the tube below the 
visible band, placed on a 3ml 60% sucrose cushion and
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centrifuged at 35,000 r.p.m. for 1 hour in a Beckman AH650 
rotor. The Percoll sedimented into the sucrose layer, and 
the virus remained in the upper iso-osmotic solution. The 
virus was diluted in O.IM Tris then pelleted at 35,000 
r.p.m. in a Beckman AH650 for 1 hour. After resuspension 
in a small volume of NTE (0.5 - 5ml), virus DNA was extracted,
The virus suspension was sonicated in an ultrasonic 
bath and 20% (wt/vol) SDS added to a final concentration of 
1%. An equal volume of NTE-equilibrated phenol was added 
and the tube agitated gently on a rock-and-roller for 10 
min. The mixture was centrifuged at 2,000 r.p.m. at 6°C 
for 10 min, in an MSE Coolspin centrifuge. The upper 
aqueous phase was removed and re-extracted with two further 
volumes of NTE-equilibrated phenol. Finally the aqueous 
phase was extracted with chloroform to remove all traces of 
phenol. The DNA was precipitated by adding 0.1 volumes of 
3M NaAc pH 7.0 and 2,5 volumes of ethanol and leaving on 
dry ice for at least 30 min. The DNA was pelleted, washed 
with 70% ethanol, drained well and resuspended in a small 
volume of 0.1 x SSC. The DNA concentration was estimated 
approximately by visual comparison of samples with known 
quantities of DNA on ethidium bromide stained agarose mini­
gels under UV illumination (365nm) . EHV-1 DNA was stored 
at -20°C.
EHV-1 subtype 2 DNA was prepared, in some instances, 
by an alternative method which did not involve use of 
Percoll gradients. A virus pellet was obtained as 
described above except that, it was resuspended in 10ml NTE 
and briefly sonicated instead of loading onto a Percoll
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gradient. Contaminating cellular DNA was degraded by 
adding DNase at lOyg/ml and incubating at 37°C for 1 hour. 
SDS was added to a final concentration of 2%, and the 
preparation was extracted approximately 3 times with NTE- 
equilibrated phenol until a clear interphase was obtained,
A chloroform extraction was followed by ethanol 
precipitation of the DNA as described above. The DNA was 
pelleted, washed with 70% ethanol, resuspended in 10ml of 
lOOmM NaCl and lOpg/ml RNase and left overnight at room 
temperature. Further purification was achieved by 
treatment with 1mg/ml proteinase K for 2 hours at 31°C.
The DNA was extracted once with phenol ; chloroform (1:1 
vol/vol), once with chloroform, ethanol precipitated, 
drained well and resuspended in 0.1 X SSC.
Electron Microscopy of EHV-1 Subtype 2 DNA
Intramolecular annealing studies were performed 
essentially by the method of Ruyechan ei ai. (1982), lug 
of EHV-1 subtype 2 DNA in lOyl 0.IM SSC was mixed with 40pl 
of deionised formamide and denatured by heating at 60°C for 
10 min. The formamide concentration was reduced from 80% 
to 66% by the addition of 0.2M Tris-HCl, 0.02M EDTA pH 8.5, 
and the single-stranded DNA allowed to self-anneal at 25°C 
for 2 hours. The sample was diluted to a final 
concentration of 50% formamide, lOOmM Tris-HCl (pH 8.5), 
lOmM EDTA and lOOpg/ml cytochrome c. Both single-stranded 
and double—stranded circles of (|)X174 RF DNA were added as 
markers. For visualising by electron microscopy, lOpl of
this mixture was spread onto 20% formamide, lOmM Tris-HCl
(pH 8.5), ImM EDTA and picked up on a parlodion-coated 400
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mesh copper grid. The preparation was stained for 10 sec 
in lOyg/ml uranyl acetate in 90% ethanol, rinsed in 90% 
ethanol for 5 sec and rotary shadowed at 70°C with 
platinum/palladium. The grid was stabilised by shadowing 
with carbon and examined at 90kv in a Jeol lOOS electron 
microscope. All photographs were taken and the length of 
EHV-1 and $X174 DNA was measured using a Summagraphics ID 
digitizing tablet controlled by a PDP-11 minicomputer 
(Rixon ei gT., 1984a). The sizes of the single-stranded
loops and double-stranded stems of the self-annealed EHV-1 
DNA, which corresponded to the U and TR_/IR_ regions 
respectively, were calculated by the ratio of their lengths 
with respect to the marker DNA lengths. Histograms of the 
measurements were drawn.
All restriction digests were carried out in 20mM Tris- 
HCl (pH 7.5), 20mM MgCl^, lOOmM NaCl, 6mJt 2-mercaptoethanol 
and 0.02% wt/vol sterile bovine serum albumin. Sufficient 
enzyme was added to produce a limit digest of the purified 
DNA, and the mixture was incubated at 37°C for a minimum of 
3 hours. Reactions were terminated by the addition of 2% 
vol/vol of dye Ficoll, which contained 10% wt/vol Ficoll 
400, O.IM EDTA and 0.1% wt/vol bromophenol blue in 5 x E 
buffer.
AgariQS£_Gie.l_Eiaq±-i:QphQr£sis
DNA fragments resulting from restriction endonuclease 
cleavage were fractionated by electrophoresis. Horizontal 
gels were used with agarose concentrations of 0.5—1.0% as
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indicated in the appropriate figure legends. The agarose 
was dissolved in E buffer by boiling in a Tappan microwave 
oven. The fluorescent dye ethidium bromide <0.5pg/ml) was 
added (Sharp ei aX., 1973) and the agarose allowed to cool
to about 50°C before pouring onto a glass plate. -A comb 
was fixed in the molten agar and removed when the gel had 
set to leave appropriate-sized loading wells. The gel was 
submerged in E buffer containing 0.5yig/ml ethidium bromide, 
and the DNA samples with added dye-Ficoll introduced into 
the wells. Electrophoresis was for 15-20 hours at 2V/cm at 
room temperature or until the samples had migrated the 
required distance in the gel. Gels were photographed under 
long (365nm) or short (254nm) wavelength UV irradiation 
using Polaroid type 667 or type 665 film.
A technique similar to that described by Veislander 
(1979) was used for the recovery of DNA from low melting 
temperature agarose. Restriction fragments were 
electrophoresed on a 0.7% low-melting-point agarose gel in 
1 X TBE in the presence of 0.5|jg/ml ethidium bromide. 
Electrophoresis was carried out at 2V/cm for 36 hours at 
room temperature. The fragments were visualised under long 
(365nm) wavelength UV irradiation and excised from the gel. 
To minimise cross—contamination a clean scalpel blade was 
used for each fragment. Gel slices were melted in about 3 
volumes of TE by heating at 65°C for 10 min. Except where 
the DNA was to be used in recombination experiments 20yg of 
yeast tRNA was added to aid DNA precipitation. The melted 
gel slice was extracted with two volumes of TE-equi1ibrated
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phenol at 65°C, mixed and centrifuged for 2 min in a mini­
centrifuge, The aqueous phase was recovered and re­
extracted twice with TE-equilibrated phenol at 65°C. The 
preparation was extracted once with ether and the DNA 
precipitated with 1/10 volume of 3M NaAc and 2.5 volumes of 
ethanol on dry ice. The DNA was pelleted by centrifugation 
and dried in a lyophiliser.
3 2
Xn vitro labelling of DNA with [ ot - P3 
deoxyribonucleoside triphosphates was done essentially as 
described by Ribgy al.. (1977). Nick translation 
reactions were set up on ice and typically contained 0.5pg 
of DNA in a volume of 20pl of the following solution;- 
50mM Tris-HCl pH 7.5, 5mM MgCl^* ImM dithiothreitol, 0.05%
wt/vol bovine serum albumin, l y l each of unlabelled 2mM
3 2
dATP, dTTP, and dGTP and l y l  ^  -  F dCTP (lOpCi). The
reaction mixture was incubated at 15°C for 90 min after
-4addition of DNase to 10 mg/ml and 1 unit of DNA 
polymerase I. After incubation the mixture was made up to 
50pl with distilled water and the labelled DNA precipitated 
twice with 1/10 volume 3M NaAc and 0.75 volume isopropanol 
on dry ice for a minimum of 30 min. The radioactivity of 
the DNA was monitored using a portable beta counter.
Radiolabel11ng_Q£_M13_EnQbes
Approximately 0.5pg of M13 clone DNA was annealed for 
30 min at 37°C to approximately 4ng of hybridization probe 
primer in a final volume of lOul of 15mM Tris, 15mM MgCl^ 
pH 8.5. The reaction mixture was then incubated at 37°C
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for 15 min in the presence of Ipl of each of 0.5mM dGTP, 
dCTP, dTTP, lul c L -  dATP (lOpCi) and Ipl of Klenow DNA
polymerase. At the end of this period the reaction was 
terminated by the addition of Ipl 0.25M EDTA and the DNA 
precipitated twice with isopropanol, as described above.
Xraasfer ..of ..-DNA-t o_Nltm£allulQsa
The transfer of DNA fragments from agarose gels to 
nitrocellulose membranes was accomplished by the technique 
of Southern (1975). The DNA was digested with the 
appropriate restriction enzyme and electrophoresed in a 
single wide-slot 0.5% agarose gel. After electrophoresis 
the DNA was denatured by soaking the gel for 45 min in gel 
soak I (0.2M NaOH, IM NaCl) and then neutralized by soaking 
for 45 min in gel soak II (IM Tris-HCl pH 8, IM NaCl). The 
gel was transferred to a glass plate wrapped in 2 sheets of 
Whatman 3MM paper moistened with 10 x SSC. The plate was 
supported in a tray of 2 litres of 10 x SSC. Care was 
taken to ensure that there were no air bubbles between the 
3MM paper and either the plate or the gel. A sheet of 
nitrocellulose paper was floated on the surface of the 10 x 
SSC until it was soaked from beneath, then it was applied 
to the gel surface. All air bubbles between the gel and 
the filter were removed. Two moistened sheets of 3MM paper 
cut to the same size as the filter were placed on top of 
the nitrocellulose followed by a weighted stack of paper 
towels. DNA fragments transferred from the gel to the 
nitrocellulose overnight, maintaining their original 
spatial arrangement. The filter was dried at room
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temperature and baked in a vacuum oven at 80°C for 2 hours
Radioactively labelled probes were used to detect 
homologous sequences in the single-stranded DNA immobilized 
on the nitrocellulose. The stringency of the hybridization 
conditions was varied by altering the temperature or the 
formamide concentration (McConaughy si aJL. » 1969; Hutton,
1977). Hybridizations were performed at 37°C in 30% 
vol/vol formamide or at 42°C in 50% vol/vol formamide. The 
hybridization of M13 cloned DNA to virus DNA was at 68°C in 
the absence of formamide. The nitrocellulose filter was 
cut into 5mm strips and placed in individual 15ml plastic 
tubes with tightly fitting metal caps. The strips were 
incubated overnight in 5ml of the appropriate hybridization 
solution at 37°C or 42°C in a shaking water bath. 
Hybridization solutions routinely used consisted of 3 x 
SSC, 5 X Denhardt's solution (Denhardt, 1966; 0.02% wt/vol
Ficoll 400, 0.02% wt/vol polyvinylpyrrolidone, 0.02% wt/vol
bovine serum albumin) and lOOpg/ml denatured salmon sperm 
DNA in 50% or 30% vol/vol formamide. Hybridization 
solution for M13 probes consisted fo 20mM Tris pH 7.5, 3 x
SSC, 5 X Denhardt's solution, lOOpg/ml denatured salmon 
sperm DNA and 0.5% SDS.
Nick translated probe DNA was denatured by heating at 
100°C for 2-3 min in 80% vol/vol formamide. The tubes 
containing the preincubated nitrocellulose strips were 
drained and the denatured probe added in 5ml of fresh 
hybridization solution. Hybridization at 42°C in 50% 
vol/vol formamide were incubated in a shaking water bath
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overnight. The filters were then transferred to a plastic 
sandwich box and washed in 3 x SSC, 0.2% SDS, lOmM NaPO^ pH 
7.5 at 50°C for at least three hours. The buffer was 
changed every hour. Hybridization in 30% vol/vol formamide 
at 37°C was allowed to proceed for 2-3 days and the strips 
were then washed at 45°C. Hybridization of M13 probes was 
overnight at 68°C. Washing was for three hours in 2 x SSC, 
0.5% SDS, changing the washing solution every hour. After 
washing, the strips were dried in air and baked in a vacuum 
oven at 80°C for 15 min. They were then applied to a glass 
plate using double-sided sellotape and autoradiographed.
Autoradiography
Nitrocellulose strips hybridized at 42° in 50% vol/vol 
formamide were autoradiographed at room temperature with 
Kodak X-Omat S film. Those hybridized at 37°C in 30% 
vol/vol formamide were autoradiographed at -70°C with 
preflashed Kodak X-Omat film and a Dupont Cronex 
phosphotungstate screen.
Ligation ol EHV DNA Into Elaomlds
EHV-1 subtype 2 DNA fragments were ligated into the 
vector pUC9, a plasmid which includes the ampicillin- 
resistance gene from pBR322 and the polylinker region from 
M13mp9 (Vieira and Messing, 1982). 5|jg of EHV-1 subtype 2 
DNA and 5pg pUC9 DNA were separately digested with Earn HI. 
22 units of calf intestinal phosphatase were also added to 
the pUC9 digestion to remove terminal 5'- phosphate groups.
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Complete digestion was verified by gel electrophoresis of 
aliquots of the reactions and then the DNA was extracted 
twice with an equal volume of phenol:chloroform (1:1) and 
ethanol-precipitated. Ligation was performed essentially 
by the method of Tanaka and Veisblum (1975). Approximately 
0. Ipg of Earn HI digested pUC9 and lyg of Bam Hl-digested 
EHV-1 DNA were mixed in 50mM Tris-HCl pH 7.5, 8mM MgCl^, 
lOmM dithiothreitol, ImM ATP in a final volume of 40pl. 2 
units of T4 DNA ligase (0.5^1) were then added. Two 
control reactions were also set up, one identical to the 
ligation mixture above but containing no EHV-1 DNA, the 
second containing neither EHV-1 DNA nor T4 DNA ligase. The 
three reactions were incubated at 4°C for 16 hours. The 
extent of ligation was ascertained by comparing gel 
electrophoretic patterns of aliquots of the reaction 
mixtures with undigested pUC9 and Bam Hl-digested EHV-1 
subtype 2 DNA.
Calcium—shocked E , coli DHI (Hanahan, 1983) were 
transformed with recombinant DNA essentially as described 
by Cohen ei al- (1972). The host was grown at 37°C in 
100ml of L-broth (0.17M NaCl, lOg/1 Difco bactotryptone, 
5g/l yeast extract) to an optical density of 0.6 at 630nm 
in a Gallenkamp orbital incubator. The cells were 
harvested by centrifugation at 8,000 r.p.m. for 2 min at 
4°C, washed by resuspending gently in 50ml of ice-cold lOmM 
CaClg and centrifuged again at 8,000 r.p.m. for 2 min at 
4°. The pellet was gently resuspended in 40ml of ice-cold
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75mM CaClg and left on ice for 20 min. The cells were
harvested as before and resuspended in 1ml 75mM CaCl^ and
kept on ice. The three ligation mixtures and an additional
-4control of 5 x 10 pg undigested pUC9 were added to 0.2ml 
aliquots of competent cells, and after a further 60 min on 
ice were incubated for 2 min at 42°. Each sample was then 
added to 3ml L-broth and incubated at 37°C for 60 min in a 
Gallenkamp orbital shaker.
Aliquots of 0. 1ml were spread on 90mm L-broth agar 
plates containing lOOpg/ml ampicillin, and the plates were 
incubated at 37°C overnight. Transformation efficiency was 
usually around 10^/colonies/pg. All procedures involving 
growth of live bacteria subsequent to transformation were 
done under conditions of good microbiological practice, as 
advised by the Genetic Manipulation Advisory Group and the 
local safety committee.
Analysis of Recombinant DNA Clones
Bacterial colonies were picked using sterile cocktail 
sticks and incubated overnight in 2ml of L-broth containing 
lOOpg/ml ampicillin at 37°C in an orbital shaker. The 
recombinant plasmids were harvested from minicultures by 
the method of Holmes and Quigley (1981). 0.5ml of the
overnight cultures was centrifuged for 2 min in an 
Eppendorf centrifuge and resuspended in 50ul of 8% sucrose, 
0.5% Triton X-100, 50mM EDTA, lOmM Tris-HCl pH 8.0. 5pl of 
a freshly-prepared solution of lysozyme (lOmg/ml) was added 
and the mixture placed in a boiling water bath for 40 sec. 
The preparation was immediately centrifuged in an Eppendorf
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centrifuge for 10 min. The supernatant was removed into a 
clean 1.5ml tube and the DNA precipitated by adding 1/10 
volume 3M NaAC pH 7.5 and an equal volume isopropanol and 
left at -20°C for 1 hour. The DNA was pelleted, washed in 
70% ethanol, dried and resuspended in distilled water. 
Insert sizes were ascertained by gel electrophoresis of 
HI cleavage products. Those colonies chosen to form the 
clone library were colony purified once, and bacterial 
stocks were stored at -20°C in 1% Difco Bactopeptone, 40%
glycerol. Stocks of plasmid DNA were prepared from these 
bacteria.
A bacterial colony or 20pl from the stock was picked 
with a sterile loop and used to inoculate 5ml of 2TY broth 
(lOg Difco bactotryptone, lOg yeast extract, 5g/l NaCl) 
containing lOOpg/ml of ampicillin. The starter culture was 
incubated at 37°C for 24 hours and was then added to 200ml 
of 2TY broth not containing ampicillin. The culture was 
incubated at 37°C overnight in a Gallenkamp orbital 
incubator. The cells were harvested by centrifugation at 
8,000 r.p.m. for 5 min in a GSA rotor. They were 
resuspended in 5ml ice cold 25% sucrose, 50mM Tris pH 8 and 
kept on ice. 2.5ml of a freshly-made solution of lysozyme 
<5mg/ml) were added and the cells left on ice for 30 min.
At the end of this period 2.5ml of ice-cold 0.2M EDTA were 
added and the bacteria left on ice for 20 min, when 2ml of 
cold 1.5% NP40 were added. After a further 10 min on ice 
the cells were centrifuged at 18,000 r.p.m. for 30 min in 
an SS34 rotor to pellet bacterial debris. The supernatant
— 68 —
was extracted twice with phenol : chloroform (1:1) after the 
addition of SDS to a final concentration of 1%. 20yl of 
lOOmg/ml RNase A was added and the preparation left for 30 
min at 37°C. After another phenol : chloroform (1:1) 
extraction, the DNA was precipitated overnight at room 
temperature by adding 1/10 volume 3M NaAc pH 7 and 0,5 
volume isopropanol. A DNA pellet was obtained by 
centrifugation at 2,200 r.p.m. for 15 min. The plasmid DNA 
was then purified by equilibrium centrifugation in a 
caesium chloride-ethidium bromide gradient. 63.5g of 
caesium chloride were added to 4.25ml ethidium bromide 
(lOmg/ml) and made up to a final volume of 85ml with 
distilled water. The DNA pellet was resuspended by 
vortexing with 4.7ml of this mixture, and the resuspended 
DNA was centrifuged in a TV865 rotor at 40,000 r.p.m. for 
16 hours at 15°C. The DNA formed two bands, the lower of 
which consisted of closed circular plasmid DNA. A 
hypodermic needle was inserted into the side of the tube 
and the lower band of DNA collected. The ethidium bromide 
was removed by extracting several times with an equal 
volume of caesium chloride saturated isopropanol, and the 
DNA was dialysed overnight against 0.1 x SSC. The DNA was 
ethanol precipitated, pelleted, drained well and 
resuspended. Finally, the DNA concentration was estimated 
by spectrophotometry.
D ats.i:iB iiiatiQ ii_Q l_D N A _S e.q,ue.ii£S L£
DNA was sequenced using the M13-dideoxynucleotide chain
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terminator method (Sanger at al. , 1977, 1980). Single­
stranded template DÎTA was prepared as follows.
Approximately 50pg of a plasmid containing the EaiD HI 
1 fragment of EHV-1 subtype 2 were digested with EaiD HI and 
electrophoresed on a 1% low melting temperature agarose 
gel. Approximately lOpg of EaiD HI 1 were purified by phenol 
extraction of the appropriate gel slice. The DNA was 
resuspended in 50pl of ligase buffer (SOOmM Tris-HCl pH 
7.5, lOOmM MgClg, lOOmM dithiothreitol) to which 10 units 
of ligase were added and incubated overnight at 15°C. The 
sample was then diluted to 0.5ml in UTE, sonicated at 0°C 
for 7 x 3  sec with 1 min intervals and ethanol 
precipitated. The ends of the sheared fragments were 
repaired by resuspending the DHA in a 20pl solution of GTmM 
Tris-HCl pH 7.9, 6.7mM MgCl^» 5mM dithiothreitol, 0,2mM 
each of dATP, dGTP, dCTP and TTP and 10 units of T4 
polymerase. The reaction was incubated for 2 - 3  hours at 
15°C. The repaired DNA was extracted twice with an equal 
volume of NTE-equilibrated phenol and precipitated by 
adding 2.5 volumes of ethanol on dry ice. The centrifuged 
pellet was washed in 70% ethanol, dried, resuspended in 8% 
PEG and 0.41M NaCl, and left overnight on ice. The DNA was 
pelleted and washed in 70% ethanol. It was then 
resuspended in 50pl NTE and precipitated by the addition of 
an equal volume of isopropanol on dry ice. The pellet was 
washed with 70% ethanol and dissolved in 20pl of distilled 
water. Gel electrophoresis showed that sheared fragments 
were sized 400-1,500bp. 5pg of the processed EHV-1 DNA 
fragments were ligated as described above into Ipg of
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M13mplô DNA which had been cleaved with Sma I and treated 
simultaneously with calf intestinal phosphatase. 100 units 
of T4 DNA ligase were used to ligate the DNA in a volume of 
20pl. Competent cells for transfection by the ligated DNA 
were prepared as follows. A colony of coli K12 strain 
JMlOl (Messing, 1979) was inoculated into 100ml of 2YT 
broth and incubated until the optical density at a 
wavelength of 630nm was 0.3. The cells were harvested by 
centrifugation at 8,000 r.p.m. for 2 min at 8°C and 
resuspended in 50ml of ice-cold 50mM CaCl^. After 30 min 
on ice the cells were again pelleted by brief 
centrifugation at 8,000 r.p.m. The pellet was resuspended 
in 5ml of ice-cold 50mM CaCl^ and kept on ice. Appropriate 
controls were included in the transfection. 0.2ml aliquots 
of calcium—shocked cells were added to tubes containing the 
ligation reactions, mixed well and left on ice for 40 - 60 
min. The cells were then incubated at 42°C for 2 min. E. 
coli JMlOl cells in exponential phase (0.2ml), isopropyl-p 
-D-thio-galactopyranoside (25ul of 25mg/ml in water) and 5- 
bromo-4-chloro-3-indoyl-p -galactosidase (25ul of 25mg/ml 
in dimethylformamide) were dispensed into 3ml aliquots of 
H-top agar (lOg bactotryptone, 8g NaCl and 8g agar per 
litre) at 42°C and the transformed cells added. The 
mixture was swirled before plating out on L-broth-agar 
plates (7.5g/l bacto-agar in L-broth). The plates were 
inverted and incubated overnight at 37°C. Colourless 
plaques were picked with sterile cocktail sticks into 1.5ml 
aliquots of a 1/100 dilution of an overnight JMlOl culture 
in 2YT broth, and incubated at 37°C for six hours in an
T A B L E  1. 1
dGTP mix dATP mix TTP mix dCTP mix
0.5mM aTTP 200 200 10 200
0.5mM dCTP 200 200 200 10
0.5mM dGTP 10 200 200 200
50mM Tris-HCl 
pH 8
ImM Na2EDTA
50 50 50 50
0.2mM
ddGTP
0.7mM
ddATP
0.3mM
ddTTP
0.7mM
ddCTP
5mM ddGTP 40 — - —
5mM ddATP - 14 - -
5mM ddTTP - - 60 -
5mM ddCTP - - - 14
water 960 986 940 986
dNTPmix ddNTP mix Water
dGTP/ddGTP mix 400 150 250
dATP/ddATP mix 400 200 200
dTTP/ddTTP mix 400 400 -
dCTP/ddCTP mix 400 200 200
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orbital incubator. The bacteria were pelleted by 
microfuging for five min. Each supernatent was decanted 
into a fresh tube, and the phage precipitated by the 
addition of ISOul 20% polyethylene glycol 6000 in 2.5M 
NaCl. The preparations were mixed well and left overnight 
at 4°C. The phage was pelleted by microfuging for 5 min, 
resuspended in lOOpl TE and extracted with 50pl of TE- 
equilibrated phenol. Phage DNA was ethanol precipitated, 
washed with 70% ethanol and lyophilised. The lyophilised 
pellets of single-stranded DNA were redissolved in 30pl of 
distilled water and stored at -20°C. Of the 319 templates 
prepared in this way the DNA sequences of 305 were 
determined and those of 186 formed the database.
Eighteen templates were sequenced and electrophoresed 
on a single gel. 9pl of annealing mix d p i  TM buffer, Ipl 
pentadecamer primer, 7pl distilled water) were aliquoted 
into 18 1.5ml tubes. Ipl of template was added to each of 
the tubes, which were whirlimixed and then incubated at
37°C for 30 min. Meanwhile, 40pl dATP mix <23.3pl 0.5mM
32
dATP, 976.6pl water) were added to 8pl <80pCi) C P]dATP 
(PB.10204; Amersham) and whirlimixed briefly. dNTP/ddNTP 
mixes were made as shown in Table 1.1.
Approximately 80 units of the Klenow fragment of E. 
coli DNA polymerase I were added to 50pl 0.1 x TM, 
whirlimixed briefly, and then 2pl were added to each 
annealed template. The templates were centrifuged briefly 
and 2pl of each template was dispensed into the bottom of 
four wells of a 96-well round-bottomed Nunc microtitre
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plate. 2pl aliquots of the appropriate 
32
[ P] dATP/dNTP/ddlTTP mix were aliquoted onto the side of 
the appropriate wells. The lid of the microtitre plate was 
replaced and the drops combined by tapping the plate 
sharply against the edge of the bench. The plate was then 
whirlimixed well, and incubated at 31°C for 15 min. At 
the end of this period, 40 units of the Klenow fragment of 
DNA polymerase I were added to 150pl dNTP chase mix (dNTPs 
at 0.25mM), and 2pl aliquots were added to the side of each 
well and mixed as described above. The reactions were 
incubated at 31°C for 30 min and electrophoresed either 
immediately or as after storing overnight at -20°C
Two 45 X 45cm glass plates, one notched, were cleaned 
thoroughly. The notched plate was then scrubbed with 5ml 
of ethanol, then coated with 5ml of B.D.H. Repelcote and 
scrubbed again with 5ml of ethanol. The plain glass plate 
was scrubbed with 5ml ethanol and coated with Vacker 
solution (5ml ethanol, 0.15ml 10% acetic acid, 25pl Vacker) 
and then scrubbed vigorously three times with 5ml ethanol. 
The two plates were then assembled, treated sides inwards, 
with Sylglass tape after applying 0.6mm Plasticard spacers. 
The gel mixes were prepared. The basic solutions are 10 x 
TBE, 40% acrylamide (380g/l acrylamide, 20g/l N,N'- 
methylenebis-acrylamide, deionized) and 575g/l deionized 
urea. Top gel mix for each gel was made by combining 80ml 
urea with 5ml 10 x TBE and 15ml of 40% acrylamide solution. 
Bottom gel mix consists of 460g/l urea, 250ml/l 10 x TBE,
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150ml/l 40% acrylamide, 50g/l sucrose, 50mg/l bromophenol 
blue.
Two foldback clips were fixed to each edge of the gel 
sandwich before pouring the gel. 120^1 of 25% (wt/vol) 
ammonium persulphate were added to 100ml top gel mix, and 
28pl to 14ml bottom gel mix. The same volumes of TEMED 
were then added to the solutions. 12ml of polymerizing top 
gel mix were taken up immediately into a 25ml pipette, 
followed by 12ml of polymerizing bottom gel mix. Four or 
five air bubbles were allowed to pass up the pipette, and 
the gradient was poured down one side into the gel 
sandwich, which was positioned vertically. A 60ml syringe 
was then used to quickly pour 40ml polymerizing top gel mix 
across the width of the gel, followed by 30ml down the 
other side of the sandwich. All trapped air bubbles were 
tapped out vigourously with the heel of the hand, the gel 
was supported at an angle of 10 - 15° from the horizontal 
and two 40-tooth 0.6mm Plasticard combs were placed into 
the top of the gel and clipped into position with foldback 
clips. When the gel had set completely (about 10 min), the 
clips and the tape at the bottom of the sandwich were 
removed, and the sandwich was placed in a gel kit. Three 
litres of 1 x TBE was divided between the top and bottom 
buffer tanks. The combs were removed carefully and the 
wells washed out with buffer from the top tank. 2 y l  of 
lg/1 bromophenol blue, lg/1 xylene cyanol FF, lOmM Na^EDTA 
in deionized formamide were added to the sequencing 
reactions and the DNA denatured by heating in a boiling 
bath for 1 min. The lanes in the first half of the gel
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were washed out again and loaded with 3pl of the samples 
using a lOpl Hamilton syringe. When the first half of the 
gel was loaded, the second half was washed out and loaded. 
Eighteen templates were electrophoresed on 72 lanes in each 
gel at 60 watts for 2.5 to 3 hours, until about 15 min had 
elapsed after the bromophenol blue dye had electrophoresed 
from the bottom of the gel. The radioactive tank buffer 
was syphoned out, the gel removed from the kit, the 
remaining Sylglas tape removed and the glass plates 
separated. The plain glass plate, to which the gel was 
covalently attached, was soaked in 10% acetic acid for 30 
min with occasional shaking. The gel was rinsed with 
water and baked in a circulating hot air oven at 130°C for 
at least 2 hours. The dried gel was allowed to cool and 
exposed to a sheet of 35 x 43cm Kodak XSl (1596) film for 
24 - 48 hours.
Problems associated with secondary structure, which 
give rise to "compressed" regions in the sequencing ladder 
were solved by substituting dGTP and ddGTP by dITP and 
ddlTP in the sequencing reactions. The 0,5mM dGTP in the 
dNTP mixes was replaced by 2.0mM dITP and the 0.2mM ddGTP 
was replaced by ImM ddlTP. The chase mix was as described 
above.
DNA sequence data were manipulated and analysed in a 
DEC PDP -11/44 computer running under the R5X11M system. 
The programs described by Staden (1977, 1978, 1979, 1980,
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1982) were used to screen gel readings for vector pUC9 
sequences and Earn HI sites, to construct the database and 
to analyse the resulting completed sequence. Codon usage 
was examined by the program of Staden and McLachlan (1982). 
Amino acid sequences were obtained using the translation 
program of Taylor (1986). Analysis of predicted amino acid 
sequences was carried out using a matrix comparison program 
(Pustell and Kafatos, 1982), an alignment program (Taylor,
1984) and a hydrophobicity program (Kyte and Doolittle, 
1982).
CHAPTER 3
STUDIES ON THE STRUCTURE OF THE 
EHV-1 SUBTYPE 2 (2EN0ME
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It has recently been shown that viruses currently 
classified as equine herpesvirus type 1 (EHV—1) represent 
two distinct herpesviruses: subtype 1, primarily an
abortigenic virus, and subtype 2, primarily associated with 
upper respiratory tract disease. Almost all available 
molecular data concern the former, but at the commencement 
of this work nothing was known about the genome structure of 
the latter. Thus, the main objectives of the first part of 
this project were to characterize the genome of the 
respiratory subtype of EHV-1 in order to determine whether 
the two subtypes share a common genome structure, and to 
construct the first restriction endonuclease maps of the 
virus DNA.
Virus Growth and DNA Preparation
The abortigenic subtype of EHV-1 grows on a wide
variety of animal cell lines. Bagust (1971) listed 17
primary cultures and 14 continuous cell line cultures which
support virus growth. Plummer and Vaterson (1963) recorded
the ready propagation of EHV-1 in rabbit kidney cells. The
virus grows to a moderately high titre in cell culture.
For example, in the work described here, stocks of EHV-1
subtype 1 strain Vol939 with titres of 10^ p.f.u./ml and
2
particle/p.f.u. ratios of approximately 10 were prepared 
on RK13 cells.
Subtype 2 of EHV-1 grows to a lower titre in cell 
culture and shows a greater host cell specificity than the
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abortigenic virus (Burrows and Goodridge, 1973; Studdert 
and Blackney, 1979) . The subtype 2 virus used in this work 
was plaque-purified on NBL-6 cells, the only equine cell 
line commercially available in the U.K. One disadvantage 
of this cell line is that on some occasions monolayers 
failed to attain confluency. Subtype 2 isolates have been 
grown on pig kidney cells (Burrows and Goodridge, 1973; 
Studdert and Blackney, 1979), so initial attempts were made 
to plaque-purify the virus on PK(15), an established cell 
line. These cells were more reliable in their growth 
properties than NBL-6 cells, but plaques were smaller and 
virus yields were lower. Therefore, NBL-6 cells were 
used for plaque purification and preparation of working 
stocks of respiratory isolate 1942. Titres of up to 10^
3
p.f.u./ml with particle/p.f.u. ratios of 1-5 x 10 were 
obtained. Virus growth in NBL-6 cells yielded negligible 
amounts of DNA, but an average yield of l-2pg of virus DNA 
per roller bottle was obtained when the virus was cultured 
in an SV40-transformed sheep cell line (SHELUT).
Electron Microscopy of EHV-1 DNA
EHV-1 subtype 2 DNA was denatured and the single 
strands allowed to self-anneal as described in the Methods. 
The aim of this approach was to identify inverted repeat 
sequences in the EHV-1 subtype 2 genome. Figure 3.1 shows 
electron micrographs of EHV-1 self-annealed single strands. 
Each consists of a single-stranded loop joined to a double­
stranded region contiguous with a long single strand. The 
structures are interpreted as the result of annealing of a
EiGIIEE_aJ.
Electron micrographs of annealed single-stranded EHV- 
1 subtype 2 DNA molecules. The molecules show a single­
stranded loop (Ug) with a double-stranded stem (TRg/IRg) 
contiguous with a long single-stranded tail. Single­
stranded (^X174 DNA molecules are indicated by arrows.
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terminal sequence to an internal inverted complementary 
sequence to form a double-stranded region. The single­
stranded loop connecting these sequences and the long 
single-stranded tail, thus represent unique sequences. The 
results were similar to those obtained in electron 
microscopic studies of annealed single strands from PRV DNA 
(Stevely, 1977; Ben-Porat aX. ,1979), EHV-1 subtype 1 
(Ruyechan ei aJL. , 1982) and EHV-3 (Atherton at at. , 1982) .
The genome structure of these viruses consists of an L 
(long) segment of unique sequence linked to an S (short) 
segment comprising an unique sequence (Ug) flanked by 
inverted repeat sequences (TRg/IRg). Therefore, the data 
described here suggest that the genome of EHV-1 subtype 2 
is similar to those of EHV-1 subtype 1, EHV-3 and PRV. The 
loop in the electron micrographs would represent Ug and the 
double-stranded region would result from the annealing of 
TRg and IRg. The long single-stranded tail would 
represent L.
No "dumbel1-shaped" molecules (two single-stranded 
circles joined by a duplex region), indicative of an HSV- 
type genome structure (group E), were observed, and there 
was no evidence to suggest that sequences from the L 
terminus were also present elsewhere in the genome in 
inverted orientation. However, it was concluded from the 
variable length of the single-stranded tails that no full 
length EHV-1 DNA molecules were observed. This was 
probably owing to the presence of nicks or gaps within the 
DNA (O'Callaghan al-, 1983). Thus, the presence of 
additional inverted repeats in the L segment is not ruled
Histogram showing the length distribution of 
molecules of single-stranded |dX174 DNA.
Total number of molecules; 394
Mean length: 5,385.51n (actual length = 5,386n)
Standard deviation: 436.29n
Histogram showing the length distribution of single 
stranded loops of self-annealed EHV-1 subtype 2 DNA. The 
peak at around 5,500 nucleotides (indicated by the arrow) 
probably represents the j uxtapositioning of t|)X174 
molecules with EHV-1 DNA. Values between 12,000 and 
14,500 nucleotides which constitute the second major peak 
were used to estimate the mean size of Ug.
Sample size: 27
Mean length: 13,304.58n
Standard deviation: 511.30n
Figure 3 2a
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out by the electron microscopic data.
The lengths of single-stranded loops in self-annealed 
molecules were measured using a Summagraphics digitizing 
tablet. The size of was calculated from the ratio of 
these lengths to those of single-stranded (|)X174 DNA. 
Histograms of the measurements of cjiX174 and EHV-1 subtype 2 
DNA are shown in Figures 3.2a and 3.2b, respectively. The 
EHV-1 single-stranded loops are represented by a much wider 
range of values than the c|)X174 circles. The reason for 
this is unknown, but it is possible that the ends of the 
single-stranded L regions of some EHV-1 DNA molecules may 
have folded back to give apparent loops. The larger loops 
may be due to partial dissociation of double-stranded 
stems. The first peak at 5,500n for the measurement of 
EHV-1 loops (see arrow in Figure 3.2b) coincides with the 
peak value in measurements of single-stranded ^X174 circles 
(Figure 3.2a) and is probably an artefact due to 
j uxtapositioning of ^iX174 molecules with EHV-1 DNA. To 
calculate the size of U„ of EHV-1 subtype 2, only the 
values representing the main peak, between 12,000 and 
14,500n were considered. The mean value of the 27 samples 
in this range was 13,304.38n. The size of Ug was estimated 
at 13,306n, a result derived by dividing the product of the 
known length of single-stranded c|>X174 (5,386n; Sanger ei 
ai.. , 1978) and the appropriate mean sample value of the
EHV-1 loops (13,304.38n) by the mean value of the 
measurements of the ^X174 circles (5,385.51n).
Measurement of the double-stranded stem structures 
characteristic of the inverted repeat sequences was
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problematic as the boundary of the duplex was difficult to 
distinguish, but the largest measurements gave an estimated 
length of 8,896bp by comparison with measurements of c|)X174 
RF DNA.
Eestric.tlQ ii_Eiiz.yiiie._EaLtte.m £_Q f_EEV:ol_DNA
It has been recognized for some time that EHV-1 
isolates from the respiratory tract tend to differ from 
those from aborted foetuses on the grounds of epidemiology 
(Miller, 1966), pathogenicity (Burrows and Goodridge, 1973) 
and growth characteristics jji vitro (Burrows and Goodridge, 
1973; Studdert and Blackney, 1979). More recently, it has 
been shown both with Australian and American isolates that 
the two virus subtypes can be clearly differentiated by 
restriction endonuclease analysis (Sabine at aJL. , 1981;
Studdert at aJL- » 1981; Turtinen at al. , 1982). Samples of
purified DNA from the two British isolates used in this 
study were digested with restriction enzymes Bam HI and Eco 
RI and separated by agarose gel electrophoresis. Figure 
3.3a shows that the respiratory isolate (1942) is clearly 
distinguishable from the abortigenic isolate (Vol939). The 
restriction endonuclease analysis of the two British 
isolates correlates well with the published profiles of the 
two subtypes (Allen at. aX- , 1983a; Studdert, 1983). The
electropherotype common to the majority of isolates from 
cases of EHV-l-associated abortion in the central area of 
Kentucky from 1960 to 1981 was designated IP. This strain 
now appears to have been largely replaced by one with a 
different electropherotype designated IB (Allen at al_. ,
1985). Vol939 has the restriction profile of a IP isolate/
(a) Horizontal 0 . 7 %  agarose gel showing products of EHV- 
1 subtype 1 and subtype 2 DNA digested with 
restriction endonucleases.
The molecular weights of the EHV-1 subtype 2 
DNA fragments were calibrated from the Hind III 
digest of X  DNA shown in tracks 1 and 6.
Figure 3 3a
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digests of the DNA of both subtypes of EHV-1, 
showing the assignment of letters to bands.
Figure 3 3b
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T A B L E  3.1 
SIZES (kbp) OP EHV-1 SUBTYPE 2 DNA FRAGMENTS
Bam HI Ego RI
Fragments Estimated
Size
Estimated
Molarity
Fragments Estimated
Size
Estimated
Molarity
a 18.5 1 ab 27.5 2
bed 14.1 3 c 18.5 1
e 12.7 1 d 14.1 1
f 11.0 1 e 12.0 1
g 9.5 1 f 9.5 1
h 8.4 1 g 7.3 1
i 6.4 1 h 6.3 1
jkl 4.6 3 ij 6.0
mnn 4.5 3 k 3.4 1
0 4.2 1 1 2.9 1
P 3.6 1 m 2.2 1
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The molecular weights of restriction endonuclease 
fragments of EHV-1 subtype 1 DNA have been published 
(Vhalley et a l . ,  1981; Henry e.t a l . ,  1981). Figure 3.3a 
shows that digestion of EHV-1 subtype 2 DNA with
restriction endonucleases Eam HI and Eco RI yielded 11
visible bands in each case, when electrophoresed in a 0.7% 
agarose gel. The molecular weights of fragments were 
determined by comparison with a Hind III digest of phage X
DNA (Maniatis a l . , 1975). The distance migrated by each
DNA fragment was plotted against the logarithm of the 
molecular weight, and the calibration curve was then used 
to estimate the molecular weights of EHV-1 restriction 
fragments. Bam HI digestion generated fragments ranging 
from 18.5kbp to 3.6kbp in size, and Eco RI fragments ranged 
from 27.5kbp to 2.2kbp. Fragments of both digests were 
assigned letters alphabetically in descending order of 
molecular weight (Figure 3,3b, Table 3,1). The relative 
molarities of the bands of EHV-1 subtype 2 DNA visualized 
in agarose gels were estimated from densitometrie traces 
(Table 3.1) and these values were supported by 
hybridization studies using EHV-1 subtype 2 DNA fragments 
isolated from virion DNA or cloned in a plasmid vector.
The relative molarities of the bands were taken into 
account when estimating the size of the genome. The sum of 
the sizes of individual restriction fragments gives the 
approximate size of the entire EHV-1 subtype 2 genome as 
144kbp.
E1GUEE_3^
Autoradiograph showing the results of hybridizing 
[ P3-labelled Bam HI fragments of EHV-1 subtype 2 DNA to 
a Bam HI digest of the same DNA.
The radiolabelled fragments were hybridized for 
approximately 12 hours to unlabelled DNA immobilized on 
nitrocellulose at 42°C in hybridization solution 
containing 50% formamide. The nitrocellulose strips were 
then washed at 50°C for three hours and autoradiographed.
A summary of the results of this experiment is shown in 
Table 3.2.
EHV-1 subtype 2 Bam HI
Bam HI virion probes
a bed e f g h i jk l  mn o
EHV-1
a
bed
'kino
Autoradiograph, showing the results of hybridizing
op
[ P3-labelled Eco RI fragments of EHV-1 subtype 2 DNA to 
an Ecq RI digest of the same DNA.
Conditions of hybridization and washing were identical to 
those referred to in Figure 3.4.
A summary of the results is shown in Table 3.3.
EHV-1 subtype 2 EcoRI
Eco RI virion probes
EHV-1
f
■
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HybrIdizatlon Studies of EHV-1 Subtype 2 DNA Using Probes
l sQlat.ed_£r_Qm_ V lriQ D  DNA
Sequence homology between DNA fragments may be
investigated by hybridization studies using the blotting
technique developed by Southern (1975). Figure 3.4 shows
32an autoradiograph of the results of hybridizing C P]- 
labelled Eâffi HI fragments of EHV-1 subtype 2 DNA to a Bam 
HI digest of EHV-1 subtype 2 DNA. This experiment was 
designed to verify the presence of the repeated DNA 
sequences detected by electron microscopy. A EajD HI digest 
of EHV-1 subtype 2 DNA was electrophoresed in a 0.5% 
agarose gel and transferred onto nitrocellulose. A second 
Bam HI digest of subtype 2 DNA was electrophoresed in a 1% 
low melting temperature agarose gel. The fragments were 
excised individually, purified and nick translated. The 
nitrocellulose blot was cut into strips and radiolabelled 
Bam HI fragments used as probes. The results are shown in 
Figure 3.4 and summarized in Table 3.2. As expected, each 
DNA probe hybridized to the equivalent fragment in the Baffi 
HI digest. Each probe fragment was unavoidably 
contaminated with fragments which migrated above and below 
it in the low melting temperature gel. For example, in the 
first track of Figure 3.4, hybridization of probe a to band 
bed was due to the contamination of probe a with bed. The 
hybridization resulting from contaminating fragments was 
taken into account when formulating Tables 3.2 and 3.’3. 
However, the hybridization of probe bed to jkl, of probe 
jkl to bed and to p, and probe p to jkl cannot be explained 
on the basis of contamination. These results indicate the
FIGURE 3 .6
Autoradiograph showing the results of hybridizing
[ P]-labelled Bam HI fragments of EHV-1 subtype 2 DNA to
an Eco RI digest of the same DNA. Conditions for 
hybridization and washing were identical to those referred 
to in Figure 3.4. A summary of the results is shown in 
Table 3.2.
The hybridization of probe Bam HI jkl to Eco RI p and
of probe Bam HI bed to Eco RI q was clearer on a longer
autoradiographic exposure.
EHV-1 subtype 2 EcoRI
Bam HI virion probes
a bed e f g h I jkl mnn o p EHV-1
L
ab
IJ
k
I
m
n?
o
P
q
Autoradiograph showing the results of hybridizing
op
[ P3-labelled Eco RI fragments of EHV-1 subtype 2 DNA to 
a Bam HI digest of the same DNA.
Conditions for hybridization and washing were identical to 
those referred to in Figure 3.4. A summary of these 
results is shown in Table 3.3.
EHV-1 subtype 2 Bam HI
EcoRI virion probes 
a b e d  e f g h i j k  I m
EHV-1
t
t
#
T A B L E  3.2
Results of Hybridizing-Nick-Translated Bam HI Fragments 
prepared from EHV-1 Subtype 2 Virion DNA, to Bam HI or 
Eco RI Fragments of EHV-1 Subtype 2 DNA.
Bam HI Probe
Hybridizing 
Bam HI Fragment
Hybridizing 
Eco RI Fragment
a a c,h
bod bod,jkl ab,d,e,f,g,ij,l,m,n,q
e e ab
f f ab
g 6 d,h
h h c,k,p
i i ab
jkl jkl,bed,p ab,e,f ,g,ij ,o,p
mnn mnn ab,e,f
0 0 ab
P jkl,p ab,f
T A B L E  3.3
Results of Hybridizing Nick-Translated Eco RI Fragments 
prepared from EHV-1 Subtype 2 Virion DNA to Eco RI or 
Bam HI Fragments of EHV-1 Subtype 2 DNA*
Eco RI Probe
Hybridizing 
Eco RI Fragments
Hybridizing 
Bam HI Fragments
ab ab,f bcd,e,f,i,jkl,mnn,o,%
c c a,h
d d bed,g
e e bed,jkl,mnn
f f ,ab bed,jkl,mnn,p
g g,ij bed,jkl
h h a,g
ij ij,g bed,jkl
k k h
1 1 bed
m m bed
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presence of repeated DNA sequences within the EHV-1 subtype 
2 genome.
Figure 3.5 shows an autoradiograph of the 
32hybridization of C P]-labelled Eco PI fragments isolated 
from virion DNA to an Eq q  RI digest of EHV-1 subtype 2 DNA. 
These data are summarized in Table 3.3. Again, each 
fragment hybridized to its equivalent, and the existence of 
repeated sequences is demonstrated by the hybridization of 
probe ab to f and probe f to ab. There is also some 
indication that probe ij hybridized to g and that probe g 
hybridized to ij.
Figure 3.6 shows an autoradiograph of the hybridization 
of Earn HI probes prepared from virion DNA to an Eca RI 
digest of EHV-1 subtype 2 DNA, and Figure 3.7 shows the 
hybridization of Eco RI probes prepared from virion DNA to 
a Bam HI digest. These data are summarized in Tables 3.2 
and 3.3. Both Eco RI ab and f hybridized to, among other 
fragments, EaJD HI bed, Jkl and p. Similarly, in addition 
to other fragments, Bajl HI bed, Jkl and p hybridized to Esa 
RI ab and f. These results are consistent with the 
presence of portions of these fragments in repeated regions 
of the genome.
In addition to identifying fragments from the repeated 
regions, it was possible from these data to determine the 
relative locations of several fragments in other regions of 
the EHV-1 subtype 2 genome. For example, EcQ RI h 
hybridized to Bam HI a and g, implying that these two Earn HI 
fragments are adjacent to each other in the genome. In 
turn, Eaiu HI a hybridized to Eq q RI c and h implying that
—  84
Eq û ri c and h are beside each other in the genome.
However, the presence of bands containing more than one 
fragment (e.g. EaiD HI bed and jkl), and the fact that the 
majority of these gave very complex hybridization 
patterns owing to the presence of component fragments in 
repeated regions, made it impossible to derive complete 
restriction endonuclease maps from these data alone. 
Fragment contamination also gave rise to major problems in 
the interpretation of the results.
Cloning.Ql_the EHV-1_Subtype 2 Genome and Use of Clones in 
Mapplng_Stu.di£s
Bam HI fragments of EHV-1 subtype 2 DNA were cloned 
into plasmid vector pUC9 and propagated in Ej_ coli K12 
strain JM83 (Vieira and Messing, 1982). Figure 3.8 
demonstrates that most of the clones contained small 
inserts and that clones containing larger inserts were 
rare. Of the 112 cloned EHV-1 subtype 2 DNA fragments 
analysed, none was larger than lOkbp. Additional clones 
were prepared and propagated in coli K12 strain DHl 
(Hanahan, 1983). 117 clones with inserts were analysed.
Most of the larger Eaju HI fragments of EHV-1 subtype 2 were 
cloned successfully. A library of 13 clones which 
represents approximately 75% of the genome was compiled and 
a stock of each plasmid DNA was prepared. Clones of Bam HI 
k,p,d and e were not obtained. The hybridization and 
restriction endonuclease double digest data discussed below 
suggested that clone 4 may contain Bam HI k and Bam HI b 
with the loss of a Bam HI site. However, the structure of
Electrophoretic analysis of plasmids containing EHV-1 
subtype 2 EaJtt HI inserts. Approximately lug of each 
plasmid was digested to completion with Bam HI and 
electrophoresed on a horizontal 1% agarose gel. The 
centre track shows standard EHV-1 subtype 2 DNA digested 
with Bam HI.
Figure 3 8
Electrophoretic analysis of plasmids containing 
EHV-1 subtype 2 Bam HI fragments
Plasmids PlasmidsEHV-1
”  1
ElGHEE_a^
Autoradiograph showing the results of hybridizing 
C P3-labelled Bam HI cloned fragments of EHV-1 subtype 2 
DNA to a Bam HI digest of the same DNA.
Hybridization and washing conditions were identical to 
those referred to in Figure 3,4. The results are listed 
in Table 3.4. The faint band common to all tracks was 
thought to be a contaminant, perhaps pUC9, which may have 
been present in the dye Ficoll.
EHV-1 subtype 2 Bam HI
EHV-1 a
Bam-HI clones
 1
b c 4  f g h  i j I m n  n+o
t  f f I f- t r. t c ;
9
*\
E1&ÜRE_3^1Û
Autoradiograph showing the results of hybridizing 
[ P]-labelled Bam HI cloned fragments of EHV-1 subtype 2 
DNA to an Eco PI digest of the same DNA. Hybridization 
and washing conditions were identical to those referred to 
in Figure 3.4.
The results are listed in Table 3.4.
The hybridization of cloned Bam HI h and j to Eco RI p was 
clearer on a longer autoradiographic exposure.
The faint band migrating below Eq q  RI 1, in all tracks may 
represent contaminating pUC9 in the dye Ficoll.
EHV-1 subtype 2 EcoRI
Bam HI clones
EHV-1 a b 0 4  f g h i I m n n+o q
ab
0
d
0
9 . #
ii''
m
n
o
P
»
m
Î
T A B L E  3.4
HYBRIDIZATION DATA FOR BAM HI CLONES
Bajn HI Cloned Probes
Hybridizing 
Bam HI Bands
Hybridizing 
Eeo RI Bands
a c ,ha
b bed d,ij,l
0 bed ab,e
4 bed;jkl,p ab,d,f,ij,1
f f ab
g g d,h
h h p,k,e
1 i ab
j jkl e,o,p
1 bed,jkl ab,f,g,ij
m mnn e
n mnn ab,f
n+o mnn, o ab,f
q - e
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this insert was not clearly ascertained. A second clone 
used in most hybridization experiments contains Bam HI n 
and o. Clones containing Bam HI n and o separately were 
also obtained.
• The clones were used in two ways to map the genome of 
EHV-1 subtype 2. Firstly, they were used in hybridization 
studies analogous to those described above in order to 
determine the order of restriction fragments in the genome, 
Secondly, the products of digestion by two restriction 
endonucleases were analysed in order to elucidate the 
locations of Bam HI and E c j q  RI cleavage sites in the 
genome.
The use of cloned DNA fragments in hybridization 
experiments eliminated problems due to fragment 
contamination evident in the autoradiographs shown in 
Figures 3,4 - 3.7, and allowed fragments in multiple bands 
(e.g. Bam HI bed and jkl) to be hybridized separately, 
0.5ug of each plasmid DNA was nick translated and 
hybridized to Bam HI and Ec.Q RI digests of EHV-1 subtype 2 
DNA. The results are shown in Figures 3.9 and 3.10 and 
summarized in Table 3.4.
Restriction EndoDuclease_Daubl&_Dls&st_B%Derlm&p±a
The plasmids were used in restriction endonuclease 
double digest experiments in order to determine the 
locations of RI sites in each cloned Bam HI fragment.
Figure 3.11 shows selected results; the data for all 
digestions are summarized in Table 3.5. The sum of the
ElGIIBE_aaJLi
Cleavage of EHV-1 subtype 2 plasmids with Bam HI and 
Ec q RI.
The DNA was digested and electrophoresed on a 0.7% agarose 
gel. Hind III digests of A  DNA were used as size markers 
(tracks M).
a. Fragments produced by cleavage with Bam HI alone.
b. Fragments produced by cleavage with Bam and ECQ RI.
c. Fragments produced by cleavage with Ec q  RI alone.
Figure 3 11
Restriction Endonuclease analysis of
EHV-1 subtype 2 plasmids
M. Hind III digest of \  DNA,
a. Fragments produced by cleavage with Bam HI alone.
b. Fragments produced by cleavage with Bam HI and Eco
RI.
c. Fragments produced by cleavage with Ec q  RI alone.
Figure 3 11 cont.
Restriction Endonuclease analysis of
EHV-1 subtype 2 plasmids
T A B L E 3.5
Sizes (kbp) of Fragments generated by 
digesting cloned EHV-1 Subtype 2,
DNA Fragments with Bam HI and Eco RI
CLONES
EHV-1
DNA
FRAGMENTS
PRODUCTS 
of 
Bam HI 
DIGESTION
PRODUCTS 
of Bam HI 
+ Eco RI 
DIGESTION
PRODUCTS 
of 
Eco RI 
DIGESTION
a 18.5, 2.7 13.7, 4.8, 2.7 13.7, 7.5
b 14.1, 2.7 6.3, 5.0, 2.8, 2.7 6.3, 7.8, 2.7
c 14.1, 2.7 10.0, 3.1, 2.7, 1.0 12.6, 3.2, 1.0
4 18.7, 2.7 9.8, 5.0, 2.8, 2.7 9.8, 7.8, 2.7
f 11.0, 2.7 11.0, 2.7 13.7
g 9.5, 2.7 8.0, 2.7, 1.5 1.5, 10.7
h 8.4, 2.7 4.7, 3.3, 2.7 7.4, 3.3
1 6.4, 2.7 6.4, 2.7 9.1
j 4.6, 2.7 3.4, 2.7, 1.0 7.3
1 4.6, 2.7 3.0, 2.7, 1.6 4.3, 3.0
m 4.5, 2.7 4.5, 2.7 7.2
n 4.5, 2.7 4.5, 2.7 7.2
0 4.2, 2.7 4.2, 2.7 6.9
q 1.0, 2.7 1.0, 2.7 3.7
pUC9 = 2.7 kbp in size.
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molecular weights of EHV-1 DNA fragments resulting from 
digestion with EaiD HI plus Eqq RI agreed well with the 
molecular weight of each intact fragment.
D&rl%atiQn_af_th&_R&strlGt i Qn_EndQiiLL£le.aLae,_] 
of the EHV-1 Subtype 2 Genome
The hybridization of Bam HI virion DNA fragments 
to a Bam HI digest of EHV-1 subtype 2 DNA (Figure 3.4) 
showed that, in addition to hybridizing to themselves, Bam 
HI bed hybridized to jkl, Eaffi HI jkl hybridized to bed and 
to p, and Bam HI p hybridized to jkl. These data indicate 
the presence of portions of the fragments in these bands in 
repeated DNA sequences. The use of cloned DNA as 
hybridization probes helped to identify the individual 
fragments mapping in the repeats. Cloned Bam HI 1
hybridized to Bam HI jkl and bed, but neither cloned Bam HI b
nor cloned Bam HI c hybridized to Bam HI jkl (Figure 3.9).
This implies that Bam HI 1 hybridizes only to Bam HI d,
which was not cloned. Bam HI p from virion DNA hybridized 
to Bam HI jkl (Figure 3.4) and, since neither cloned Bam HI 
1 nor cloned Bam HI j hybridized to p, Bam HI k, which was 
not cloned, must hybridize to p (Figure 3.9).
The hybridization of Eco RI virion DNA probes to an 
Eco RI digest of EHV-1 subtype 2 DNA (Figure 3.5) indicated 
the presence of portions of Eco RI f and one or both of EcLQ 
RI ab in the repeated regions, as Ecfi RI f and ab 
hybridized to themselves and to each other. Similarly, the 
results in Figure 3.5 suggest that Ecm RI g and either or 
both of ij hybridized to each other. However, the weak 
hybridization between Eco RI g and ij indicates that
A diagrammatic representation of the derivation of 
the Bam HI and Eco RI linkage maps for the S segment of 
the EHV-1 subtype 2 genome. The linkage maps are shown 
above and below the representative genome, in which 
inverted repeats are denoted by hatched rectangles. 
Fragments, not drawn to scale are represented by broken 
lines. The letters x and y denote possible additional E&Q 
RI fragments at the locations indicated by the arrows.
Figure 3 12
Derivation of the Bam HI and EcoRI Linkage Maps for the S region
of the EHV-1 subtype 2 genome
a.
Bam HI
m m ?
Eco RI
b.
Bam HI
EcoRI
c.
Bam HI
k n
r I------
Eco RI
d.
Bam HI
Eco RI
______I I_____
g m j
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hybridizing fragments share only a short sequence. These 
data are interpreted as follows. Firstly, Eco RI b and f, 
which show a high degree of homology originate from the S 
terminus and L-S joint. Eco RI f is the smaller of the 
fragments and therefore represents the S terminal fragment, 
and Eco RI b contains the L-S joint. Secondly, Eco RI g and 
j contain the TRg/U^ and IR^/Ug junctions. The proposed 
arrangement of Eco RI fragments in S is illustrated in 
Figure 3.12a, but does not exclude the presence of 
additional Eco RI fragments between b and g, g and j , and j 
and f. Hybridization of cloned B&m HI 1 to EcQ RI ab, f , 
g and ij (Figure 3,10) shows that this fragment spans the 
junction between Ec.Q RI b and g or j and f. The stronger 
hybridization to Eco RI ij than to g indicates that Bam HI 
1 shares more sequence with the former, and therefore that 
Bam HI 1 spans the junction between Eco RI j and f. This 
arrangement is illustrated in Figure 3,12b. Restriction 
endonuclease analysis showed that Bam HI 1 is cleaved by 
Eco RI to give fragments of 3kbp and 1.6kbp (Table 3.5).
The stronger hybridization of Earn HI 1 to Ecj2 RI ij than to 
Eco RI f (Figure 3.10) suggests that the Eco RI site is 
nearer the right end of Earn HI 1. This found proof in the 
DNA sequence of E&m HI 1 discussed in Chapter 5. The Esja 
HI site which divides 1 and n is located approximately 8kbp 
from the S terminus, and an equivalent Eam HI site is 
located in IR^. The genome location of E&m HI d, which 
hybridized to Eâffi HI 1 (Figure 3.9), is shown in Figure 
3.12b.
Eco RI f hybridized to Bam HI bands bed, jkl, mnn and
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p (Figure 3.7). Cloned EaJD HI n hybridized to Eq.q RI ab 
and f, and Earn HI mnn, verifying the location of this 
fragment completely within TR^/IR^ (Figures 3.9 and 3.10). 
Earn HI n was not cleaved by Ec.Q RI (Table 3.5), and is 
unlikely to be the S terminal fragment because it was 
cloned. Eco RI f also hybridized to Bam HI p, which 
hybridized to itself and to Earn HI k (Figures 3.4 and
3.7). Neither Bam HI p nor Bam HI k were cloned, but, on
the basis of size, it is proposed p is at the S terminus 
and k at the L-S joint. The data are consistent with the 
location of Bam HI n between 1 and p, as shown in Figure 
3.12c. The sum of the sizes of Earn HI p, n and the portion 
of 1 within Eco RI f corresponds to the size of Ecu RI f , 
implying that all large Earn HI fragments in TR^/IRg have 
been accounted for. However, the sum of the sizes of Earn 
HI d and 1 is 18.7kbp, whereas the sum of the sizes of Eq q 
RI j and Eco RI g plus twice the size of the portion of Bam 
HI 1 to the right of the Eco RI site is only 16.5kbp. The 
difference between these sizes implies that there is a 
2.2kbp fragment between Eco RI g and j. Bam HI bed from 
virion DNA hybridized to EQ.Q RI ab, d, e , f , g, i j , 1, m
and n (Figure 3.6). Cloned Bam HI b hybridized to Eq.Q RI
d, ij and 1 while clone Bam HI c hybridized to EsiQ RI ab
and e (Figure 3.10). Thus Eco RI m and n are candidates for 
the small fragment between Eco RI g and j. Ecû RI n is 
anomalous in being present in reduced molarity on the 
control filter in Figure 3.6, and is possibly related to 
another fragment such as Eco RI m. Ecü RI m has a size of 
2.2kbp, and is therefore the best candidate for the small
—- 89 —"
fragment between Eco RI g and j . The complete Earn HI and 
Eco RI restriction endonuclease maps for the S segment of 
the genome of EHV-1 subtype 2 is shown in Figure 3.12d,
Earn HI k, which contains the L-S junction, was not 
cloned. Cloned Bam HI b and cloned 4 both hybridized to 
Bam HI bed (Figure 3.9) and to Eco RI d, ij and 1 (Figure 
3.10). Clone 4 also hybridized to Bam HI jkl and p (Figure
3.9) and to Eco RI ab and f (Figure 3.10). This suggests 
that clone 4 contains sequences from Bam HI b and Eaffi HI k.
[%1—Siibtype
Eco RI b contains the L-S joint and a portion of this 
fragment makes up the major part of IR^ (Figure 3.12d).
The hybridization data concerning Esü RI ab were analysed 
in an attempt to determine the relationship of Eco RI b to 
other fragments in and to ascertain which Bam HI 
fragments hybridized to Eco RI a and not to b. Probe Eco 
RI ab hybridized to Bam HI bed, e, f, i, jkl, mnn, o and p 
(Figure 3.7). EâJD HI d, k, 1, n and p hybridized to a
portion of Ec.Q RI b in IRg. Cloned Bam HI fragments b, j
and m did not hybridize to Eco RI ab (Figure 3.10). Thus, 
Bam HI c, e, f, i and o overlap ECQ RI a or the portion of 
b in U^. The hybridization patterns of these Bam HI
fragments were studied to elucidate the location of Eco RI
a. Cloned Eaifl HI c hybridized to EcQ RI ab and e (Figure
3.10) and produced fragments of lOkbp, l.Okbp and 3.1kbp on 
digestion with Eco RI and Bam HI (Table 3.5). These data 
imply that the left end of EoJi RI b or one end of Eco RI a
FIGURE 3.13
A diagranmiatic representation of the derivation of 
the Bam and Eco RI linkage maps for a portion of the of 
the EHV-1 subtype 2 genome. The linkage maps are shown 
above and below the representative genome, in which 
inverted repeats are denoted by hatched rectangles. 
Fragments not drawn to scale are represented by broken 
lines.
Figure 3 13
Derivation of the Bam HI and EcoRI Linkage Maps for the of the
EHV-1 subtype 2 Genome
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A diagrammatic representation of the derivation of 
the Bam HI and Eco RI linkage maps for a portion of the 
of EHV-1 subtype 2 genome. The linkage maps are shown 
above and below the representative genome.
Figure 3 14
Derivation of the Bam HI and EcoRI Linkage Maps for the Ul of the
EHV-1 subtype 2 Genome
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contained within E&ID HI c and located between RI e and
a was identified as Ec.q RI q on the basis of hybridization 
of Bam HI bed to an Eq.Q RI digest of EHV-1 subtype 2 DNA 
(Figure 3.14a). Probe RI e hybridized to EaiB HI bed,
jkl and mnn (Figure 3.7). Cloned Bam HI q and m hybridized 
only to Eco RI e , and cloned Bam HI j hybridized to Ec.Q RI 
e and to two smaller fragments, Eq q  RI o and p (Figure
3.10). Therefore, Eâlû HI fragments m and q, which were not 
cleaved by Eco RI (Table 3.5), are located between EâlB HI j 
and c. It was not possible to determine the order of Earn 
HI m and q from these data (Figure 3.14b). They are shown 
in the order m-q in the final map of in Figure 3.14.
Cloned Bam HI j and h hybridized to Eco RI p but only 
Bam HI j hybridized to Eco RI o, thus implying that Eq q  RI 
o is contained completely within Bam HI j and maps adjacent 
to Eco RI e (Figures 3.10 and 3.14b). Digestion of cloned 
Bam HI j with Bam HI and Eco RI resulted in fragments of 
3.4kbp and Ikbp (Table 3.5), which represent a portion of 
Eco RI e and the whole of Eco RI o, respectively, EsQ RI p 
contains the Bam HI site between EâlB HI j and h, but the 
small portion of this fragment within Eani HI j was not 
detected by restriction endonuclease digestion (Figure 
3.14c).
Cloned Bam HI h hybridized to Ec.Q RI p, k and c 
(Figure 3.10). Eco RI k hybridized only to E&m HI h 
(Figure 3.7) and one of the fragments resulting from 
digestion of cloned Bam HI h with EâîB HI and Es.Q RI is 
equivalent in size to Eco RI k (Table 3.5). This indicates 
that Ecld RI k is contained wholly within EaiB HI h, and is
9;
thus located between Eq.q RI p and Ec q RI c (Figure 3. 14c) . 
Hybridization of Ecia RI c to a Eaili HI digest of EHV-1 
subtype 2 DNA (Figure 3.7) showed that Eaiu HI a and h are 
adjacent (Figure 3.14d). Cloned Earn HI a hybridized to Eco 
RI c and h (Figure 3.10), thus locating Eco RI h next to 
Eq q  RI c, and E&O RI h hybridized to Earn HI g and a (Figure
3.7), indicating that Bam HI g is next to Bam HI a (Figure 
3.14d). These fragment locations were confirmed by double 
digestion of cloned Earn HI a and g (Table 3.5).
EC-Q RI d hybridized to Bam HI bed and g (Figure 3.7). 
As Earn HI c and d were mapped previously, Earn HI b must be 
adjacent to Bam HI g (Figure 3.14e). Cloned Bam HI b 
hybridized to Ec.Q RI d, ij and 1 (Figure 3.10) and on 
digestion with Bam HI and Eco RI yielded products of
6.3kbp, 5kbp and 2.8kbp. The 6.3kbp product plus the 8kbp 
product of cloned Eam HI g is equivalent in size to Eco RI
d. The 2.8kbp product represents the whole of 1, and the 
remaining 5kbp is equivalent to the portion of Eg.Q RI i 
which overlaps Bam HI b. Bam HI b was cloned and therefore 
is unlikely to be the fragment at the L terminus. The 
restriction endonuclease digestion results suggest that the 
Ikbp of EQ-Q RI i which does not map in Eam HI b is present 
in a small EaiB HI fragment at the L terminus. The complete 
Earn HI and EcQ RI restriction endonuclease maps of the EHV- 
1 subtype 2 genome are shown in Figure 3.15.
EISÜEËJi.^ 15
Bam HI and Eco RI maps of EHV-1 subtype 2 DNA, The 
location of the cleavage sites are shown above and below 
the representative genome. The inverted repeat sequences 
are represented by hatched rectangles.
Figure 3 15
Restriction Endonuclease Maps of the EHV-1 subtype 2 Genome
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Restriction endonuclease maps of EHV-1 subtype 1 and 
subtype 2 DNA, The locations of the Eao HI and Eco RI 
cleavage sites are shown above the representative genomes. 
The inverted repeat sequences are represented by hatched 
rectangles.
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DISQUSSIQÏÏ
The analysis of EHV-1 subtype 2 DNA is consistent with 
a model for the genome structure similar to that for EHV-1 
subtype 1. However, the comparison of restriction 
endonuclease maps in Figure 3,16 shows that the two 
subtypes are quite different in the arrangement of 
restriction sites.
The size of the EHV-1 subtype 2 genome was estimated 
at approximately 144kbp <93.5 x 10^ daltons) from the sums 
of the sizes of Bam HI and EcQ RI fragments. However, 
hybridization studies and double digestion of cloned DNA 
fragments revealed the existence of several additional 
small fragments, allowing the original estimate to be 
revised to 146kbp <95 x 10^ daltons). The genome consists 
of two segments: L (lllkbp) and S (35kbp). The S segment
comprises a unique sequence (U^) flanked by inverted repeat 
sequences (TRg/IRg). From estimates of fragment size, 
TRg/IRg are larger than 9.5kbp (Eco RI f) and less than 
12.7kbp (Bam HI 1+n+p). The electron microscopy data 
indicate a size of 13.3kbp for U^, suggesting that the 
TRg/IRg are lO.Skbp in size, a value which falls within 
this range. The genome of EHV-1 subtype 1 is 153kbp (100 x 
10^ daltons) in size (Vhalley ei aX., 1981) . The S
segment of EHV-1 subtype 1 (40kbp) is approximately 5kbp
larger than that of EHV-1 subtype 2, and the estimated size 
of IRg/TRg is between 8.6kbp and 13.4kbp, implying that 
has a minimum size of 12.Ikbp.
The hybridization data do not indicate the presence of 
an inverted repeat flanking of EHV-1 subtype 2.
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However, a very small repeat, such as that present in the 
VZV genome (Davison, 1984), cannot be ruled out at present. 
Similarly, no indication of a terminal redundancy akin to 
the HSV-1 a sequence was found.
Since both Eco RI and Bam HI cleave within the 
inverted repeat sequences of the subtype 2 genome it is not 
known whether U„ inverts relative to a fixed orientation of 
L, as occurs in subtype 1.
CHAPTER 4
STUDIES ON THE LOCATION OF HOMOLOGOUS 
SEQUENCES IN THE GENOMES OF THE 
TWO SUBTYPES OF EHV-1 AND HSV-1
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RESULTS 
IntcQduciioû
At the onset of this project none of the genes of EHV-
1 subtype 2 had been mapped. The object of this section
was to use comparative hybridization to study the extent
and distribution of homologous sequences between the
genomes of the two subtypes of EHV-1 and between the
genomes of EHV-1 subtype 2 and HSV-1. Since the
development of methods for immobilizing DNA on
nitrocellulose filters (Nygaard and Hall, 1964) and for
detecting bound nucleic acid with radiolabelled probes
(Denhardt, 1966; Gillespie and Spiegelman, 1965),
hybridization procedures have been used widely to determine
relationships between nucleic acids. Moreover, the Southern
blot technique allows DNA sequences fractionated by agarose
gel electrophoresis to be transfered to nitrocellulose
prior to detection by hybridization (Southern, 1975).
Southern hybridization was employed by Davison and Vilkie
(1983) and Ben-Porat eJL &T. (1983) to identify the more
highly conserved regions in the genomes of several members
of the Alphaherpesvirinae. Davison and Vilkie (1983) used
cloned DNA probes to investigate homologous sequences in
the genomes of HSV-1, HSV-2, EHV-1 subtype 1, VZV and PRV.
Conserved sequences include those which in HSV-1 code for
the major DNA-binding protein, the major capsid protein,
the DNA polymerase, the immediate-early protein V^^IE 175
and one or both of the early proteins V 136 and V 38,
^ mw mw
which are the two subunits of the active HSV-1 
ribonucleotide reductase (Bacchetti et al. , 1984; Preston
Hybridization of cloned Kpn I fragments of HSV-1 to a 
Bam HI digest of EHV-1 subtype 2 DNA. Hybridization was 
carried out in 30% formamide at 37°C for approximately 50 
hours, after which the nitrocellulose strips were washed
at 45°C.
EHV-1 subtype 2 Bam HI
HSV-1 Kpn I probes
EHV-1 S V 4 0  a’ i p k s
mnn ■
FIGU£E-4^
Restriction endonuclease maps of HSV-1 and. EHV-1 
subtypes 1 and 2. The maps are shown below each 
representative genome and those for HSV-1 are in the 
arrangement. The inverted repeat sequences are 
represented by cross-hatched boxes. The HSV-1 Ba.zn HI map 
is from Davison and Vilkie <1981), the HSV-1 Kpn I map is 
from Preston o X  al* (1978), the EHV-1 subtype 1 maps are 
from Vhalley q X  aX« (1981) and the EHV-1 subtype 2 maps 
have been discussed in Chapter 3.
Figure 4 2
Restriction endonuclease maps of the DNA of HSV-1 and EHV-1 subtypes 1 & 2
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et al., 1984; Frame at al. » 1985). Davison and Vilkie
(1983) concluded that HSV-1 probes which contain sequences 
from better conserved genes could be used to locate 
counterparts of these genes in other members of the
Figure 4.1 shows the result of hybridizing five nick-
translated HSV-1 probes to a Bam HI digest of EHV-1 subtype
2 DNA immobilized on nitrocellulose. Hybridization was
carried out under conditions of low stringency, as EHV-1
subtype 2 and HSV-1 are only distantly related. The probes
comprised Kpn I fragments of HSV-1 (Figure 4.2) cloned in
pAT153, and each contains a conserved region identified by
Davison and Vilkie (1983). Kpn I a' (l.lkbp) is completely
contained within the protein-coding sequence of the DNA
polymerase gene (Quinn and McGeoch, 1985); Kpn I i
(9.7kbp) contains the entire coding sequences of three
genes, including the major capsid protein gene, and
portions of two other genes (Davison and Scott, 1986b); Kpn
I p (3.5kbp) contains the majority of the coding region for
the major DNA binding protein (Quinn and McGeoch, 1985) and
one other gene of unknown function; Kpn I k (7.4kbp)
encodes V IE 175, V IE 12 and portions of a DNA-binding mw mw
protein and a tegument phosphoprotein (Murchie and McGeoch, 
1982; McGeoch at al-, 1985; Dalziel and Marsden, 1984;
Frame at al-, 1986b); Kpn. I s (3.4kbp) contains portions of 
the genes encoding the two subunits of ribonucleotide
T A B L E  4.1
Hybridizing of Plasmids Containing HSV-1 DNA Fragments 
to EHV-1 Subtype 2 DNA Blotted Onto Nitrocellulose.
Probe DNA 
HSV-1 I
Bam HI Fragments of EHV-1 Subtype 2  ^
to which Probe Hybridized
a' -
i f
P mnn
k jkl,mnnjp
8 a
SV40 DNA jkl,p
ElGUEE_â^
Location of highly conserved genes on the EHV-1 
subtype 2 genome. The R q j b HI and Ec,C2 RI maps are shown 
above and below the representative genome. The inverted 
repeat sequences are represented by cross-hatched boxes. 
The predicted location of the gene coding for the 
ribonucleotide reductase (red), the DNA polymerase (pol), 
the DNA-binding protein (DBF), glycoprotein B (gB), the 
major capsid protein V^^175 (IE175) are indicated by 
vertical lines.
Figure 4 3
Location of highly conserved genes on the EHV-1 subtype 2 genome
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reductase (Draper al. , 1982; McLauchlan and Clements,
1983). The hybridization results are listed in Table 4.1 
and the approximate positions of several highly conserved 
genes on the EHV-1 subtype 2 genome are indicated in Figure
4.3.
No hybridization of HSV Kpn I a ' to EHV-1 subtype 2 
DNA was detected. The predicted amino acid sequence of the 
HSV-1 and EBV DNA polymerases share considerable homology, 
reflected in the DNA sequences, but the most highly 
conserved region (amino acid residues 880 to 896 in the 
HSV-1 DNA polymerase) is coded by Kpn I x (Quinn and 
McGeoch, 1985). It is possible that a probe from elsewhere 
in the HSV-1 DNA polymerase gene would have hybridized to 
EHV-1 subtype 2 DNA. SV40 DNA was also used as a probe in 
the experiment in order to eliminate the remote possibility 
that EHV-1 subtype 2 DNA prepared from SHELUT cells, a line 
generated by SV40 transformation of sheep cells, contained 
SV40 DNA. Under conditions of low stringency the SV40 
probe hybridized to EHV-1 subtype 2 Bam HI j kl and p. This 
hybridization is probably non-specific and indicative of 
the higher G+C content of the TR^/IR^, as discussed in 
Chapter 5. However, it suggests that care must be taken in 
the interpretation of the results of hybridization of other 
probes to these fragments,
m i z i
The two subtypes of EHV-1 cross-neutralize and share 
multiple antigens (Allen and Bryans, 1986). Kinetic 
analysis of re-association experiments indicate that the
E1QUEE_A^
Hybridization of cloned EaJQ HI fragments of EHV-1 
subtype 2 DNA to an Eq.q  RI digest of EHV-1 subtype 1 DNA. 
Hybridization was carried out in 30% formamide at 37 C for 
approximately 24 hours, after which the nitrocellulose 
strips were washed at 45°C. The results of this 
experiment are listed in Table 4.2.
EHV-1 subtype 1 EcoRI
EHV-1 subtype 2 Bam HI clones
EHV-1
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T A B L E  4.2
Homologous DNA Fragments of EHV-1 Subtypes 1 and 2
PROBE HYBRIDIZATION TO BLOTS
Bam HI Clones Eco RI Bam HI
EHV-1 Subtype 2 EHV-1 Subtype 1 EHV-1 Subtype 1
a ghi,n,m,p a,m,l,k
b ghi,3,0 g,3,t
0 a b,i
4 b,c,d,f,ghi,3 ,o g,e,3 ,n,t
f a b,f
6 ghi,n h, j
h ghi a
i e,l 0,0
j a, ghi a
1 b,c,d,f,k d,n,p
m a a
n b,c,d,f,ghi qrs
0 b,d,l,3 e
q a a
Summary of the regions of homology between the 
genomes of the two subtypes of EHV-1. Representative 
genome structures define the axes, and regions of homology 
are shown by stippling. Only regions of homology 
identified by the hybridization of EHV-1 subtype 2 
fragments to both a Bam HI and Eco RI digest of EHV-1 
subtype 1 are represented. The map locations of several 
EHV-1 subtype 2 Earn HI fragments are ambiguous. Homology 
between these fragments and EHV-1 subtype 1 DNA is 
indicated by open boxes. The uncloned EHV-1 subtype 2 
fragments k, p, d and e are indicated by a line below the 
genome. No data are available on the homology between 
these regions of the genome and EHV-1 subtype 1 DNA.
Figure 4 5
Homology between the Genomes of the two subtypes of EHV-1
EHV-1 subtype 2
EHV-1 
subtype 1
EHV-1 
subtype 1
EHV-1 subtype 2
FIGURE 4.6
Hybridization of cloned Bam HI fragments of EHV-1 
subtype 2 DNA to a Kpn I digest of HSV-1 DNA.
Hybridization was carried out in 30% formamide at 37°C for 
approximately 50 hours, after which the nitrocellulose 
strips were washed at 45°C. The results of this 
experiment are listed in Table 4,3.
HSV-1 Kpn 1
EHV-1 B a m  HI clones
HSV-1 a
a b e d
n m
w x  #
EiaU££-A^Z
Hybridization of cloned Bam HI fragments of EHV-1 
subtype 2 DNA to a Bam HI digest of HSV-1 DNA. 
Hybridization was in 30% formamide at 37°C for 
approximately 50 hours, after which the nitrocellulose 
strips" were washed at 45°C.
The results of this experiment are listed in Table 4.3
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T A B L E  4.3 
Homologous DNA Fragments of HSV-1 and EHV-1 Subtype 2
PROBE DNA FRAGMENTS TO WHICH CLONES HYBRIDIZED
Bam HI Dlones Bam HI K£n I
EHV-1 Subtype 2 HSV-1 HSV-1
a 0 s
b N N
0 6 no,p,t
4 N N
f a,m wz,i
g N N
h w abed
i c,e abed
j r wx
1 N N
m g P
n b,e,3 abed,efg,h
0 N N
q N N
N e No significant hybridization*
ElûUEE_4.a_S.
Summary of homology between the genomes of EHV-1 
subtype 2 and HSV-1, These regions were identified by the 
hybridization of cloned HSV-1 Kpn I fragments to EHV-1 DNA 
(Figure 4.1) and by hybridization of cloned EHV-1 subtype 
2 Bam HI fragments to HSV-1 DNA (Figures 4.6 and 4.7), 
Representative genome structures define the axes, and 
regions of homology are shown by stippling. The HSV-1 
genome is illustrated in the I^ orientation. EHV-1 
subtype 2 EaiB HI fragments k, p, d and e were not cloned. 
HSV-1 cloned Kpn I k hybridized to the former two 
fragments amongst others (Figure 4.1). No homology data 
are available for EHV-1 subtype 2 Bam HI d and e. These 
fragments are indicated by a line at the side of the EHV-1 
genome. Hybridization of regions of the EHV-1 subtype 2 
genome' which were not unambiguously mapped are indicated 
by open boxes.
Figure 4 8
Regions of Homology between the Genomes of HSV-1 and EHV-1 subtype 2
HSV-1
EHV-1 
subtype 2
□
□
EHV-1 
subtype 2
HSV-1
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(1983) demonstrated that HSV-1 DNA probes hybridized to 
limited areas of the EHV-1 subtype 1 genome and that 
homologous regions in the EHV-1 genome are colinear with 
the arrangement (Figure 1.1) of the HSV genome. As the 
genomes of the two subtypes of EHV-1 appear to be colinear 
(Figure 4.5), it is likely that the genome of EHV-1 subtype 
2, like that of subtype 1 is also colinear with HSV. To 
test this hypothesis, cloned fragments of EHV-1 subtype 2 
DNA were hybridized to restriction endonuclease digests of 
HSV-1 DNA. These experiments also served to verify the 
results of hybridizing HSV-1 probes containing sequences 
from highly conserved genes to EHV-1 subtype 2 DNA. 
Representative autoradiographs showing the results of 
hybridizing cloned Earn HI fragments of EHV-1 subtype 2 DNA 
to Kpn I and Earn HI digests of HSV-1 DNA are shown in 
Figures 4.6 and 4.7, respectively. The results are listed 
in Table 4.3 and summarized graphically in Figure 4.8. 
Hybridization of EHV-1 subtype 2 clones to HSV-1 DNA was 
weaker than that observed between the two subtypes of EHV-1 
under identical conditions of low stringency. Also, under 
these conditions, homology was confined to certain regions 
of the genomes. Earn HI b, g,l, o and q of EHV-1 subtype 2 
demonstrated no significant hybridization to HSV-1 DNA. 
Homologous regions correspond well to those containing the 
highly conserved HSV-1 genes identified by Davison and 
Vilkie (1983). Bam HI f of EHV-1 subtype 2, which 
hybridized to the HSV-1 probe containing the major capsid 
protein gene (Figure 4.1), hybridized in these experiments 
to HSV-1 Kpn I w and i and Earn HI a and m. The gene
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encoding the HSV-1 major capsid protein is located in these 
fragments. Bam HI a of EHV-1 subtype 2 hybridized to HSV-1 
EaiD HI o and Kpn I s, and EHV-1 Eaffl HI m hybridized to HSV- 
1 Kpn I p and Bam HI g. These results substantiate the 
hybridization of HSV-1 probes for the ribonucleotide 
reductase and major DNA binding protein genes to EHV-1 
subtype 2 Bam HI a and m, respectively (Figure 4.1). EHV-1 
subtype 2 Bam HI j hybridized to HSV-1 Bam HI r and Kpn I 
X ,  which contain sequences from the DNA polymerase gene.
The functions of proteins encoded by HSV-1 DNA sequences 
which hybridized strongly to Bam HI i of EHV-1 subtype 2 
are unknown. However, proteins coded by DNA sequences in 
this region ore.highly homologous to the equivalent VZV 
protein (D.J. McGeoch and A.J. Davison, personal 
communication) . EHV-1 subtype 2 Bam HI h hybridized to 
HSV-1 sequences adjacent to those encoding the DNA 
polymerase, and Bam HI c hybridized to the region of the 
HSV-1 genome which encodes the major DNA binding protein 
and glycoprotein gB. In summary. Figure 4.8 shows that 
homologous regions in the EHV-1 subtype 2 genome are 
colinear with the I^ or 1^^ genome arrangement of HSV-1.
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DISQUSSIQE
Re-association kinetic and thermal dénaturation 
analysis of the equine herpesvirus genomes indicated that 
the EHV-1 subtype 1 and EHV-3 genomes share 7 - 10% 
sequence homology, whereas EHV-2 is less closely related to 
either virus, sharing 2 - 3% homology with EHV-1 subtype 1 
and 1 - 2% homology with EHV-3 (Allen g.t ai. , 1977b;
Staczek ei aX-» 1983). In cross-hybridization studies the
two subtypes of EHV-1 showed 17% homology (Allen and 
Turtinen 1982), and similar experiments indicated that HSV- 
1 and HSV-2 share up to 50% of their genome nucleotide 
sequence (Kieff at. aX. , 1972; Ludwig at aX. , 1972; Sugino
and Kingsbury, 1976). Antigenic cross-reactivity and 
overlap in disease potential suggests that the relationship 
between the subtypes of EHV-1 may be somewhat analogous to 
that between HSV-1 and HSV-2 (Turtinen, 1983). Vilkie at 
aX* (1979) demonstrated that almost all regions of HSV-1 
and HSV-2 were homologous to some extent, areas of least 
homology including TR^/IR^ and most of the S segment. The 
close relationship between and colinearity of the HSV-1 and 
HSV-2 genomes was verified by Davison and Vilkie (1983),
In 50% formamide at 37% every Kpa I fragment of the HSV-1 
genome hybridized to filters containing HSV-2 DNA 
fragments. The colinear distribution of homologous regions 
complemented earlier genetic data indicating colinearity 
between the genomes of HSV-1 and HSV-2 (Chartrand e.i. 2.X. , 
1979; Easton and Clements, 1980; Halliburton fi.t. iaX- »
1980). In the experiments described above, all cloned EHV-
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1 subtype 2 fragments hybridized to EHV-1 subtype 1 DNA at 
colinear positions. This suggests that, like HSV-1 and 
HSV-2, the two subtypes of EHV-1 share a common gene 
arrangement. These findings also support the notion that 
the latter evolved from a common ancestor, the subtype 2 
virus having lost the ability, except on rare occasions, to 
cross the placenta (Turtinen, 1983). Southern blot 
hybridization analyses also indicated a highly conserved 
evolutionary relationship between EHV-1 and EHV-3 which 
does not appear to be shared to the same degree by EHV-2 
(O'Callaghan ei &1. , 1984; Baumann ei aJL. , 1986), Initial
studies by O'Callaghan s.t. aX. (1984) revealed that, 
although probes from the region of the EHV-1 subtype 1 
genome hybridized only to sequences present in the EHV-3 
U^, many homologous regions were non-colinear in 
distribution. It was suggested that sequences in EHV-1 
subtype 1 from 0.20 - 0.64 map units are inverted 
relative to the homologous sequences in EHV-3 This
conclusion was later refuted by the subsequent revision of 
the EHV-1 subtype 1 restriction endonuclease maps derived 
by this group, and the EHV-1 and EHV-3 genomes were found 
to hybridize to each other colinearly (Baumann eX. aX.,
1986). The hybridization conditions used by Baumann aX« 
(1986) permitted up to 23% base pair mismatch. Under these 
conditions no homology between EHV-1 Ug and EHV-3 Ug was 
detected. This is consistent with the findings of Davison 
and Vilkie (1983), who concluded that Ug is the most 
heterologous region in several genomes of the 
AXphaharp&svlrXnae. In this study, homology between EHV-1
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subtype 1 Ug and subtype 2 Ug could not be ascertained 
because Bam HI d, which contains the major portion of EHV-1 
subtype 2 Ug, was not cloned.
HSV-1 is by far the best characterized member of the 
Herpesviridae. In contrast very little is known about the 
genetic organisation of the equine herpesviruses. Under 
hybridization conditions which permitted detection of DNA 
sequences that displayed approximately 25% or less base 
pair mismatch, EHV-1 subtype 2 cloned fragments hybridized 
to colinear HSV-1 DNA sequences (Figures 4.6 and 4.7).
This is illustrated graphically in Figure 4.8. The 
observation that regions of homology between EHV-1 subtype 
2 and HSV-1 are dispersed throughout the genomes in a 
colinear manner is consistent with the colinearity between 
the EHV-1 subtype 1 and HSV-1 genomes (Davison and Wilkie, 
1983) and the colinearity between the two subtypes of EHV-1 
discussed above. The molecular hybridization studies of 
Davison and Vilkie (1983) indicated that HSV-1, HSV-2, EHV- 
1 subtype 1, VZV and PRV have a similar gene arrangement. 
These authors proposed that genetic colinearity in these 
viruses is not limited to highly conserved genes but 
extends to those for which no hybridization was detected. 
Thus, they suggested that the locations of many genes, in 
HSV-2, EHV-1 subtype 1, VZV and PRV, including those for 
which no homology was detected, could be predicted on the 
basis of existing knowledge of HSV-1 gene location. This 
has proven to be correct for VZV. VZV is the first member 
of the Alphaherpesvirinae whose complete DNA sequence has 
been determined (Davison and Scott, 1986a). On comparison
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of the amino acid sequences of predicted VZV proteins with 
those available for HSV-1, the genetic arrangement of the 
two viruses was found to be very similar (Davison and 
Scott, 1986a). In the context of the results discussed 
above this implies that the locations of most EHV-1 subtype 
2 genes may be predicted on a similar basis. Thus, the 
large body of existing knowledge on the molecular genetics 
of HSV-1 can be applied to a virus whose gene layout is 
currently unstudied.
Several proteins are highly conserved amongst the 
Alphaherpesvirinae. These include two essential virus 
specific enzymes, the DNA polymerase and ribonucleotide 
reductase, and the major DNA-binding protein, the major 
capsid protein, glycoprotein B (gB) and an immediate-early 
protein, V^^IE 175. The latter protein plays an essential 
role in the transition from immediate-early gene expression 
to delayed-early and late gene expression (Vatson and 
Clements, 1978, 1980; Preston, 1979, 1981; Dixon and
Schaffer, 1980). The major DNA-binding protein has been 
shown to be essential in HSV replication (Powell e± aX., 
1981; Conley ei aX., 1981) but the exact function of this
protein is at present unclear. In immunodiffusion tests 
the major DNA-binding proteins, and to a lesser extent the 
major capsid proteins of HSV-1, HSV-2, BMV, PRV and EHV-1 
subtype 1, demonstrate cross-reactive antigenicity (Yeo e.t 
aX. , 1981). gB, one of the major glycoproteins specified
by HSV is involved in fusion of the virion envelope to the 
cellular membrane and plays an important role in 
stimulating the hosts immune response (Manservigi at aX.,
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1977; Sarmiento et. aX* » 1979; Spear, 1984; Yasukawa and
Zarling, 1985). The antigenic relatedness of HSV-1 gB and 
HSV-2 gB to their EHV-1 subtype 1 and BMV counterpart has 
been demonstrated by agar gel immunodiffusion and by 
Western blot analysis (Snowden e t  aX. » 1985; Snowden and
Halliburton, 1985). Tryptic peptide analysis was employed 
to illustrate the structural similarities between the 
cross-reacting DNA-binding proteins of HSV-1, HSV-2, BMV, 
PRV and EHV-1 subtype 1 (Littler e t  aX< , 1981) and the gBs
of HSV-1, HSV-2, BMV and EHV-1 subtype 1 (Snowden e t  a X - ,
1985).
Davison and Wilkie (1983) noted that virion DNA probes
from EHV-1, PRV and VZV hybridized to a subset of HSV
sequences. These homologous regions contain several genes
of unknown function, as well as those encoding the major
DNA-binding protein, the major capsid protein, the DNA
polymerase, the ribonucleotide reductase and V IE 175.
^ mw
Moreover, conservation of these genes in EHV-1 subtype 2 is
evident from the results discussed above. Davison and
Wilkie (1983) proposed that HSV-1 probes containing
detectably conserved genes could be used to locate
counterparts of these genes in heterologous genomes. The
approximate locations of the EHV-1 subtype 2 genes encoding
the major DNA binding protein, the major capsid protein,
V IE 175 and ribonucleotide reductase were determined mw
using the appropriate HSV-1 probes. In addition 
hybridization of cloned fragments of EHV-1 subtype 2 DNA to 
HSV-1 DNA allowed the location of genes encoding the EHV-1 
subtype 2 DNA polymerase and gB counterparts to be
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determined. The usefulness of hybridization assays to 
locate highly conserved genes has recently been confirmed 
by the derivation of the complete DNA sequence of VZV 
(Davison and Scott, 1986a). The locations of the VZV genes 
encoding the homologues of HSV-1 DNA polymerase, the major 
DNA-binding protein, the major capsid protein, V^^IE 175 
and the ribonucleotide reductase corresponded to those 
predicted from the results of the hybridization studies of 
Davison and Vilkie (1983). The HSV-1 DNA polymerase (Quinn 
and McGeoch, 1985), the major capsid protein (Davison and 
Scott, 1986b), the major DNA-binding protein (Quinn and 
McGeoch, 1985), gB (Bzik e.t aX- » 1984), V^^IE 175 (McGeoch
et al . f 1986a) and the small (McLauchlan and Clements, 1983) 
and large (Y. Nikas and J.B. Clements, personal 
communication) subunits of the HSV ribonucleotide reductase 
are among the proteins whose predicted amino acid sequences 
are strongly homologous to proteins predicted from the VZV 
sequence (Davison and Scott, 1986a). Moreover, the 
conservation of proteins is not limited to the 
Alphaherpesvirinae. Comparisons of the amino acid 
sequences of predicted HSV and EBV proteins have 
demonstrated that the two subunits of the ribonucleotide 
reductase (Gibson si aX-, 1984), the DNA polymerase (Quinn
and McGeoch, 1985; Gibbs S-t aX. , 1985), the major DNA-
binding protein (Quinn and McGeoch, 1985), glycoproteins gB 
(Pellet e.X aX. , 1985) and gH (McGeoch and Davison, 1986),
the exonuclease (McGeoch si aX.» 1986b), the major capsid
protein (Davison and Scott, 1986b) and three genes of 
unknown function (Costa st aX* , 1985; McGeoch st aX- ,
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1986b) are conserved. VZV counterparts for these and other 
EBV genes have been identified by sequence comparison 
(Davison and Taylor, 1986). Of these proteins the 
ribonucleotide reductase and the DNA polymerase appear to 
be the most highly conserved whereas the homology between 
the VZV DNA-binding protein and its EBV counterpart is weak 
(Davison and Taylor, 1986). Interestingly, no EBV 
homologue for V^^IE 175 or its VZV counterpart has been 
detected (McGeoch st al-, 1986a; Davison and Taylor, 1986).
The hybridization data published to date and presented 
here constitute compelling evidence for the divergence of 
the Alphaherpesvirinae from an ancestral herpesvirus. 
Molecular hybridization studies demonstrated the genetic 
colinearity of HSV-1, HSV-2, EHV-1 subtype 1 and VZV 
(Davison and Vilkie, 1983) and of EHV-1 subtype 1 and EHV-3 
(Baumann st al-, 1986) and EHV-1 subtype 2 (see above).
The PRV genome is colinear with HSV with the exception of a 
region comprising about half of which is relatively 
inverted (Davison and Vilkie, 1983; Ben-Porat st aX< ,
1983). This inversion is probably indicative of a 
rearrangement which occured during the evolution of PRV 
from the progenitor virus.
Comparisons of VZV and HSV-1 DNA sequence data revealed 
relationships between genes which had not been detected by 
DNA-DNA hybridization and confirmed that these two members 
of the Alphaherpesvirinae have a similar gene arrangement 
(Davison and Scott, 1986a). DNA sequence analysis of the S 
segment of HSV-1 (McGeoch et al. , 1985, 1986a) and VZV
(Davison, 1983; Davison and Scott, 1985) and comparison of
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the amino acid sequences of predicted proteins demonstrated 
that the seven unique VZV genes in this region all have 
counterparts amongst the 13 unique genes of the HSV-1 S 
region (Davison and McGeoch, 1986), Thus, although these 
regions of the two genomes are among the most heterologous 
(Davison and Vilkie, 1983) and differ significantly in gene 
layout, they are clearly related. An evolutionary model 
has been proposed for their descent from the S segment of 
an ancestral virus by a series of recombinational events 
(Davison and McGeoch, 1986).
Evolutionary comparisons have not been confined to 
members of a single subfamily. Vhile VZV and HSV-1 are 
more closely related than is VZV to EBV the counterparts of 
29 of the 67 unique VZV genes have been found in EBV by 
sequence comparison (Davison and Taylor, 1986). Moreover, 
certain VZV and EBV genes are similar in size, location and 
orientation, and hydrophobicity profile, yet they share no 
detectable homology (Davison and Taylor, 1986), Vhether or 
not these similarities are considered, the large number of 
genes conserved in VZV and EBV is strong evidence that 
these two viruses as representatives of the 
Alphaherpesvirinae and Gammaherpesvlrlnae respectively 
diverged from an ancestral herpesvirus. All conserved 
genes are also located in and their quasi-colinear 
layout suggests that large-scale sequence rearrangements 
have occured in the evolution of one or both of these 
viruses from the progenitor. In conclusion, there is 
substantial evidence to suggest that the alpha- and gamma- 
herpesviruses evolved from an ancestral virus.
CHAPTER 5
THE DNA SEQUENCE ANALYSIS OF AN EHV-1 SUBTYPE 2 
FRAGMENT CONTAINING THE JUNCTION 
BETWEEN Ug AND TR^
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The genetic relatedness of the 
has been demonstrated by molecular hybridization (Davison 
and" Wilkie, 1983; Ben-Porat ei al. , 1983) and by DNA
sequence analysis (Davison and McGeoch, 1986; Robbins e.t 
al.» 1986; McGeoch and Davison, 1986; Davison and Scott, 
1986a,b). The S segment is the most heterologous component 
of the Alphaherpesvirinae genomes (Davison and Wilkie,
1983; Davison and McGeoch, 1986). The DNA sequences of 
the S segment of HSV-1 (Murchie and McGeoch, 1982; McGeoch 
et al., 1985, 1986a) and VZV (Davison 1983; Davison and
Scott, 1985) have been determined and the predicted encoded 
proteins compared (Davison and McGeoch, 1986). The HSV-1 
Ug and TRg/IRg are larger than those of VZV (Figure 5.1) 
and six of the genes in HSV-1 S have no VZV homologues 
(Davison and McGeoch, 1986). Each gene in the VZV S 
segment has an HSV-1 counterpart (Davison and McGeoch,
1986). It is clear from the restriction endonuclease maps 
of the genome of EHV-1 subtype 2 (Figure 3.15) that the S 
segment (32kbp) is larger than the S segment of HSV (26kbp) 
or VZV (20kbp) (Figure 5.1). This suggests that the S 
segment of the EHV-1 subtype 2 may contain more genes than 
the S segments of HSV-1 and VZV. The cloned fragment 
containing the junction between the Ug and TRg of the EHV- 
1, subtype 2 genome showed no homology to HSV-1 DNA in 
comparative hybridization experiments. The DNA sequence of 
this fragment was determined to elucidate the nature of the 
genes near the Ug - TRg junction. These data also allowed
A diagrammatic representation of the S segments of 
VZV, HSV-1 and EHV-1 subtype 1 and 2, The inverted repeat 
sequences are represented by cross-hatched boxes.
s Regions of VZV, HSV-1 and EHV-1 subtypes 1 and 2
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L- - - - - - - - - - - 1- - - - - - - - - - - - 1- - - - - - - - - - - - 1- - - - - - - - - - - - 1_ _ _ _ _ _ _ _ _ _ _ _ L J _ _ _ _ _ _ _ _ _ _ _ _ L
10 15 20 25 30 35 40
jkbp
EHV-1 subtype 2
■_____________________ '_____________________ I  i------------------- _ i ' 410 15 20 25 30 35
jkbp
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a more accurate estimation of the exact location of the 
junction than that afforded by the restriction endonuclease 
maps.
ElSULIS_AND_DISQ iISSiQ I
DIA_Sequence_Anaiysis
EHV-1 subtype 2 Eam HI 1 is a 4.57kbp fragment which 
contains the junction between Ug and TRg. Random fragments 
of Ham HI 1 isolated from a plasmid were generated by 
sonication and cloned into bacteriophage M13mp8. Single­
stranded DNA was isolated from the M13 clones and sequenced 
using the Sanger dideoxynucleotide chain terminating 
method. The data were compiled with the aid of a computer, 
as described in Materials and Methods. An autoradiograph 
of one of the gels used to sequence Bam HI 1 is shown in 
Figure 5,2 and the sequence database is shown in Figure
5.3. 98% of the fragment was sequenced on both strands.
The DNA sequence of EHV-1 subtype 2 Ham HI 1 is shown in 
Figure 5.4. The sequence was analysed for potential 
protein-coding regions by considering the locations of open 
reading frames (ORFs), initiator ATG triplets (Kozak, 1981, 
1983) and elements associated with polyadenylation 
(Proudfoot and Brownlee, 1976). Codon usage within the 
sequence was examined using the program of Staden and 
McLachlan (1982). The analysis revealed the presence of 
two complete ATG-initiated ORFs and parts of two additional 
ORFs likely to encode proteins. The locations of three 
copies of the element AATAAA, a sequence usually present 
(as AAUAAA) close upstream of the 3' termini of eukaryotic
Autoradiograph of one of the 6% polyacrylamide-urea 
gels used to sequence EHV-1 subtype 2 Bam HI 1.
\ TCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATCGATC
I  •
I: 'a =-=e! =i=:* . * - *  “ç
Database of the DNA sequence of M13 subclones of Bam 
HI 1 of EHV-1 subtype 2. The numbers on the left 
represent the individual M13 clones the DNA sequences of 
which are shown as the rightward 5'-3' strand. Those 
clones assigned a negative value were sequenced on the 
other strand. The consensus sequence is unnumbered. The 
total database contains approximately 40,000 nucleotides 
and each nucleotide was sequenced, on average, 8.6 times. 
The asterisks represent padding characters inserted by the 
computer program to produce an alignment. After the 
database was compiled initially all errors were removed by 
careful reading of the best sequence for each strand at 
each nucleotide location.
10 20 30 40 50 60 70 80 90 100 110 120
-28 GGATCCACATOGCCTTCTCGGTCCCATAGTACTTTGTTGGGCGATAGGCCACATTTTATCCAACC0GCACCAAACAGGGTAGACTTGTTATTCAAAGATATACCCGA»ATCACGACCGGG 
-72 GGATCCACATGGCCT * CTC
7 3 GGATCCACATC•••••*  *CGGTGCCATAGTACTTTGTTGGGCGATAGGCCACATTTTATCCAACCGGCACCAAACAGGGTAGACTTGTTATTCAAAGATATACCCGA*TCAGCGACCGGG 
102 GGATCCACATGGCCTTCTCGG»*CCATAGTACTTTGTTGGGCGATAGGCCACATTTTATCCAACCGGCACCAAACAGGGTAGACTTGTTATTCAAAGATATACCCGAATCAGCGACCGGG 
-140 GGATCCACATGGCCTTCTCGGTGCCATAGTACTTTGTTGGGC 
146 GGATCCACATGGCCTTCTCGGTGCCATAGTACTTTGTTGGGCGATAGGCCACATTTTATCCAACCGGCACCAAACAGGGTAGACTTGTTATTCAAAGATATACCCGAATCAGCGACCGGG 
120 GGG
GGATCCACATGGCCTTCTCGGTGCCATAGTACTTTGTTGGGCGATAGGCCACATTTTATCCAACCGGCACCAAACAGGGTAGACTTGTTATTCAAAGATATACCCGAATCAGCGACCGGG
130 140 150 160 170 180 190 200 210 220 230 240
-28 TTGTATGTGTTTGTCTTATTGTACAACGGACATCCGGAGGCGTGGACGTATACGTTGCTTTCTACAGCAAATCACTTTATGAACGTGCTTACGGACCGAACACGCCCACGGCTAGGAGAG
7 3 ttctatgtgtttgtgttattgtacaacggacatccggaggcgtggacgtatacgttgc*ttctcaagcaatattttagactgtt
102 ttgtatgtgtttgtgttattgtacaacggacatccggaggcgtggacgtatacgttgctttctacagcaaatcactttatg*acgtgcttacggaccgaacacgcccaggcctaggagag
146 TTGTATGTGTTTGTGTTATTGTACAC
120 TTGTATGTGTTTGTGTTATTGTACAACGGACATCCGGAGGCGTGGACGTATACGTTGCTTTCTACAGCAAATCACTTTATGAACGTGCTTACGGACCGAACACGCCCACGGCTAGGAGAG 
10 CTACAGCAAATCACTTTATGAACGTGCTTACGGACCGAACACGCCCACGGCTAGGAGAG
-107 TACAGCAAATCACTTTATGAACGTGCTTACGGACCGAACACGCCCACGGCTAGGAGAG
- 35 AACGTGCTTACGGACCGAACACGCCCACGGCTAGGAAGA
78 TTACGGACCGAACACGCCCACGGCTAGGAGAG
14 2 CTAGGAGAG
TTGTATGTGTTTGTGTTATTGTACAACGGACATCCGGAGGCGTGGACGTATACGTTGCTTTCTACAGCAAATCACTTTATGAACGTGCTTACGGACCGAACACGCCCACGGCTAGGAGAG
250 260 270 200 290 300 310 320 330 340 350 360
-28 C 
102 CACTTT
120 CACTTTTATA*GGACCACGGGCACACGCTTTTCACTC»TCATCCATCTGA 
10 CACTTTTATACGGACCACGGGCACCAGCTTTTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACACTACCTCGCTTTTTTGTTGATCATAATCTGCACC 
-107 CACTTTTATACGGACCACGGGCACCAGCTTTTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACACTACCTCGCTTTTTTGTTGATCATAATCTGCACC 
-35 CAC*TTTATACGGACCACGGGCACCACTT»TTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACACTACCTCGCTTTTTTGTTGATCATAATCTGCACC 
78 CACTTTTATACGGACCACGGGCACCAGCTTCTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCT«GGACCAGACATA*»CTCGCTTTTG*»*TGATCATATCTCGACT 
14 2 CACTTTTATACGGACCACGGGCACCAGCTTTTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACA*TACCTCGC**TTTTGTTGATCATA*TCTGCAC* 
-2 TGTTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGG*AGCTTGGACCAGACACTACCTCGCTTTTT*GTTGATCATAATCTGCACC
-26 ATCCATCT»AGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACACTACCTCGC»TTTTTGTTGATCATAATCTGCACC
32 CTTGGACCAGACACTACCTCGCTTTTTTGTTGATCATAATCTGCACC
CACTTTTATACGGACCACGGGCACCAGCTTTTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACACTACCTCGCTTTTTTGTTGATCATAATCTGCACC
370 300 390 400 410 420 430 440 450 460 470 480
10 TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAAGCAACCGCAAGCCGTATGAAGTACTAAACC**TTT 
-107 TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAA»CAACCGCAAGCCGTATGAAGTACTAAACCCGTTT 
-35 TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAAGCAACCGCAAGCCGTATGAAGTACTAAACCCGTTTGAAACGGTTTA 
142 TGT
-2 TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAAGCAJ^ CCGCAAGCCGTATGAAGTACTAAACCCGTTTGAAACGGnTACACAAGCGTTCCCAGCAAC 
-26 TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAAGCAACCGCAAGCCGTATGAAGTACTAAACCCGTTTGAAACGGTTTACACAAGCGTTCCCAGCAAC
32 tgtgccgcgctgctaattgccttggtggtgtggggctgcattctatacatccgaagcaaccgcaagccgtatgaagtactaaacccgtttgaaacggtttacacaagcgttcccagcaac 
-7 tgctaattgccttggtggtgtggggctgcattctatacatccgaagcaaccgcaagccgtatgaagtactaaacc»g*ttgaaacggtttacacaa*cgttcccagcaac
-56 GGGGCTGCA*TCTATACATCCGAAGCAACCGCAAGCCGTATGAAGTACTAAA*CCGTTTGAAACGGTTTACACAAGCGTTCCCAGCAAC
-71 AGATCCGA**CAACCG**AGCCGTATGAAGTACTACCA**GTTT*AAACGGTTTACAC*AGCGTTCCCAGCAAC
63 CCGTTTGAAACGGTTTACACAAGCGTTCCCAGCAAC
TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAAGCAACCGCAAGCCGTATGAAGTAtTAAACCCGTTTGAAACGGTTTACACAAGCGTTCCCAGCAAC
490 500 510 520 530 540 550 560 570 580 590 600
-2 GATCCAACCGACGAAGTCTTGGTATTTGAGCGTCTGGCTTCAGACTCCGACGACTCCTTCGACTCAAGTTCAGACGA 
-26 GATCCAACCGACGAAGTCTTGGTATTTGA * CGTCTGGCTTCAGACTCCGACGACTCCTTCGACTCAAGTTCAGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAG 
32 GATCCAACCGACGAAGTCTTGGTATTTGAGCGTCTGGCTT»AGACTCCGACGACTCCTTCGACTCAAGTT»AGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAG 
-7 GATCCAACCGACGAA*TCTTGGTATTTGA•CGTCTGGCTTCAGACTCCGACGACTCCTTCGACTCAAGTTCAGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAG 
-56 GATCCAACCGACGAAGTCTTGGTATTTGAGCGTCTGGCTTCAGACTCCGACGACTCCTTCGACTCAAGTTCAGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAG 
-71 GATCCAAC»GACGAA»TCTTGGTATTTGAGCGTCTGGCTTCAGACTCCGACGACTCCTTCGACTCAA 
63 GATCCAACCGACGAAGTCTTGGTATTTGAGCGTGTGGCTTCAGACTCCGACGACTCCTTCGACTCAAGTTCAGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAG 
GATCCAACCGACGAAGTCTTGGTATTTGAGCGTCTGGCTTCAGACTCCGACGACTCCTTCGACTCAAGTTCAGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAG
610 620 630 640 650 660 670 680 690 700 710 720
-26 CCGTATAGTTCACTAGAAAGTGCAGA 
32 CCGTATAGTTCACTAGAAAGTGCAGAC
-7 CCGTATAGTTCACTAGAAAGTGCAGACGCGTCGAGAGGCCGGTCGGGTTTCAAG 
-56 CCGTATAGTTCACTAG
63 CCGTATAGTTCACTAGAAAGTGCAGACGCGTCGAGAGGCCGGTCGGGTTTCAAGGTCTGGTTCCGCGATACACCAGAGGCGTCTCCGGAGCCGCTTCATAGACCAA*CCCACCCGTCGGA 
22 TAGTTCACTAGAAAGTGCAGACGCGTCGAGAGGCCGGTCGGGTTTCAAGGTCTGGTTCCGCGATACACCAGAGGCGTCTCCGGAGCCGCTTCATAGACCAACCCCACCCGTCGGA
58 ACTAGAAAGTGCAGACGCGTCGAGAGGCCGGTCGGGTTTCAAGGTCTGGTTCCGCGATACACCAGAGGCGTCTCCGGAGCCGCTTCATAGACCAACCCCACCCGTCGGA
-91 GAAGAGGCCGGTCGGGTTTCAAGGTCTGGTTCCGCGATACACCAGAGGCGTCTCCGGAGCCGCTTCATAGACCAACCC*A*CCGTCGGA
-30 agaggccggtc»ggtttcaaggtctggttccgcgatacaccagaggcgtctccggagc*gcttcatagaccaaccccacccgt*gga
138 TCCGGAGCCGCTTCATAGACCAACCCCACCCGTCGGA
ccgtatagttcactagaaagtgcagacgcgtcgagaggccggtcgggtttcaaggtctggttccgcgatacaccagaggcgtctccggagccgcttcatagaccaaccccacccgtcgga
730 740 750 760 770 780 790 800 810 820 830 840
63 CCGGACTACAGCAAGG
22 CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTT*AACAACAAAGATACCGCTTGCGCAGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA 
58 CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCGCTTGCGCAGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA 
-91 CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCG»TTGCGCAGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA 
-30 CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCG'TTGCGCAGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA 
138 CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCGCTTGCG*AGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA 
-90 AAGGTCGCGTCAGAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCG'TTGCGCAGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA
-114 TACGTTGCGCAGGAAATGTGTGCTATGCTGAAGGACTA»GCAATCGTAAGAGTA
-79 AAGAGTA
CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCGCTTGCGCAGGAAATGTGTGCTATGCTGAAGGACTACGCAATCGTAAGAGTA
850 860 870 080 890 900 910 920 930 940 950 960
GTCCGGTTCGAAACAGCACCTTCGAAGAGTATCTCGA*TCACTTAATAATTACGACCGCCG*TTGAGAGCTGACTCAACTTCAGATTCGGACTCTGG*TGTAAA**CCCTCTGA»GAGCA 
GTCCGGTTCGAAACAGCACCTTCGAAGAGTATCTCGACTCACTTAATA*TTACG*CCGCCGTTTAG 
GTCCGGTTCGAAACAGCACCTTCGAAGAGTATCTCGACTCACTTAATAATTACGACCGCCGTTTGAGAGCT
GTCCGGTTCGAAACAGCACCTTCGAAGAGTATCTCGACTCACTTAATAATTACGACCGCCGTTTGAGAGCTGACTCAACTTCAGATTCGGACTCTGGGTGTAAACCCCCTCTGAAGACGA 
GTCCGGTTCGAACACA* * * CTTCGAGA
gtccggttcgaaacagcaccttcgaagagtatctcgactcacttaataattacgaccgccgtttgagagctgactcaacttcagattcggactctgg*tgtaaaccccctctgaagacga 
gtccggttcgaaacagcaccttcgaagagtatctcgact»acttaataattacgaccgccgtttgagagctgact*aacttcagattcggactctgggtgtaaaccccctctgaagacga
GTCCG• ‘ TCGAAACAACACCTTCG * AGAGTATCTCGACT* ACTTAATAATTACGAC * GCCG *TTGAGAGCTGACTC•ACTTCAGATTCGGACTCTGG «TGTAAACCCCCTCTGAAGACGA 
GAAACAGGACCT*CG*AGAGTATCTCGAC'rTACTTAATAATTACGACGGCCGTTTGAGAGCTGACTGAACTTCAGATTCGGACTCTGGGTGTAAACCCCCTCTGAAGACGA
GCCGTTTGAGAGCTGACTCAACTTCAGATTCGGACTCTGGGTGTAAACCCCCTCTGAAGACGA
AAGACGA 
CGA
gtccggttcgaaacagcaccttcgaagagtatctcgactcacttaataattacgaccgccgtttgagagctgactcaacttcagattcggactctgggtgtaaaccccctctgaagacga
970 960 990 1000 1010 1020 1030 1040 1050 1060 1070 1080
22 TTC*AATATCAA»GAGTTTC 
-30 TTCAAATATCAAAGAGTTTACAAAAATTATGGATCT
-90 ttcaaatatca
-114 TTCAAATATCAAAGAGTTTACAAAAATTATGGATCTAA 
-79 TTCAAATATCAGAGAGTTTACAGAAATTATGGATCTACAACCACCATCTCCAGACCCCGAGCCAGCGGCGGCAGAAGAGCCGGTTAGC 
-BO TTCAAATATCAAAGAGTTTAGAAAAATTATGGATCTAAAACCACCATCTCCAGAACCCGAGCCA
4 TTCAAATATCAAAGAGTTTACAAAAATTATGGATCTAAAACCACCATCTCCAGAACCCGAGCCAGCGGC'GCAGAAGAGCCGGTTAGCACCGCCGTTTACATCTTAAACGAGTGGGTGGC 
24 TTCAAATATCAAAGAGTTTACAAAAATTATGGATCTAAAACCACCATCTCCAGAACCCGAGCCAGCGGC*GCAGAAGAGCCGGTTAGCACCGCCGTTTACATCTTAAACGAGTGGGTGGC 
151 TT*AAATATCAAAGAGTTTACAAAAATTATGGATCTAAAACCACCATCTCCAGAACCCGCGCCAGCG*»GGCAGAAGAGCCGGTTAGCACCGCCGTTTACATCTTAAACGAGTGGGTGGC 
66 AAATTATGGATCTAAAACCACCATCTCCAGAACCCGAGCCAGCGCC»»CAGAAGAGCCGGTTAGCACCGCCGTTTACATCTTAAACGAGTCGGTGGC
_45 GCCGG*TAGCACCGCCGTTAG»ATCTT* «acgagtgggtggc
GTTTAAATCTTA**CGAGTGG*TGGC
TTCAAATATCAAAGAGTTTACAAAAATTATGGATCTAAAACCACCATCTCCAGAACCCGAGCCAGCGGCGGCAGAAGAGCCGGTTAGCACCGCCGTTTACATCTTAAACGAGTGOGTGGC
1090 1100 1110 1120 1130 1140 1150 1160 1170 1180 1190 1200
4 cCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTT»ATATGCAAGCGCTAA*»CCAACACTAA 
24 CCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATGCAAGCGCTAAACCCAACA»TAA 
151 CCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATGCAAGCGT*AAACCCAACA*TAA 
86 CCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCAC*»TATTTAGTTGTTTGTTTTATATGCAAGC 
-4 5 CCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATGCAAGCGCTAAACCCAACACTAA 
-116 CCCAATGCTTGGAGATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATG'AAGCGCTAAACCCAACACTAA 
IB TATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATGCAAGCGCTAAACCCAACACTAA
94 GTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATGCAAGCGCTAAACCCAACACTAA
CCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGTTTTATATGCAAGCGCTAAACCCAACACTAA
1210 1220 1230 1240 1250 1260 1270 1280 1290 1300 1310 1320
4 AGGG
24 AGGGTTATATATTATCCCGGGG’ACTTTTGCAGTAATATATATTCTGCTGCCAGTGTTCACTGGTGCTCAGTGCGCCCAACCAGCACAGCCCGTTTTAATCTCTATACTCTCTGTCTATT
151 agggttatatat*atcccgggg*acTTgTc
-4 5 agggttatatattatcccgggggacttttgcagtaatatatattttgctgccagtgttcactggtgctcag 
-116 agggttatatattatcccgggggaattttgcagtaatatatattttgct
18 AGGGTTAT at ATTATCCCGGGGGACTTTTGCAGTAAT AT AT ATTTTGCTGCCAGTGTTCACTGGTGCTCAGTGCGCCCAACCAGCACAGCCCGTTTTAATCTCTATACTCTCTGTCT ATT 
94 AGGGTTATATATTATCCCGGGGGACTTT»GCAGTAATATATATT*TGCTGCCAGTG»TCACTGGTGCTCAG 
105 TTAATCTCTATACTCTCTGTCTATT
AGGGTTATATATTATCCCGGGGGACTTTTGCAGTAATATATATTTTGCTGCCAGTGTTCACTGGTGCTCAGTGCGCCCAACCAGCACAGCCCGTTTTAATCTCTATACTCTCTGTCTATT
1330 1340 1350 1360 1370 1380 1390 1400 1410 1420 1430 1440
24 T
18 TTCCTTACCCCGCTCCGTAACACCTCACTTTCTCTCATACTACCGC‘ *TTTTCACGCTACTCCA*CAGCTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACC 
105 TTCCTTACCCCGCTCCGTAACACCTCACTTTCTCTCATACTACCGCCTTTTTCACGCTACTCCAACAGCTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACCACCAAGCCAC 
-19 CCTTACCCCGCTCCGTAACACCTCACTTTCTCTCATACTACCGCC*TTTTCACG*TACTCCAACA*CTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACCACCAAGCCAC 
-15 3 GTACACCCC* * • • • * • • •CA*••*ACTTTCTCTCATACTACGCC* *TTTTCACGCTACTCCAACAGCTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACCACCAAGCCAC
139 CACCTCACTTTCTCTCATACTACCGCCTTTTTCACGCTACTCCAACAGCTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACCACCAAGC'AC
-85 TAACA**CAAGCCAC
-1 AC
TTCCTTACCCCGCTCCGTAACACCTCACTTTCTCTCATACTACCGCCTTTTTCACGCTACTCCAACAGCTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACCACCAAGCCAC
1450 1460 1470 1480 1490 1500 1510 1520 1530 1540 1550 1560
105 ATGGGTGAGCCTGAACCTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACAACCCCAACTACAGGAGTGATAACGCACTCATAGCCGATGGTGATTCCAGCCCCATTGG 
-19 ATGGGTGAGCCT»AACCTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACAACCCCAACTACAGGAGTGATAACGCACTCATAGCCGATGGTGATTCCAGCCCCATTGGGGGG 
-153 ATGGGTGAGCCTGAACCTGTGGTAGCGTTGACTAA 
139 ATGGGTGAGCCTGAA»CTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACA»CCCCAACTACAGGAGTGATAACGCA*TCATAGCCGATGGTGATTCCAGCCCCATTGGGGG* 
-85 ATGGT»»AGCCT*AACCTGTGGTAGCGT*GACTGAAGACGCTCCACTGTCCGTGTACAACCC»AACTACAGGAGTGATAA*GCACTCATAGCCGATGGTGATTCCAGCCCCATTGGGGGG 
-1 AT«GGTGAGCCT*AACCTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACAACCCCAACTACAGGAGTGATAACGCACTCATAGCCGATGGTGATTCCAGCCCCATTGGGGGG 
-62 ATGGGTGAGCCTGAACCTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACAACCCCAACTACAGGAGTGATAACGCACTCATAGCCGATGGTGATTCCAGCCCCATTGGGGGG 
-40 TGTAC*ACCCCAACTACAGGAGTGATAACGCACTCATAGCCGATGGTGATTCCAGCCCCATT*GGGGG
-136 ACCCCAACTACAGGAGTGATAACGCACTCATA*CCGATGGTCATTCCAG*CCCATTGGGGGG
ATGGGTGAGCCTGAACCTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACAACCCCAACTACAGGAGTGATAACGCACTCATAGCCGATGGTGATTCCAGCCCCATTGGGGGG
1570 1580 1590 1600 1610 1620 1630 1640 1650 1660 1670 1680
-19 GATTGTTGTCCGGCAGAGGCGGTGGCTGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCT 
139 «ATTGTTCC
-85 •ATTGTTGTCCGGCAGAGGCGGTGG*TGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGAC
-1 GATTGTTGTCCGGCAGAGGCGGTGGCTGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGAC
-62 GATTGTTGTCCGGCAGAGGCGGTGACTGCCGCTGAGGAGGTAGCTACGGATGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGAC
-40 GATTGTTGTCCGGCAGAGGCGGTGGCTGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGAC
-136 GATTGTTGTCCGGCAGAGGCGGTG**TGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTT 
-96 AGGTAGCTACGGTTGCTTT*GCTTCTGAGTG»ATCTACGAGATGCATATCAG*TCCTGCATTTCTTCGACCACATGCGGTGAC
11 GGCTGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGAC
-38 TTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATT»CTT»CACCACATGCGGTGAC
-84 AAATCTACGAGATGCATATAC*ATCCT*CATTTCTT*CACCACATGCGGTGAC
57 CCACCACATGCGGTGAC
83 CACATGCGCTGAC
-117 GAC
GATTGTTGTCCGGCAGAGGCGGTGGCTGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCTTCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGAC
1690 1700 1710 1720 1730 1740 1750 1760 1770 1780 1790 1800
-85 CATAATAACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAGTGTCACC 
-1 CATAATAACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAG 
-62 CATAATAACTCAATCGGCGTAACAT
-40 CATAATAACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGT 
-96 CATAAT
11 CATAATAACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAGTGTCA*CCCCCGTCCCCAGAGGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
-38 CATAATAACTCAATCGGCGTAACATCGGG'CTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGTCCCCAGAGGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
-84 CATAATAACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGTCCCCAGA*GCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
57 CATAATAACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGTCCCCAGAGGCCGTAG*TATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
83 CATAATAACTCAATCGGCGTAACATCGGGG»TTACTGTTCGCGCGG*TGAGTGTCACCCCCCGTCCCCAGAGGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
-117 CAAAATAACTCAGTCGGCGTAACATCGGG*CTTACTGTGTCCCCGGCTGACTGTCACCCCCCGTCCCCAGAG»CCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
-95 ATAAT*ACTCAATCGGCGTAACATC*GGGCTTACTGTTCGCGCGGCTGAGTGTCACCCCCGT**CCCAGAGGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
61 CATC*GGGCTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGTCCCCAGAGGCCGTA*GTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
-77 ATGTCACCCCC•*T*CCCAGA* GCCGTAGGTATTGAGGATGTGGTGGTTGT•CAAACTGCGGCTACCACT
-112 CATCCCCAGAAGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT
-93 agatt»***»***»gtogtt»tgcaa»ct*cggctac*act
115 CT
CAT AAT AACTCAATCGGCGTAACATCGGGGCTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGTCCCCAGAGGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCT ACCACT
1810 1820 1830 1840 1850 I860 1870 1880 1890 1900 1910 1920
aatcgcccctcagatacactacccgccagtgctgcggcct*actgattagcgatgataacogctgtgtaccgctg*tagggtca»gcc
AATGGCCCCTCAGATACACTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTT 
AATGGCCCCTCAGATACAGTACCCGCCAGTGCTOCCGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGOAGTCTGGC 
AATGGCCCCTCACATACAGTACCCGCCAGTGCTCCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAA'CTATGACTTGGAGTCTCC 
AATGGCCCCTCAGATACAGTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTG*TAGGGTCGCTGGAATAG*»»**AAACTATGACTTGGAGTGTTG-C 
AATGGCCCCTCAGATACAGTACC»GCCAATGCTGCGGCCTCAATGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAG
AATGGCCCCTCAGATACTGTA»CCGCCA*TGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC 
AATGGCCCCTCAGATACAGTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGATCCGCTGCTAGGGTCGCGCCTGGAACTAG*AAACTATGACTTGGAGTCTGGC 
AATGCCCCCTCAGATACAGTACC*GCCA*TGCTGCGGCCTCA*TGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC 
AATGGCCCCTCAGATACAGTA‘ CCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAGCGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC 
AT****CCCT»AGATACAGTACCCGCCA»TGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC 
AATGGCCCCTCAGATACAGTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC 
CTCAGATACAGTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTG-GC
TACCGCTGCTAGG^ TCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC 
TGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTG-GC 
CTAGGT'CACGCCTGGAACTAGAAAACTATGACTTGGAGTCTCGC
TGGC
AATGGCCCCTCAGATACAGTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTGGAACTAGAAAACTATGACTTGGAGTCTGGC
1930 1940 1950 1960 1970 1980 1990 2000 2010 2020 2030 2040
-84 TGCTACTACAGCGAAAGCGACAAC 
83 TGCTACTACAGCGAAAGC 
-95 TGCTACTACAGCGAAAGCGACAACGAAACCGCCAGCCTGTTCATCCAGA 
61 TGCTACTACAGCGAA 
-77 TGCTACTACAGCGAAAGCGAC 
-112 TGCTACTACAGCGAAAGCGACAACAAAACCGCCAGCCT 
-93 TGCTACTACAGCGAAAGCGACAACGAAACCGCCAGCCTGTTCATCCAGA 
115 TGCTACTACAGCGAAA*••ACAACGAAACCGCCAGCCTGTTAATCCagagggtcggccggcgc 
144 TGCTACTACAGCGAAACAC**AACGAAACCGCCAGCCTGTTCATCCAGAGGGTCGGCCGGCGC
-60 TGCTACTACAGCGAAAGCGACAACGAAACCGCCAGCCTGTTCATCCACAGGGTCGGCCGGCGGCAGGCGCGGCGACACAGGCGGCGACGCGTGGCCCTCACGGTCGCCGGCGTCCTGCTC 
106 TGCTACTACAGCGAAAC*»*CAACGAAACCGCCAGCCTGTTCATCCAGAGGGTCGGCCGGCGGCAGGCGCGGCGACACAGGCGGCGACGCGTGGCCCTCACGGTCG**GGCGTCGTGrTC 
81 TGCTACTACAGCGAAA**GACAACGAAACCGCCAGCCTGTTCATCCAGAGGGTCGGCCGGCGGCAGGCGCGGCG*CACAGG**GCGACGCGTGGCCCTCACGGTCGCCGGCGTCGTGrrC 
130 TGCTACTACAGCGAAAGC*••AACGAAACCGCCAGCCTGTTCATCCAGAGGGTCGGCCGGCGGCAGGCGCGGCGACACAGGCGGCGACGCGTGGCCCTCACGGTCGCCGGCGTCGTGCTC 
-110 ACCTGTTCATCCAGAGGGTCGGCCG*CGGCA*GCGCGGCGACACA*GCGGCGACGCGTGGCCCTCACGGTCGCCGGCGTGT**CTC
-126 GTCTGTTCATC*AGA*GGTCGG»CGGCGGCA*GCGCGGCGACACAGGCGGCGACGCGTGGCCCTCACGGTCGCCGGCGTCGTGCTC
-148 GCGACACA*GCGGCGACGCGTGGCCCT*ACGGTCGCCGGCGTCGTGCTC
152 GTC*****»*T**TCGCTC
TGCTACTACAGCGAAAGCGACAACGAAACCGCCAGCCTGTTCATCCAGAGGGTCGGCCGGCGGCAGGCGCGGCGACACAGGCGGCGACGCGTGGCCCTCACGGTCGCCGGCGTCGTGCTC
2050 2060 2070 2080 2090 2100 2110 2120 2130 2140 2150 2160
-60 gtcgctgtcctgtgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaa*cc*cggacgcggccatcgcctctaccgccacgatttccac 
106 gtcgctgtcctgtgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaa*cc*cggacgcggccatcgcctctaccgcag 
81 gtcgtg*tcctgtgcgcgatatccgggagtgctgggg
130 gtcgctgtcctgtgcgcgatatc*gggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaa»ccgcggacgcggccatcgc*tctaccgca»*gattt 
-110 gtcgctgtcctgtgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaa*gc*gg*acgcggccatcgcctctaccgccacgatttcccaccctgctgtc 
-126 gtcgctgtcctatgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaa* ccg cggacgcggccatcgcctctaccgccacgatttcccaccctgctgtc 
-148 gacggtgtcctgtgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgaggcgaa*ccgcggacgcggccatcgcctctaccgccacgatttcccacc»tgct 
152 gtcgcagtcctgtgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaacccgcggacgcggccatcgcctctaccgccacgatttcccaccctgctgtc 
-37 tttcctttgcgcgatatccgggatcgtcggggcgttcctcgcgcgcgtatttcagtgacgcgaa»cc*cggacgcggccatcgcctctaccgccacgatttcccaccctgctgtc
-47 aatatccgggatcgtcggggcgttcctcgcgcgc*tatttcagtgacgcgaa*cc*cggacgcggccatcgcctctaccgccacgatttcccaccctgctgtc
-14 ccgcacccgccagtcaataaaacctcatagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggtgggg 
50 ccgcacccgccagtcaataaaacctcatagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggtgggg 
163 ccgcacccgccagtcaataaaacctcatagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttccxaccccctatcggaggtggggaggtggggaggtgggg
176 ccgcacccgccagtcaataaaacctcatagtagagagccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttgccaccccctatcggaggtggggaggtggggaggtgggg
177 ccgcacccgccagtcaataaaaccccatagtagagaaccccagcctctgcgcgtttgttcgatggccccggtagcttgtttgccaccccctatcggaggtggggaggtggggaggtgggg 
160 ccgcacccgccagtcaataaaacctcatagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttccxaccccxtatcggaggtggggaggtggggaggtgggg
-162 ccgcacccgccaxtcaataaaxcctcataxtagaxaaccccagcctctgcgcgtttgttcxatggcccgggtagcttgtttccxaccccctatcggaggtggggaggtggggaggtgggg
15 aataaaacctcatagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggtc-ggg
170 cctcatagtagagaaccccagcctctccccttctgttcgatggccccgggtagttgtttcccaccccctatcggaggtggggaggtggggaggtgggg
16 atagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttcccaccccxtatcggaggtggggaggtggggaggtgggg
174 atagtagagaaccccagcctctgcgcgtttgttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggtgggg
-175 aaccccagcctctgcgcgtttgttcxatgxcccgxxtagcttgtttccxaccccxtatcggaggtggggaggtggggaggtgc-gg
5 ctctgcgcgtttgttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggtgsgg
171 tgcgcgtttgttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggtgggg
52 gttcgatggcccgggtagcttgtttcccaccccctatcggaggtggggaggtggggaggt-g-ggg
-17 ATGXXXXCCGTAGCTTGTTTCCXACCCCCTATGGGAGGTGGGGAGGTGGGGAGGTG3GC
67 CCTATCGGAGGTGGGGAGGTGGGGAGGTGGGG
-68 TGGGGAGGTGGGGAGGTG03G
CCGCACCCGCCAGTCAATAAAACCTCATAGTAGAGAACCCCAGCCTCTGCGCGTTTGTTCGATGGCCCGGGTAGCTTGTTTCCCACCCCCTATCGGAGGTGGGGAGGTGGGGAGGT'GGGG
2290 2300 2310 2320 2330 2340 2350 2360 2370 2380 2390 24-00
-14 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGT
50 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGA
163 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtgc-gg
176 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtgggg
177 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGXAGGT
160 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGG 
-162 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAG
15 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTG-GGG
170 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGG
16 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaoo^ «kjgaggtggggaggtc-ggg 
174 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtgggg
-175 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggtggt
5 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtgggg
171 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGOGG
52 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtgggg
-17 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGOGG
67 aggtggcgaggtggggaggtggggaggtggggaggtccggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtgggg
-68 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGG 
165 GGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGG AGGTGGGG
51 GGGAGGTGGGG 
AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAG6TGGGGAGGTGGGGAGGTOGGGAGGTGOGG
2410 2420 2430 2440 2450 2460 2470 2480 2490 2500 2510 2520
16 3 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGT
176 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGT
160 aggtggggaggtggggaggtggggaggtggggaggtggggaggtg
15 AGGT
170 AGGTGGGGAGGTGGGGAGGTGGGGATTGG
16 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGG ATACTTCTTATCAA 
174 aggtggggaggtggggaggtcgggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggagxtacttxaacgctt
5 aggtggggaggtggggaggtggggaggtggggaggt
171 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggagxtacttxaacgctt 
52 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggagga
-17 aggtggggaggtggggaggtggggaggtg 
67 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggagxtactxgaacxgtt 
-68 aggtggggaggtggggaggtggggaggtggggagg
165 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggta
51 aggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtacttcaacgctt 
-69 ggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtggggaggtacttgaacgctt
-172 AGGTGGGGAGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
-17 3 AGGTGGGGAGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGCGGGGAGGTGGGGAGGTACCTGAACGCTT
-66 AGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
-34 GGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
-164 GGGG AGGTGGGG AGGTGGGGAGGTGGGGAGGTGGGG AGGTGGGGAGGTGGGG AGGTOGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
-168 GGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAAC
-169 AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
-161 GGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTG
166 GTGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTCAACGCTT
-167 TGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
-33 CCCCGTAGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
AGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT
2530 2540 2550 2560 2570 2580 2590 2600 2610 2620 2630 2640
16 AT
174 TGXTTXAT
171 TGXTTTATXCAATATAXAAAXTTTAAAXXTTT 
67 TTGTT
51 TXGTTTATGCAATATAGAAAXTCTAAAAXTTTATTGATTGACTXGCCAXCGATACC 
-69 TGGT 
-172 TGGTTTATGCAATATAGAAAGTTTAAAA
-173 TGGTTTATGCAATATAGAAAGTTTAAAAGTTTATTGATTGACTG 
-66 TGGTTTATGCAATATAGAAAGTTTAAAAGTTTATTGATTGACTGGCCACCGATACCGTCXCGGAACCCGCCTGTGGGGGCAGGG 
-34 TGGTTTATGCAATATAGAAAGTTTAAAAG 
-164 TGGTTTATGCAATAT 
-169 TGGTTTAT
166 TGGTTTATGCAATATAGAAACTTTAAAACTTTATTCATTGACTGXCCACCGATACCGTCGCGGAACCCXCCTGTGGGGXCAGGGG 
-167 TGGTTTATGCAATATAGAAAGTTTA 
-33 TGGTTTATGCAATATAGAA
99 GTTT ATGCAAT AT AGAAAGTTT AAAAGTTTATTGATTGACTGGCCACCGATACCGTCGCGGAACCCGCCTGTGGGGGCAGGGGGAGCGGGAGCTTTCGGCCTCGGGTACGCAGGT ACG
12 AATATAGAAAGTTTAAAAGTTTATTGATTGACTGGCCACCGATACCGTCGCGGAACCCGCCTGTGGGGGCAGGGGGAGCGGGAGCTTTCGGCCTCGGGTACGCAGGTACG
123 AGTTTAAAAGTTTATTGATTGACTGGCCACCGAT ACCGTCGCGGAACCCGCCTGTGGGGGCAGGGGGAGCGGGAGCTTTCGGCCTCGGGTACGCAGGT ACG
-137 GTTT ACA**TTTATGA»»TGACTGGCCACCGATACCGTC*CGGAACCCGCCTGTGGGGGCAGGGGGAGCGGGAGCTTTCGGCCTCGGGTACGCAGGT ACG
-156 AGTT*AGT»ATTGACTGGCCACCGATACCGTCG**GAA*CCGCCTGTGGGG*CA»GGGGAGCGGGAGCTTT*GGCCTCGGGTACGCAGGTACG
119 TTT ATTGATTG ACTGGCC ACCG AT ACCGTCGCGGAACCCGCCTGTGGGGGC AGGGGGAGCGGGAG • *TTCGCCCTCGGGTACGCAGGT ACG
109 TGTGGGCAGGGGGAGCGGGAG»TTTCGGCCTCGGGTACGCAGGTACG
-74 AGTACGG»»»*«CG
-143 CGCAGGTACG
TGGTTT ATGCAAT AT AGAAAGTTT AAAAGTTTATTGATTGACTGGCCACCGATACCGTCGCGGAACCCGCCTGTGGGGGCAGGGGGAGCGGGAGCTTTCGGCCTCGGGTACGCAGGT ACG
2650 2660 2670 2680 2690 2700 2710 2720 2730 2740 2750 2760
99 CGGCGGCGGCGGCGTGTCGGGGAAATAGCTCCGGATCGGCCCC*GCCATGTCCAGCAGCGCCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGAT*CCGAGTCT«GCT*»GA 
12 CGGCGGCGGCGGCGTGTCGGGGAAATAGCTCCGGATCGGCCCCCGCCATGTCCAGCAGCGCCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCACTTCGA 
123 CGGCGGCGGCGGCGTGTCGGGGAAATAGCTCCGGATCGG*CCCCGCCATGTCCAGCAGCGCCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCC*GAGTGT»GCTT*GA 
-137 CGGCGGCGGCGGCGTGTCGGGGAAATA* CTCCGGAT
-156 CGGCGGCGGCGGCGTGTCGGGGAAATAGCTCCGG ATCGGCCCCCGCCATGTCCAGCA* CGCC ACCCAGTAGCGCTCCG AGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA 
119 CGGCGGCGGCGGCGTGTCAGGGAAATAGCTCCGGATCGGCCCCCGCCATGTCCAGCAGCGCCACCCAGT AGCGCTCCGAGTCG • CTGGGGGGGTCTCCCCGATCCCGAGTGTCGCTTCGA 
109 CGGCGGCGGCGGCGTGTCGGGGAAATAGCTCCGGATCGGCCCCCGCCATGTCCAGCAGCGCCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA 
- 74 CGGCGGCGGCGGCG * • *GGGAAAT A* CTCCGGATCGG * CCCCGCCATGTCCAGCA* CGCC ACCCATATA» GCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA 
-14 3 CGGCGGCGGCGGCGTGTCGGGGAAATA»CTCCGGATC*GCCCCCGCCATGTCCATCA»CGCCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGA
92 CCGCCATGTCCAGCAGCG•CACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA
-49 ACGCCACCCAATTACGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA
104 GGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA
CGGCGGCGGCGGCGTGTCGGGGAAATAGCTCCGGATCGGCCCCCGCCATGTCCAGCAGCGCCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGA
2770 2780 2790 2800 2810 2820 2830 2840 2850 2860 2870 2880
99 AAA
12 AAAACCGTGCGCACTCG 
123 AAA
-1 56 AAAACCGTG»••ACTCGCGCTCGTACATGG *CTGGCGGGAACAGCCGAACGCGTGCCCCAGGCA 
119 AA
109 AAAACCGTGCGCACTCGG»»TCGTACATGGCCTGGCGGGAACAGC»GAACGCGTGCCCCAGGACG*ACCAGT«GGCGCAAAAA 
-74 AAAACCGTGCGCACTCGCGCTCGTACATGG«CTGGCGGGAACAGCCGAACGCGTGCCCCA 
92 AAAACCGTGCGCACTCGCG*TCGTACATGGCCTGGCGGGAACAGC*GAACGCGTGCCCCAGG*AGCACCAGTGG*CGC»AAAAAGGAGGCGGGTGCTAAGCTCAGC*TGGGTCTCAC 
-49 AAAACCGTGCGCACTCGCGCTCGTACATGGCCTGGCGGGAACAGCCGAACGCGTGCCCCAGGCAGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGG 
104 AAAACCGTGCGCACTCG*GCTCGTACATGGCCTGGCGGGAACAGC*GAACGCGTGCCCCAGG»AGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCG 
ISO ACTCGCCCTCGTACATGGCCTGGCGGGAACAGCCGAACGCGTGCCCCAGGCAGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCG
108 GGCCTGGCGG»AACAG*CGAACGCGTGCCCCAGG*AGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCG
128 GGC'GGAACAGCCGAACGCGTGCCCCAGGCAGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCG
122 CGAGCGCGTGCCCCAGG*AGCACCATTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCT«AGC»TGGGTTTCCACCG
- 3 GCCCCAGGCAGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCG
31 CCAGT» CGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCG
-• CTAAGCTC***»»GGGTCTCCACCG
46 CTCAGCGTGGGTCTCCACCG
- 9 8 ACGTGGGTCTCCAC*•
-88 AGTGGTCTCA»»**
125 CACCG
AAAACCGTOCOCACTCGCOCTCGTACATOGCCTOOCGGGAACAOCCGAACGCGTGCCCCAOGCAGCACCAGTGGGCGCAAAAAAOGAGGCGOGTGCTAAGCTCAOCGTGGGTCTCCACCG
2890 2900 2910 2920 2930 2940 2950 2960 2970 2910 2990 3000
104 OCOCOCCC*CTAOOTCTACCACCTACCTCCCAACCGCOCOOCGTACCGOGTCCOCCGAGTG<3AAAA* ‘GGCATGOOC
150 OCXJCOGCGC»TAGGTCTACCAGGTACCTCCCCACCOCGCOOCGTAGCGGGTCCOCCaAOTGGAAAACOGGCATGOGG»TOACCOCATATCOOCCOAATAGTTCGCACAACATGCG<rrACG 
108 GCOCGGCOC'TACGTCTACCAGCTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCOCATATCGOCCOAATACTTCGCAOA'CATGCGGTACG 
128 GCGCGGCGCCTAGGTCTACCAGGTACCTCCCCACCGCOCGGCGTAGCOGGTCCQCCGAGTOGAAAACOGQCATOGGGCTGACCGCATATCGGCCGAATAGTTCGCAGAACATGCGGTACG 
122 GCGCGGGG•CTAGGTCTACCAGGTGGCTCCCC
-3 ocgcggcgcctagctctaccaggtacctccccaccgcgcggcgtagcgggtccgccgagtggaaaacgggcatggggctgaccgcatatcggccgaatagttcgcagaacatgcgg 
31 gcgcggcgc*taggtctaccaggtacctccccaccgcgcggcgtagcgggtccgccgagtggaaaacgggcatggggctgaccgcatatcggccgaatagttcgcagaacatgcggtacg
-8 GCGCGGCGCCTAGGTCTACCAGGTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCGCATATCGGCC'AATAGTTCGCAGAACATGCGGTACG 
46 GCGCGGCGC»TAGGTCTACCAGGTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAOTGGAAAACGCGCATGGGGCTGACCGCATATGGGCCGAATAGTTCGCAGAiACATGCGGTACG
-98 GCGCGGCGCCTAGGTCTACCAGGTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAGACGGGCATGGGG»TGACCGCATATCG
-88 •CGCGOCCTA»••GTCTACAGTACTCCCA*••AC*•CGCGGCTACCCGGCTCATGG* * * * * •«AXACGGCAT»•GGGCTGACCGCATATCGGCCGAATAGTTCGCAGAACATGCGGTACG 
125 GCGCGGCGCCTAGGTCTACCAGGTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCGCATATCGGCCGAATAGTTCGCAGAACATGCGGTACG 
-29 CGCCTA»GTCTACCA*GTACCTCCCCACCGCGCGGC*TAGCGGGTCCGCC»AGTGGAAAACGGGCATGGGGCTGACCGCATATCGGCC»AATAGTTCGCAGAACATGCGGTACG
124 CCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCGCATATCGGCCGAATAGTTCGCAGAACATGCGGTACG
-59 CGCCGTGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCGCATATCGGCC*AATAGTTCGCAGAACATGCGGTACG
-55 CGGGCGGGTCCGCC**ATGG*AAACGGGCATGGGGCTGACCGCATATCGGCC*AATAGTTCGCAGAACATGCGGTACG
-131 GCGGGTCCGCC*AGT«GAAAAC»GGCATGGG*CT*ACCGCATATCGCC*»AATAGTTCGCAGAACATGCGGTACG
-82 ACGGGCATGGGGCTGACCGCATATCGGCCCAATAGTTCGCACAACATGCGGTACG
44 GCATATCGGCCGAATAGTTCGCAGAACATGCGGTACG
GCGCGGCGCCTAGGTCTACCAGGTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCGCATATCGGCCGAATAGTTCGCAGAACATGCGGTACG
3010 3020 3030 3040 3050 3060 3070 3080 3090 3100 3110 3120
150 CGCGCGGCCAGAT
108 CGCGCGGCCAGATTTCGGGGG*AGGCCCG»*TCCTCTCCTGAGCGTGCTA*»GGCGTCCGCG»ACATA 
128 CGCGCGGCCAGATTTCGGGGG•AGG•CCCGCTCCTC•CCT 
31 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGAGC»*CTCA**CGCGTCCGCGGACATAGCGC 
-8 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGAGCGCGTCAGCG 
46 CGCGCGGCCAGATTTCGGGGG‘AGGCCC »G•TTCTCTCCT 
-88 CGCGCGGCCAGATTTCGGGGGGAG»CCCCGCTCCTCTCCTGA»CGCGTCAGC*GCGTCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACTGA
125 CGCGCGGCCAGATTTCGGGGGGAGGCCC‘GCTCCTCTCCTGAGCGCGTCAG *»GCGT* CGCGGACATAGCGC
- 29 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGA • CGCGTCAGCGGCGTCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACTGAGCGGGGAAGCGACACCGCGT 
124 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTC*CCTGAGCGCGTCAGCGC*»TCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACT 
-59 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGAGC*CGTCAGC*GCGTCCGC*GACATAGCGCGCACCGCTGACGCGAATTCGCCCATTC
-55 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGA*»*CGTCAGCGGGGTCCGCGGACATAGCGGGCACCGCTGACGCGAATTCGCCCACTGAGCGGGGAAGCGACACCGCGT 
-131 CGCGCGGCCAGATTTCGGGGG•AGGCCCCGCTCCTCTCCTGAGCGCGTCAGCGGCGTCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACTGAGCGGGGAAGCGACACCGCGT 
-82 CGCGCGGCCAGATTTCGGGGGGAGCCGCCGCTCCTCTCCTGA»CGCGTCAGCGGCGTCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCC 
44 CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGAGCGC*GTCACGGCGTCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACTGAGCGGGGAAGCGACACCGCGT
157 ttgggggaggccc*gctcctctcctgagcgcgtga*»*gcgtccg*ggacatagcgcgcaccgctgacgcgaattcgco:actgagcggggaagcgacaccgcgt
158 ccccgctcctctcctgagcgcgtca*»*gcgtccgcggacatagcgcgcaccgctgacgcgaattcgcccactgagcggggaagcgacaccgcgt
-9 TAGC'GGGAAGCGACACCGCGT
-147 GGGAA*CGACACCGCGT
64 CCGCGT
-129 CCGCGT
CGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGAGCGCGTCAGCGGCGTCCGCGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACTGAGCGGGGAAGCGACACCGCGT
3130 3140 3150 3160 3170 3180 3190 3200 3210 3220 3230 3240
-29 gcgcggccgtgtccgtgctggtggggtacagcccctcaccgcctccgcagtct*»cccggttc 
-55 gcgcggccgtgtccgtgctggtggggtacagcccctcaccgcctccgcagtctcccccggttctcacatccc' gtct 
-131 GCGCGGCCGTGTCCGTGCTGGTGGGGTACAGCCCCTCACCGC'TCC
44 GCGCGGCCGT*CTCCGTCTGGTGGGGTACAGCCC*TCACCGCCTCCGCAGTCTCCCCG
157 GCGCGGCCGTGTCCGTGCTGGTGGGGTACAG*CCCTCACCGCCTCCGCAGTCTCCCC*GGTTCT»ACATCCCCGTCTACCGCCATGGGG*AA*CGTACGCGCAGT*CATAACTCTCGGGA
158 GCGCGGCCGTGTCCGTGCTGGTGGGGTACAG*CCCTCACCGCCTCCGCAGTCTCCCCCGGTTCTCACATCCCCGTCTACCGCCATGGGGGAAC*GTACGCGCAGTCCATAACTCTCGGCA 
-9 GCGCGGCCGTGTCCGTGCTGGTGGGGTACAGCCCCTCACCGCCTCCGCAGTCTCCCCCGGTTCTCACATCCCCGTCTACCGCCATGGGGGAACCGTACGCGCAGTCCATAACTCTCGGGA
-147 GCGCGGCGTGT**CGTGCTGGTGGGGTACAGCCCCTCACCGCCTCCGCAGTCTCCCCCGGTTCTCACATCCCCGTCTACCGCCATGGGGGAACCGTACGCGCAGTCCATAACTCTCGGGT 
64 GCGCGGCCGTGTCCGTGCTGGTGGGGTACAGCCCCTCACCGCCTCCGCAGTCTCCCCCGGTTCTCACATCCCCGTCTACCGCCATGGGGGAACCGTACGCGCAGTCCATAACTCTCGGGA 
-129 GCGCGGCC«TGTCCGTGCTGGTGGG*TACA*CCCCTCACCGCCTCCGCAGTCTCCCCCG*TTCTCACATCCCCGTCTACCGCCAT«GGGGAACCGTACGCGCAGTCCATAACTCTCGGGA 
-133 CGTGCTGGTGGGTTACAGCCCTT«ACCGCCTCCGCAGTCT«CCCCGGTTCTCACATCCCCGTCTAC*GCCATGGGGGAAC*GTACGCGCAGTC»ATAACTCT*GGGA
-6 CGAGTCTCCCC »GGT•CT•ACATCCCCGTCTACCGCCAT•GGGGAACCGTACGCGCAGTCCAT AACTCTCGGGA
97 CATGGAC**ACCGTACGCGCAGTCCATAACTCTCGGGA
gcgcggccgtgtccgtgctggtggggtacagcccctcaccgcctccgcagtctcccccggttctcacatccccgtctaccgccatgggggaaccgtacgcgcagtccataactctcggga
3250 3260 3270 3280 3290 3300 3310 3320 3330 3340 3350 3360
157 GCGTGGAGC »TAGGCG »ACTGACCGGGCG•GGC* GGGTACCAGGGGTATTTCT
158 tccggagtatttccccgacacgccgcgcgcggtagtgcgtacc
-9 gcgtggagcctaggcgcactgaccgggcgcggccgggtaccaggggtatttcctcggcggggcggggaatcgcatgtgccatagccccgcccgtgcctctatcc 
-14 7 gcgcggagcctaggcgcactgaccgg•cgcggccgggtaccag
64 gcgtggagcctagggccactgaccgggcgcgggcgggtaccaggggtatttcctcggcggg»cggggaatcgcatgtgccatagccccg*ccgtgcctctatcctattgttcttccatca 
-129 gcgtggagcctaggcgcactgaccgggcgcggccgggtaccaggggtatttcctcggcggggcggggaatcgcatgt 
-133 GCGTGGAGCCTAGGCGCACTGACCGGGCGCGGCCGGGTACCAGGGGTATTTCCTCGGTGGGGTGGGGAATTGAT
-6 GCGTGGAGCCTAGGCGCACTGACCGGGCGCGGCCGGGTACCAGGGGTATTTCCTCGGCGGGGCGGGGAATCGCATGTGCCATAGCCCCGCCCGTGCCTCTATCCTATTGTTCTTCCATCA 
97 GCGTGGAGCCTAGOCGCACTGACCGGGCGCGGCCGGGTACCAGGGGTATTTCCTCGGCGGGGCGGGGAATCGCATGTGCCATAGCCC'GCCCGTGCCTCTATCCTATTGTTCTTCCATCA 
-20 GGGGTACCAGGG*TATTT*CTCGGCGGG»»CGGGAATCG»ATGTGGCATAG*CCCGCCCGTGCCTCTATCCTATTGTTCTTCCATCA
OCGTGGAGCCTAGGCGCACTGACCGGGCGCGGCCGGGTACCAGGGGTATTTCCTCGGCGGGGCGGGGAATCGCATGTGCCATAGCCCCGCCCGTGCCTCTATCCTATTGTTCTTCCATCA
3370 3380 3390 3400 3410 3420 3430 3440 3450 3460 3470 3480
64 TGCCCTCCGG *ACACATCT *ACCC
-6 TGCCTTCCGGCACACATCTCACCCCGGCCGGCCCGTTTGCGTGGGTGCTGTTATCGC 
97 TGCCTTCC*GCACACATCTA*'CCCGGCCGGCCG *'TTGCGTGGTGTGTAT* * * «GCTCTT 
-20 TGCCTTCCGGCACACATCTCACCCCGGCCGGCCCGTTTGCGTGGGTGCTGTTATCGCTCTTCACATATTCATACGGCGATAAAGGGGCACCGTTGGGCGTACGCACACGGCTTGCACGTT
-134 TCTCACCCCG*CCG*CCCGTTTGCGTGGGTGCTGTTATCGCTCTTCACATATTCATACGGC*ATAAAGGGGCACCGTTGGGCGTACGCACACGGCTTGCACGTT
-36 CACATATTCATACGGCGATAAAGGGGCACCGTTGGGCGTACGCACACGGCTTGCACGTT
13 AGGGGCACCGTTGGGCGT ACGCACACGGCTTGCACGTT
-149 ACACGGCTTG * ACGTT
TGCCTTCCGGCACACATCTCACCCCGGCCGGCCCGTTTGCGTGGGTGCTGTTATCGCTCTTCACATATTCATACGGCGATAAAGGGGCACCGTTGGGCGTACGCACACGGCTTGCACGTT
3490 3500 3510 3520 3530 3540 3550 3560 3570 3580 3590 3600
-20 TAACGGGGAACGCGTGTTACGACGGCGGGGGAGATCTTCTGTATAGCGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG
-134 TAACGGGGAACGCGTGTTACGACGGCGGGGGAGATCTTCTGTATAGCGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG
-36 TAACGGGG**CGC*TGTTACGAC*GCGGGGGAGATCTTCTGTATA*CGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAGACACGAGATTGTGCTCGATGAAGG
13 TAACGGGGAACGCGTGTTACGACGGCGGGGGAGATCTTCTGTATAGCGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG
-149 TAACGGGGAA*GCGTGTTACGAC*GCGGGGGAGATCTTCTGTATAGCGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG
-118 GGGGCGCGTGTTACGACGCGGGGA*»*ATCTTCTGTATA»CGCTCGCCC*ACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG
127 CGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG
-25 GCACOCQACAAACACGAGATTOTOCTC*ATGAAOG
23 ACACGAGATTGTGCTCGATGAAGG
-75 ACOAGATTOTOCTCGATGAAG*
TAACGGGGAACGCGTGTTACGACGGCGGGGGAGATCTTCTGTATAGCGCTCGCCCAACCCCAATACCACCCACCGTTTCCTGCATOCACOCOACAAACACGAGATTGTOCTCGATGAAGG
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-20 TTACTCAA
-134 TTAGTCAACGATTTATTTGGTTATAAGCOGGGATAGACGCGCATTGACGCTACATATGAATTAACTG 
-36 TTAGTCAACGATTTATTTGGTTATAAC 
13 TTACTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATATGAATTAACTGCGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAA*CGGTAACT
-149 ttactcaacgatttatttggttataagcggggatagacgcgcattgatgctacatatgaattaactgcggcg
-118 TTAGTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATATGAATTAAGTGCGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAAAC 
127 TTAGTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATATGAATTAACTGCGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAA'CGGTAACT 
-2 5 TTAGTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATAT»AATTAACTGCGGCGTGTTGGCr.GTTATGGTGGGAACTAATAGGGCTACTAAAAACGGTAACT 
23 TTAGTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATATGAATTAACTGCGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAAACGGTAACT 
-75 TTATCACCA*• *TTATT*‘GTTATAC *•»GGGATAGACGCGCATTGATGCTACATAT»AATTACT*•CGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAAACG *TAACT 
-89 . GTTXXAATACGGGATAGACGCGCATXGATGCTACATATXAATTAXCTXCGXCXTGTTGGGGXTTATGXTGGXAACTAATAGGGCTACTAAAAXCGGXAACT
43 ATTGATGCTACATATGAATTAACTGCGGCGTCTTOGGGGTTATGGTGGGAACTAATAGGGCTACTAAAAACGGTAACT
111 ATTGATGCTACATATGAATTAACTGCGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAAACGGTAACT
TTAGTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATATGAATTAACTGCGGCGTGTTGGGGGTTATGGTGGGAACTAATAGGGCTACTAAAAACGGTAACT
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13 ACCTATGCGGTTT*GGTT 
127 ACCTATGCGGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGGCCGG
-25 ACCTATGCGGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGGCC*GGCGCCCGCCTTTGGGGACAGGGCGCCCGCGGCGCTTTTGAGCAGCGCGGGCACGTGTGGTGGGA 
23 ACCTATGCGGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGGCCGGGCGCCCGCCTTTGGGGACAGGGCGCCCGCGGCGCTTTTGAGCAGCGCGGGCACGTGTGGTGGGA 
-75 ACCTATGCGGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGGCC*GGCGCCCGCCTTTGGGGACA 
. ,89. ACCTAXXCCGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGXCCGGXCGCCCGCCTTTGGGGACA
43 ACCTATGCGG**CTGGTTGC*TGTGCTTCTAATCACCGGCGAGCGCTTCTGGCCGGGCGCC»*GCTTTGGGGACAGGGCGCCCGCGGCGCTTTTGAGCAGCGCGGGCACGTCTGGTGGGA 
111 ACCTATGCGGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGGCCGGGCGCCCGC'TTTGGGGACAGGGCGCCCGCGGCGCTTTTGAGCAGCGCGGGCACG
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GCATTGGGCGCCCGCGGCGCTTTTGAGCAGCGCGGGCACGTGTGGTGGGA
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-25 GGGTTGG**
23 GGGTTGT»»GGGACATCTGCCTCQCTATCGCTTTCGCTGCTAGACCA TTTCCC tca 
43 GGG
-154 GGGTTGGTGGGGACATCTGCCTCGCTATCGCTTTCGCTGCTAGACCACTTTCCCGTGCAACAAGAATC
-155 GGGTTGGTGGGGACATCTGCCTCGCTATCGCTTTCGCTGCTAGACCACTTTCCCGTGCAACAAGAGTCGTCTTCCTCGTCCGAAAAGC
48 GGGTTCGTGGGGACATCTGCCTCGCTATCGCTTTCGCTG*TAGACAC TTTCCG TGCAACAAGAGTCGTGTTCCTCGTCCGAAAAG TTTCAAAGT 
.132 GGACATCTGCCTCGCTATCGCTTTCGCTGCTAGACCACTTTCCCGTGCAACAAGAGTCGTCTTCCTCGTCCGAAAAGCTTTCAAAGTCGCTCGTGGCGCTCTCTTCCTCG
.113 CATCTGCCTCGCTATCGCTTTCGCTGCTAGACCACTTTCCCGTGCAACAAGAGTCGTCTTCCTCGTCC»»AAAGCTTTCAAAGTCGCT*CTGGCGCTCTCTTCCTCG
. 4 2  CCC'TGCAACAA* AGTCGTCTTCCTCGTCCG*AAAGCTTTCAAAGTCGCTGCTGGCGCTCTCTTCCTCG
7g GTCCGAAAAGCTTTCAAAGTCGCTGCTGGCGCTCTCTTCCTCG
.121 CCAAAAC»TTTCAAAGCCGCT**TGGGACTCTCTTCCTCG
.135 AAAAGCTTTCAAAGCGCT**CTGGCGCTCTCTTCCTCG
.55 CTTTCAAAGTCGCTGCTGGCGCTCTCTTCCTCG
GGGTTGGTGGGGACATCTGCCTCGCTATCGCTTTCGCTGCTAGACCACTTTCCCGTGCAACAAGAGTCGTCTTCCTCGTCCGAAAAGCTTTCAAAGTCGCTGCTGGCGCTCTCTTCCTCG
3970 3980 3990 4000 4010 4020 4030 4040 4050 4060 4070 4080
-132 G G A C T A A A C T C T G A A A T G G T G C T A T T T C C G C T A G C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T  CGC A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G  ATCA 
-113 G G A C T A A A C T C T G A A A T G G T G C T A T T T C C G C T A » C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G A T C A  
-42 G » A C T A G A C T C T G A A A T G G T G C T A T T T C C G C T A G C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G A T C A  
76 G G A C T A A A C T C T G A A A T G G T G C T A T T T C C G C T A G C C T C T T C C T C C T C T G A C G G A G A G T C G T C G C C G * T A A C T T C G C A C T C T T C C C C A A A G A G G G T C » T G G G T G G C T T G » T G G G C G * A T » A  
-121 G G A C T A A A C T C T G A A A T G G T G C T A T T T C C G C T A G C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G A T C A  
-135 G G A C T A A A C T C T * A A A T G G T G C T A T T T C C G C T A G C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G A T C A  
-65 G G A C T A A A C T C T G A A A T G G T G C T A T T T C C G C T A * C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A A A G T G T T T T G G G T G G C T T G C T G G G C G G A T C A  
-27 T C T T C C T C C T C T G C G G A A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A G A G G * T T T T G G G T G G C T T G C T G G G C G G A T C A
87 C C T C C T C T G A C G G A G A C T G C T C G C * * C T A A C T T C G C A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G A T C A
■ 39 T G A C G G A A A C T C G T C G C C G C T T A C T T C G C A C T C T T C C C C A A A G A G G  •TTTTGGGTGGCTTGGTGGGCGGATCA
.21 CCCAAAGA G » * » T T T G G * T * G C T T G C T « G G C G G A T C A
G G A C T A A A C T C T G A A A T G G T G C T A T T T C C G C T A G C C T C T T C C T C C T C T G A C G G A G A C T C G T C G C C G C T A A C T T C G C A C T C T T C C C C A A A G A G G G T T T T G G G T G G C T T G C T G G G C G G A T C A
4090 4100 4110 4120 4130 4140 4150 4160 4170 4180 4190 4200
-132 AGAAACCTCTGCTCGCACTTGTCTTCCGAGTTTATGGCACGGAG*GTGGCCCGC 
-113 AGAAACCTCTGCT
-42 A G A A A C C T C T G C T C G T A C T T G T C T T C C G A G T T T A T G G C A C G C A G C G T G G C C C G C A G C G G A A G G C T C T G C T C C G G C A T C A  
76 AG A A A C * T C T G * T C G T A  
-121 A G A A A C C T C T G C T C G T A C T T G T C T T C C G A G T T T A T G G C A C G C A *  CGTGGCCC G C A G C G G A A G  * CTCTGCTCC  
-13 5 AG A A A C C A C T G C T C G T A C T T G T C T T C C G A G T T T A T G G C A C G C A G C G T G G C C C G C A G C G G A A G G C T C T G C T C C G G C A T C A G C T  
-65 A G A A A C C T C T G C T C G T A C T T G T C T T C C G A G T T T A T G G C A C G C A G C G T G G C C C G C A G C G G A A G ' C T C T G C T C C G G C A T C A G C
-27 aGAAACCTCTGCTCGTACTTGTCTTCCGAGTTTATGGCACGCAGCGTGGCCCGCAGCGGAAGGCTCTGCTCCGGCATCAGCTGCAAAAGGGCCTGCCAACATTCTAGGGTAGGGCGTGCA 
87 AGAAACCTCTGCTCGTACTTGTCTTCCGAGTTTATGGCA* GCAGCGTGGCCCGCAGCGGAAGG•TCTGCTCCGGCATCAGCTGCAAAAGGGCTTGCCAACATTCTa 
-39 AGAAACCTCTGCTCGTACTTGTCTTCCGAGTTTATGGCACGCAGCGTGGCCCGCAGCGGAAGGCTCTGCTCCGGCATCAGCTGCAAAAGGGCCTGCCAACATTCTAGGGTAGGGCGTGCA 
-21 AGAAACCTCTGCTCGTACTTGTCTTCCGAGTTTATGGCACGCA*CGTGGCCCGCAGCGGAAGGC*CTGCTCCGGCATCAGCTGCAAAAGGGCCTGCCAACATTCTAGGGTAGGGCGTGCA 
53 CAGCGCGGCCCGCAGCGGAAGGCTCTGCTCCGGCATCAGCTGCAAAAGGGCCTGCCAACATTCTAGGGTAGGGCGTGCA
.54 AAGATCTAGGGTAGG'CGTGCA
AGAAACCTCTGCTCGTACTTGTCTTCCGAGTTTATGGCACGCAGCGTGGCCCGCAGCGGAAGGCTCTGCTCCGGCATCAGCTGCAAAAGGGCCTGCCAACATTCTAGGGTAGGGCGTGCA
4210 4220 4230 4240 4250 4260 4270 4280 4290 4300 4310 4320
-27 TGCGTGTACCCCATAGCGTAAAAGTCCAACAGCACCCTGCGCAGGACGCGCGAGTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGAC 
-39 TGCGTGTACCCCATAGCGTAAAAGTCCAACAGCACCCTGCGCAGGACGCGCGAGTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTA
-21 TGCGTGTACCCCATAGCGTAAAAGTCCAACAGCACCCTGCGCAGGACGCGCGAGTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG 
53 TGCGTGTACCCCATAGCGTAAAAGTCCAACAGCACCCTGCGCAGGACGCGGAGCTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG 
-54 T*CGTGTACCCCATAGCGTAAA»GTCCAACAGCACCCTGCGCAGGACGCGCGA*TCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCC»GGCGAGG 
103 GCGCAGGACGCGCGAGTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG
-41 AGTC*TCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG
100 CTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG
159 ATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG
TGCGTGTACCCCATAGCGTAAAAGTCCAACAGCACCCTGCGCAGGACGCGCGAGTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG
4330 4340 4350 4360 4370 4380 4390 4400 4410 4420 4430 4440
-21 CGGTTTACGTCTGGG*GCCACGGCGGAGCGCAGAACGCTCCCGGCCCCCGAGACAGGTACGGGCGCAGCGACCTCGGCGAGA 
53 CGGTTTACGTCTGGGCGCC'ACGGGCAGCGCAGAACAGTCCCGGCCCC'GAGACAGGTAC
-54 cggtttacgtctgggc*ccacggcggagcgcagaacgctcccggcccccgagacaggtacgggcgcagcgacctcggcgagagcggcagoccgtattccggatggtcagagccgccggga 
103 cggtttacgtctgggcgccacgg**gagcgcagaacgctcccggcccccgagacaggtacgggcgca»*gacctcggcgagagcggcaggccgtattccggatggtcagagccgccgg*a 
-41 cggtttacgtctgggcgccacggcggagcgcagaacgctcccggcccccgagacaggtacgggcgcagcgacctcggcgagagcggcaggccgtattccggatggtcagagccgccggga
100 CGGTTTACGTCTGGGCGCCACGG»GGAGCGCAGAACGCTCCCGGCCCCCGAGACAGGTACGGGCGCAG*»ACCTCGGCGAGAGCGGCAGGCCGTATrCCGGATGGTCAGAGCCGCCGG*A 
159 CGGTTTACGTCTGGGCGCCACGGCGGAGCGCAGAACGCTCCCGGCCCCCGAGACAGGTACGGGCGCAGC*ACCTCGGCGAGAGCGGCAGGCCGTATTCCGGATGGTCAGAGCCGCCGGGA 
-141 GCAG••AC***»»»*** *GCGGCA*GCCGTAT* CC*GATGGTCAGA* * CGCCGGGA
CGGTTTACGTCTGGGCGCCACGGCGGAGCGCAGAACGCTCCCGGCCCCCGAGACAGGTACGGGCGCAGCGACCTCGGCGAGAGCGGCAGGCCGTATTCCGGATGGTCAGAGCCGCCGGGA
4450 4460 4470 4480 4490 4500 4510 4520 4530 4540 4550 4560
103 AGCCTGG
-41 AGCCTGGCGGGCACGCGCACGGAGTCTATGCGCTGGCTGGAGCGTGGGGATGGGTTCCCACCA** GA*T
100 AGCCTGGCGGGCA* *CGCACGGAGTCTATGCGCTGGCTGGAGCTCGGG
159 agcctggcgggcacgcgcacggagtctatgcgctggctggagcgtggggatgggtt*ccaccagatgagggggacagg*a*ggtatgatggg
-141 a*cctg*cgggcacgcgcacggagtctatgcg*tggctggagcgtggggat*ggttcccaccagatgagggggacagggagggtatgatggg*ctggtggacggcgccccccgctgtgac 
-70 gggatxggttxccacca**tga*ggggacagggagggtatgatggggctggtggacggcg*cccccgctgtgac
14 5 AGATGAGGGGGACAGGGAGGGTATGATGGGGCTGGTGGACGGCGCCCCC * GCTGTGAC
101 gtgac 
AGCCTGGCGOGCACGCGCACGGAGTCTATGCGCTGGCTGGAGCGTGGGGATGGGTTCCCACCAGATGAGGGGGACAGGGAGGQTATGATGGGGCTGGTGGACGGCGCCCCCCGCTGTGAC
4570 4580 4590 4600 4610 4620 4630 4640 4650 4660 4670 4680
-141 ATGCGGCAGGATCC 
-70 ATGCGGCAGGATCC 
14 5 ATGCGGCAGGATCC 
101 ATGCGGCAGGATCC 
ATGCGGCAGGATCC
The DNA sequence of Bam HI 1 of EHV-1 subtype 2 shown 
as the rightward 5' - 3' strand. The amino acid sequences
of predicted encoded proteins are shown in single letter 
amino acid code above (rightward encoded) or below 
(leftward encoded) the corresponding DNA sequence, 
Polyadenylation associated sequences AATAAA and ATTAAA are 
indicated by asterisks. Reiterated sequences are marked 
X .
1 G S T W P S R C H S T L L G D R P H F I O P A P N R V D L L  30
GGATCCACATGGCCTTCTCGGTGCCATAGTACTTTG1TGGGCGATAGGCCACATTTTATCCAACCGGCACCAAACAGGGTAG>M:TTGTTA 90
F K D I P E S A T G L Y V F V L L Y N G H P E A W T Y T L L  60
TTCAAAGATATACCCGAATCAGCGACCGGGTTGTATGTGTTTGTGTTATTGTACAACGGACATCCGGAGGCGTGGACGTaTACGTTGCTT 180
S T A N H F M N V L T D R T R P R L G E H F Y T D H G H Q L  90
TCT ACAGCAAATC AC T T T ATG AACG TGC TT ACGGACCG AAC ACGCCC ACGGC T AGG AGAGCAC TTT TATACGGACCACGGGCACCAGC TT 2 70
F T P H P S E A T T Q E L G A W T R H Y L A F L L I  I I C T  120
TTCACTCCTCATCCATCTGAGGCAACAACTCAAGAGTTGGGAGCTTGGACCAGACACTACCTCGCTTTTTTGTTGATCATAATCTGCACC 360
C A A L L I A L V V W G C I  L Y I R S N R K P Y E V L N P F  150
TGTGCCGCGCTGCTAATTGCCTTGGTGGTGTGGGGCTGCATTCTATACATCCGAAGCAACCGCAAGCCGTATGAAGTACTAAACCCGTTT 450
E T V Y T S V P S N D P T D E V L V F E R L A S D S D D S F  180 
GAAACGGTTTACACAAGCGTTCCCAGCAACGATCCAACCGACGAAGTCTTGGTATTTGAGCGTCTGGCTTCAGACTCCGACGACTCCTTC 540
D S S S D E E L E L P Q P P P A A Q L Q P Y S S L E S A D A  210 
GACTCAAGTTCAGACGAAGAATTGGAACTACCACAACCTCCACCAGCCGCACAACTTCAGCCGTATAGTTCACTAGAAAGTGCAGACGCG 630
S R G R S G F K V W F R D T P E A S P E P L H R P T P P V G  240 
TCGAGAGGCCGGTCGGGTTTCAAGGTCTGGTTCCGCGATACACCAGAGGCGTCTCCGGAGCCGCTTCATAGACCAACCCCACCCGTCGGA 720
P D Y S K V A S K L R S I L K -  255
CCGGACTACAGCAAGGTCGCGTCAAAGCTCAGGTCTATCCTAAAATGAATTTCAACAACAAAGATACCGCTTGCGCAGGAAATGTGTGCT 810
ATGCTGAAGGACTACGCAATCGTAAGAGTAGTCCGGTTCGAAACAGCACCTTCGAAGAGTATCTCGACTCACTTAATAATTACGACCGCC 900
GTTTGAGAGCTGACTCAACTTCAGATTCGGACTCTGGGTGTAAACCCCCTCTGAAGACGATTCAAATATCAAAGAGTTTACAAAAATTAT 990
GGATCTAAAACCACCATCTCCAGAACCCGAGCCAGCGGCGGCAGAAGAGCCGGT TAGCACCGCCGT TTACATCTTAAACGAGTGGGTGGC 1080
CCCAATGCTTGGACATTTTCTCGCAATGTATGTGTATGATTTGCTTTTTAATTAAACCAAAGATTGTCACCACAATATTTAGTTGTTTGT 1170 
TTTATATGCAAGCGCTAAACCCAACACTAAAGGGTTAT AT ATTATCCCGGGGGACTTTTGCAGTAAT AT AT ATTTTGCTGCCAGTGTTCA 1260 
CTGGTGCTCAGTGCGCCCAACCAGCACAGCCCGTTTTAATCTCTATACTCTCTGTCTATTTTCCTTACCCCGCTCCGTAACACCTCACTT 1350 
TCTCTCATACTACCGCCTTTTTCACGCTACTCCAACAGCTCCTACAACTTACAGTTACCACCACACCATCGCCCTTAACCACCAAGCCAC 1440
2 M G E P E P V V A L T E D A P L S V Y N P N Y R S D N A L I  30 
ATGGGTGAGCCTGAACCTGTGGTAGCGTTGACTGAAGACGCTCCACTGTCCGTGTACAACCCCAACTACAGGAGTGATAACGCACTCATA 1530
A D G D S S P I G G D C C P A E A V A A A E E V A T A A L A  60
GCCGATGGTGATTCCAGCCCCATTGGGGGGGATTGTTGTCCGGCAGAGGCGGTGGCTGCCGCTGAGGAGGTAGCTACGGCTGCTTTGGCT 1620
S E E I Y E M H I K S C I S S T T C G D H N N S I G V T S G  90
TCTGAAGAAATCTACGAGATGCATATCAAATCCTGCATTTCTTCCACCACATGCGGTGACCATAATAACTCAATCGGCGTAACATCGGGG 1710
L T V R A A E C H P P S P E A V G I E D V V V V Q T A A T T  120
CTTACTGTTCGCGCGGCTGAGTGTCACCCCCCGTCCCCAGAGGCCGTAGGTATTGAGGATGTGGTGGTTGTGCAAACTGCGGCTACCACT 1800
N G P S D T V P A S A A A S V I S D D N G C V P L L G S R L  150 
AATGGCCCCTCAGATACAGTACCCGCCAGTGCTGCGGCCTCAGTGATTAGCGATGATAACGGCTGTGTACCGCTGCTAGGGTCACGCCTG 1890
E L E N Y D L E S G C Y Y S E S D N E T A S L F I Q R V G R  180 
GAACTAGAAAACTATGACTTGGAGTCTGGCTGCTACTACAGCGAAAGCGACAACGAAACCGCCAGCCTGTTCATCCAGAGGGTCGGCCGG 1980
R O A R R H R R R R V A L T V A G V V L V A V L C A I S G I  210
CGGCAGGCGCGGCGACACAGGCGGCGACGCGTGGCCCTCACGGTCGCCGGCGTCGTGCTCGTCGCTGTCCTGTGCGCGATATCCGGGATC 2070
V G A F L A R V F O -  220
GTCGGGGCGTTCCTCGCGCGCGTATTTCAGTGACGCGAACCCGCGGACGCGGCCATCGCCTCTACCGCCACGATTTCCCACCCTGCTGTC 2160
CCGCACCCGCCAGTCAATAAAACCTCATAGTAGAGAACCCCAGCCTCTGCGCGTTTGTTCGATGGCCCGGGTAGCTTGTTTCCCA(XCCC 2250
< x x x x x x x x x x
TATCGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGT 2340
X  X  X  X  X  X  X  X  X  X  X  >
GGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGG 2430
< x x x x x x x x x >
GGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTGGGGAGGTACTTGAACGCTT 2520
TGGTTTATGCAATATAGAAAGT TTAAAAGTTTATTGATTGACTGGCCACCGATACCGTCGCGGAACCCGCCTGTGGGGGCAGGGGGAGCG 2610 
3 - F N I S Q S A V S V T A S G A Q P P L P L P 2 3 8
GGAGCTTTCGGCCTCGGGTACGCAGGTACGCGGCGGCGGCGGCGTGTCGGGGAAAT AGCTCCGGATCGGCCCCCGCCATGTCCAGCAGCG 2700 
L K R G R T R L Y A A A A A H R P F L E P D A G A M D L L A 2 0 8
CCACCCAGTAGCGCTCCGAGTCGGCTGGGGGGGTCTCCCCGATCCCGAGTCTCGCTTCGAAAAACCGTGCGCACTCGCGCTCGTACATGG 2790 
V W Y R E S D A P P T E G I G L R A E F F R A C E R E Y M A 1 7 8
CCTGGCGGGAACAGCCGAACGCGTGCCCCAGGCAGCACCAGTGGGCGCAAAAAAGGAGGCGGGTGCTAAGCTCAGCGTGGGTCTCCACCXS 2880 
Q R S C G F A H G L C C W H A C F L L R T S L E A H T E V P 1 4 8
GCGCGGCGCCTAGGTCTACCAGGTACCTCCCCACCGCGCGGCGTAGCGGGTCCGCCGAGTGGAAAACGGGCATGGGGCTGACCGCATATC 2970 
A A G L D V L Y R G V A R R L P D A S H F V P M P S V A Y R 1 1 8
GGCCGAATAGTTCGCAGAACATGCGGTACGCGCGCGGCCAGATTTCGGGGGGAGGCCCCGCTCCTCTCCTGAGCGCGTCAGCGGCGTCCG 3060 
G F L E C F M R Y A R P W I  E P P P G A G R R  L A D A A D A  88
CGGACATAGCGCGCACCGCTGACGCGAATTCGCCCACTGAGCGGGGAAGCGACACCGCGTGCGCGGCCGTGTCCGTGCTGGTGGGGTACA 3150 
S M A R V A S A F E G V S R P L S V A H A A T D T S T P Y L  58
GCCCCTCACCGCCTCCGCAGTCTCCCCCGGTTCTCACATCCCCGTCTACCGCCATGGGGGAACCGTACGCGCAGTCCATAACTCTCGGGA 3240 
G E G G G C D G G T R V D G D V A M P S G Y A C D M V R P L  28
GCGTGGAGCCTAGGCGCACTGACCGGGCGCGGCCGGGTACCAGGGGTATTTCCTCGGCGGGGCGGGGAATCGCATGTGCCATAGCCCCGC 3330 
T S G L R V S R A R G P V L P I E E A P R P I A H A M  1
CCGTGCCTCTATCCTATTGTTCTTCCATCATGCCTTCCGGCACACATCTCACCCCGGCCGGCCCGTTTGCGTGGGTGCTGTTATCGCTCT 3420
TCACATATTCATACGGCGATAAAGGGGCACCGTTGGGCGTACGCACACGGCTTGCACGTTTAACGGGGAACGCGTGTTACGACGGCGGGG 3510
GAGATCTTCTGTATAGCGCTCGCCCAACCCCAATACCACCCACCGTTTGCTGCATGCACGCGACAAACACGAGATTGTGCTCGATGAAGG 3600
TTAGTCAACGATTTATTTGGTTATAAGCGGGGATAGACGCGCATTGATGCTACATATGAATTAACTGCGGCGTGTTGGGGGTTATGGTGG 3690
GAACTAATAGGGCTACTAAAAACGGTAACTACCTATGCGGTTTTGGTTGCGTGTGCTTTTAATCACCGGCGAGCGCTTTTGGCCGGGCGC 3780 
4 - R R A S K A P R 2 6 6
CCGCCTTTGGGGACAGGGCGCCCGCGGCGCTTTTGAGCAGCGCGGGCACGTGTGGTGGGAGGGTTGGTGGGGACATCTGCCTCGCTATCG 3870 
G G K P V P R G R R K O A A R A R T T P P N T P V D A E S D  236
CTTTCGCTGCTAGACCACTTTCCCGTGCAACAAGAGTCGTCTTCCTCGTCCGAAAAGCTTTCAAAGTCGCTGCTGGCGCTCTCTTCCTCG 3960 
S E S S S W K G T C C S D D E E D S F S E F D S S A S E E E  206
GGACTAAACTCTGAAATGGTGCTATTTCCGCTAGCCTCTTCCTCCTCTGACGGAGACTCGTCGCCGCTAACTTCGCACTCTTCCCCAAAG 4050 
P S F E S I T S N G S A E E E E S P S E D G S V E C E E G F  176
AGGGTTTTGGGTGGCTTGCTGGGCGGATCAAG.AAACCTCTGCTCGTACTTGTCTTCCGAGTTTATGGCACGCAGCGTGGCCCGCAGCGGA 4140 
L T K P P K S P P D L F R Q E Y K D E S N I A R L T A R L P  146
AGGCTCTGCTCCGGCATCAGCTGCAAAAGGGCCTGCCAACATTCTAGGGTAGGGCGTGCATGCGTGTACCCCATAGCGTAAAAGTCCAAC 4230 
L S Q E P M L Q L L A Q W C E L T P R A H T Y G M A Y F D L  116
AGCACCCTGCGCAGGACGCGCGAGTCTTCTGTTACGTGAATAGATGAAGTAGATATACCCCTAAACAAGCGATTGACGTCCCCGGCGAGG 4320 
L V R R L V R S D E T V H I S S T S I G R F L R N V D G A L  86
CGGTTTACGTCTGGGCGCCACGGCGGAGCGCAGAACGCTCCCGGCCCCCGAGACAGGTACGGGCGCAGCGACCTCGGCGAGAGCGGCAGG 4410 
R N V D P R W P P A C F A G P G R S L Y P R L S R P S L P L  56
CCGTATTCCGGATGGTCAGAGCCGCCGGGAAGCCTGGCGGGCACGCGCACGGAGTCTATGCGCTGGCTGGAGCGTGGGGATGGGTTCCCA 4500 
G Y E P H D S G G P L R A P V R V S D I R Q S S R P S P N G  26
CCAGATGAGGGGGACAGGGAGGGTATGATGGGGCTGGTGGACGGCGCCCCCCGCTGTGAGATGCGGCAGGATCC 4574
G S S P S L S P I I P S T S P A G R Q S M R C S G  1
ElûnEE_S^5
A graph of the G+C content of Ha.ni HI 1 of EHV-1 
subtype 2. The ORFs are represented by rectangles 
numbered 1,2,3 and 4 the pointed ends of which indicate 
the direction of transcription. The reiterated sequence 
between ORFs 2 and 3 is shown by a series of vertical 
lines and the approximate location of the TRg/Ug junction 
is indicated by a black box and the letter J.
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mRNAs, and of two copies of the variant ATTAAA are shown in 
Figure 5.4.
The ORFs were designated ORFs 1, 2, 3 and 4 from left 
to right in Bam HI 1 and predicted proteins were 
designated proteins 1, 2, 3 and 4 (Figure 5.5), 
Hydrophobicity plots of the predicted proteins were 
computed using the ' hydropathicity' parameters of Kyte and 
Doolittle (1982). This program evaluates the average 
hydropathy within a moving window as it advances through 
the amino acid sequence. The results are represented 
graphically. The amino acid sequences of the predicted 
proteins were compared with those of VZV and HSV-1 using 
the matrix program of Pustell and Kafatos (1982). This 
program also uses a moving window approach. It scores the 
number of residues in a window from one sequence which are 
identical to those in a window from a second sequence. The 
windows which are of equal length are shifted by intervals 
of one residue, and the results obtained as a matrix plot. 
The alignment program, HOMOL, (Taylor, 1984) was used to 
compare the homologous amino acid sequences detected using 
the matrix program. This program aligns amino acid 
sequences by inserting blank characters in such a way as to 
maximise the number of matched pairs. The alignment 
produced depends on the weighting values assigned to 
inserted mismatched residues and inserted blank characters. 
Lastly, the hydrophobicity of the predicted EHV-1 proteins 
was compared with that of their HSV-1 and VZV homologues. 
Counterparts of the four EHV-1, subtype 2 genes were 
detected in both HSV and VZV.
EIGIIEE. 5^6
An autoradiograph of the hybridization of EHV-1 
subtype 2 DNA, cloned in M13 to a Bam HI digest of EHV-1 
subtype 2 DNA blotted onto nitrocellulose. Hybridization 
was in aqueous solution at 68°C overnight.
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EaiD HI 1 contains the TRg/Ug junction (Figure 3.15),
To locate the junction more accurately M13 clones -40,
-117, -93, -60, -37 and -14 were radiolabelled and 
hybridized to a Earn HI digest of EHV-1 subtype 2 DNA. An 
autoradiograph of the results is shown in Figure 5.6.
Clones -6, -37 and -14 hybridized strongly to Eaifl HI d and 
1 which contain the IR„/U_ and TR_/U^ junctions
O  O  O  *3>
respectively (Figure 3.15), Clones -40, -117 and -93 
hybridized strongly to Bam HI 1 only, indicating that the 
Ug/TRg junction is located between 189 8 and 1969 bp ,
(Figure 5,5). This implies that the TR^ and IRg are each 
approximately 10.9kbp in size and that is approximately 
13.Ikbp in size. These values correlate well with previous 
estimates based on electron microscopy studies and 
restriction endonuclease analysis (Chapter 3).
The high G+C content of the TR^ portion of Bam HI 1 
differs significantly from the portion of the fragment 
(Figure 5.5). The base composition of the EHV-1 subtype 2 
genome is unknown, but the relatively high G+C content of 
repeat regions compared with that of unique sequences has 
been documented in other herpesviruses (Wadsworth e.t &!_. , 
1975; Delius and Clements, 1976; Kilpatrick and Huang,
1977; Davison and Wilkie, 1981; Murchie and McGeoch,
1982; Davison, 1983; Ruyechan ei aJL* , 1985; McGeoch e±.
al. , 1986a). McGeoch q ±. aX. (1986a) proposed that mutation
rate alone might explain the variation in herpesvirus whole 
genome G+C content but that recombination must be invoked 
to explain the high G+C content of the repeat sequences
T A B L E 5.1 P R O T E I N
AI/INO ACID COMPOSITION
Ala 6.7^ Val 5.5% Leu 11.8% Ile 3.5%
Gly 4.3^ 3 Pro 9.8% Cys 1.6% Met 0.4%
Kis 3.9$; Phe 4.7% Tyr 3.9% Trp 2.0%
Asn 2.7% Gin 2.4% Ser 9.4% Thr 7.5%
Lys 
_ .
2.4% Arg 5.9% Asp 5.9% Glu 5.9%
CODON USAGE
TTT Phe 2.7% TCT Ser 2.0% TAT Tyr 2.0% TGT Cys 0.4%
TTC Phe 2.0% TOC Ser 1 .2% TAC Tyr 2.0% TGC Cys 1.2%
TTA Leu 0.8% TCA Ser 2.3% TAA — —— 0.0% TGA — — — 0.4%
TTG Leu 4.7% TCG Ser 0.8% TAG — —— 0.0% TGG Trp 2.0%
CTT Leu 2.0% CCT Pro 1.2% CAT His 2.0% CGT Arg 0.4%
CTC Leu 0.8% CCC Pro 1.2% CAC His 2.0% CGC Arg 1.2%
OTA Leu 2.7% CCA Pro 4.3% CAA Gin 1.6% CGA Arg 0.8%
CTG Leu 0.8% CCG Pro 3.1% CAG Gin 0.8% CGG Arg 1 .2%
ATT Ile 0.8% ACT Thr 1.2% AAT Asn 0.4% AGT Ser 1 .6%
ATC Ile 2.0% ACC Thr 2.0% AAC Asn 2.3% AGC Ser 1.6%
ATA Ile 0.8% ACA Thr 2.3% AAA Lys 0.8% AGA Arg 1.2%
ATG Met 0.4% ACG Thr 2.0% AAG Lys 1.6% AGG Arg 1.2%
GTT Val 0.8% GCT Ala 1.2% GAT Asp 1.6% GGT Gly 0.4%
GTC Val 1.6% GCC Ala 1.2% GAC Asp 4.3% GGC Gly 1.2%
GTA Val 1.2% GCA Ala 2^0% GAA Glu 3.1% GGA Gly 2.0%
GTG Val 2.0% GCG Ala 2.3% GAG Glu 2.7% GGG Gly 0.8%
EKiIIEE_5^Z
Comparative data for ORFl, HSV-1 US8 and VZV US4
a. Hydrophobicity plots
The peaks represent the hydrophobic regions. The 
hydrophobicity values for each amino acid were summed 
over a window of nine residues which was moved along 
the sequence one residue at a time. The major 
hydrophic domain of each protein is represented by an 
empty rectangle and the best conserved region is 
denoted by a filled rectangle.
b. Direct alignment of residues in the conserved region.
The weighting values used throughout this study were 
5 for each mismatched residue and 3k + 7 for k 
consecutive blanks.
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VZV US4 1681
0
□-40
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HSV USB IgEl
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□
-40
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EH V I subtype 2 
protein 1 .
□
-40
342 V N L E F R D A S P Q H S G L Y L C V V Y V N D H  IHAWGH I T I STAAQYRN HSV-1
461 T T L K F V D T P E S L S G L Y V F V V Y F N G H V E A Y A Y T V V S T V D H F V N  VZV
27 VDLLFKDI PE S A TG L Y V F V L L Y NGN PE AWT Y T L L ST AN H FMN EHV-1
subtype 2
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relative to adjacent unique sequences,
QEEi
ORFl extends into the left end of BâïB HI 1 and 
terminates at a TGA stop codon located at residue 766 
(Figure 5.4). The protein-coding sequence is positioned in 
and has a G+C content of 51.5%. The codon usage of ORFl 
and the amino acid composition of the encoded portion of 
protein 1 are shown in Table 5.1. The predicted protein 
has a marked hydrophobic region near the carboxy terminal, 
as indicated in Figure 5.7a). This is a characteristic 
feature of integral membrane glycoproteins. The 
hydrophobic domain spans the membrane lipid bilayer, the 
amino-terminal domain being exposed to the exterior of the 
cell (Tomita and Marches!, 1975; Rose ei &1., 1980).
Using the matrix program a region in the predicted amino 
acid sequence of protein 1 was found to be related to those 
of HSV-1 glycoprotein E (gE) encoded by gene US8 (McGeoch 
êt al, 1985) and VZV glycoprotein gp I encoded by gene US4 
(Davison, 1983). The VZV and EHV-1 proteins are marginally
more closely related in this region than HSV-1 gE is to 
either protein. The region showing the greatest similarity 
in the three proteins is 42 residues long. Of these 13 are 
shared by all three proteins, 11 by VZV gp I and protein 1, 
3 by HSV-1 gE and VZV gp I only, and 12 by none (Figure 
5,7b). The conserved sequence starts at residue 342 of 
HSV-1 gE, 461 of VZV gp I and 27 of the portion of protein 
1. Figure 5.7a shows that the conserved region immediately 
precedes the major hydrophobic domain in each protein, A
- 114 -
shorter sequence at residues 175 to 192 of protein 1 is 
also partially conserved in the HSV-1 VZV homologues. The 
lack of significant conservation of amino acid, sequence in 
the hydrophobic domains indicates the limitations of the 
methods of analyses used here to determine amino acid 
homology. Non-identical residues can be homologous in 
hydrophobicity, charge or structure. The mRNA containing 
ORFl probably forms a 3 '-coterminal set with that of 0RF2, 
the 3' end mapping close downstream from the AATAAA at 
residues 2176, This arrangement is similar to that in HSV- 
1, where the mRNA containing US8 forms a 3'-coterminal 
family with that containing US9 (Rixon and McGeoch, 1985). 
Alternatively, the 3' end of ORFl may be located near the 
ATTAAA a variant of AATAAA, at residue 1131.
QEE2
0RF2 is located from residue 1441 to 2110 and has an 
AATAAA sequence located close downstream at 2176 (Figure 
5.4). It contains the TR^/U^ junction and has a G+C 
content of 58.7%. Codon usage within ÜRF2 and the amino 
acid composition of protein 2, which has a predicted 
molecular weight of 23,000 (23K) are shown in Table 5.2. 
Protein 2 was shown to be homologous to proteins encoded by 
HSV-1 US9 (McGeoch si &1., 1985) and VZV USl (Davison,
1983). The EHV-1 protein is approximately twice the size 
of the VZV and HSV-1 proteins which have the predicted 
molecular weights of approximately 10,000 (lOK) and 11,000 
(IIK) respectively. The hydrophobicity plot for each of 
these proteins exhibits a large hydrophobic region at the 
carboxy terminus (Figure 5. 8a ) . In the HSV-1 (McGeoch et.
T A B L E 5.2 P R O T E I N
AMINO ACID COMPOSITION
Ala 1 3.6^ Val 10.9^ Leu 6,8% H e 5.0
Gly 7.3^ 3 Pro 5.5^ 3 Cys 3.6% Met 0.9%
His 1.8$G Phe 1.4^ 5 Tyr 2.7% Trp 0.0%
Asn Gin 1.893 Ser 9.5% Thr 5.5%
Lys 0.5^ Arg 5.9^ Asp 5.5% Glu 7.7%
CODON USAGE
TTT phe 0*5% TCT Ser 1.4; TAT Tyr 0.5% TGT Cys 1.8%
TTC Phe 0.9% TOC Ser 2 .7% TAC Tyr 2.3% TGC Cys 1.8%
TTA Leu 0.0% TCA Ser 1 .8% TAA — — 0.0% TGA “ — 0.5%
TTG Leu 1.4% TCG Ser 0 .5% TAG — — — 0.0% TGG Trp 0.0%
CTT Leu 0.5% COT Pro 0 .9% CAT His 0.9% CGT Arg 0.0%
CTC Leu 1.8% CCC Pro 2 .3% CAC His 0.9% CGC Arg 1.8%
CTA Leu 0.9% CCA Pro 0 ,9% CAA Gin 0.5% CGA Arg 0.9%
CTG Leu 2.3% CCG Pro 1 .4% CAG Gin 1.4% CGG Arg 1.8%
ATT H e 1.8% ACT Thr 1,,8% AAT Asn 0.9% AGT Ser 0.9%
ATC H e 2.3% ACC Thr 1,.4% AAC Asn 3.2% AGC Ser 2.3%
ATA H e 0.9% ACA Thr 1,,4% AAA Lys 0.5% AGA Arg 0.0%
AT G Met 0.9% AC G Thr 0,.9% AAG Lys 0.0% AGG Arg 1.4%
GTT Val 0.9% GCÎ Ala 5 .0% GAT Asp 3.6% GGT Gly 1.8%
GTC Val 2.7% GCC Ala 3 6% GAC Asp 1.8% GGC Gly 2.7%
GTA Val 3.2% GCA Ala 0 ,9% GAA Glu 3.6% GGA Gly 0.0%
GTG Val 4.1% GCG Ala 4,,1% GAG Glu 4.1% GGG Gly 2.7%
ElûnEE_£^8
Comparative data for ORF 2, HSV-1 US9 and VZV USl
a. Hydrophobicity plots
The peaks represent the hydrophobic regions. The 
hydrophobicity values for each amino acid were summed 
over a window of nine residues which was moved along 
the sequence one residue at a time. The best 
conserved region is denoted by a filled rectangle.
b. Direct alignment of residues in the conserved region.
a.
40 i-
VZV USl
-40
40
HSV US9 I10K1
-40
40
EHV-1 subtype 2 Protein 2
-40
b.
31 AY Y S E S E D E A A N D F L V R M G R Q Q  HSV 
43 C Y Y S D S E N E T A D E F L R R I G K Y Q  VZV 
161 C Y Y S E S D N E T A S L F  IQRVGRRQ EHV-1
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al.. , 1985) and EHV-1 proteins this region is preceded by 6
arginine residues (RRRRRR) . In EHV-1 these are interrupted 
by a histidine residue after the first two arginine 
residues (RRHRRRR). While the VZV protein does not possess 
an equivalent arginine-rich sequence, it does have a basic 
region preceding the hydrophobic carboxy terminus 
(Davison, 1983).
HSV-1 1OK has been identified as a tegument 
phosphoprotein by the use of antisera against a synthetic 
oligopeptide corresponding to the amino terminus (Frame e.t 
al.» 1986b). The high proportion of serine and threonine in
HSV-1 lOK is consistent with the extensive phosphorylation 
characteristic of this protein. The amino terminal portion 
of the protein is 22% serine, and serine and threonine 
together account for more than 26% of the amino acid 
residues. VZV IIK is similar to HSV-1 lOK in containing 
20% serine and threonine in the amino-terminal portion of 
the protein. In EHV-1 protein 2, serine is only the third 
most abundant residue (9.5%) and serine and threonine 
account for 15% of the amino acid residues. There is no 
significant clustering of serine and threonine residues in 
the amino-terminal portion of sequence. However, the 
portion of sequence which aligns with the amino-terminal 
portion of VZV 1IK and HSV-1 lOK (Figure 5.8a) is rich in 
serine and threonine. Together, they comprise 22.6% of the 
residues from residue 111 to 173.
The best conserved amino acid sequence is close to the 
basic and hydrophobic regions in each protein (Figure 
5.8a). Ten of the 22 residues in this region are shared by
T A B L E  5.3 P R O T E I N
AMINO ACID COMPOSITION
Ala 1 5.8^ Val 6.2^ Leu 8.59r H e 1.99^
Gly 8.9^ Pro 9.39^ Cys 3.196 Met 3.196
His 2.79b Phe 3.9^ Tyr 3.1^ Trp 1.2^
Asn 0 .49; Gin 1.29b 3er 6.6/0 Thr 3.9^
Lys 0.49b Arg 10.09b Asp 4.695 Glu 5.4^
CODON USAGE
TTT Phe 1.5% TCT Ser 0.096 TAT Tyr 0.4% TGT Cys 0.4%
TTC Phe 2.3% TOC Ser 1.9% TAC Tyr 2.7% TGC Cys 2.7%
TTA Leu 0.096 TCA Ser 1 .3% TAA —  —  — 0 .4% TGA —  —  — 0.0%
TTG Leu 0.0^ TCG Ser 1.5% TAG — — — 0.0% TGG Trp 1.2%
CTT Leu 1.296 CCT Pro 0.4% CAT His 0.4% CGT Arg 0.4%
CTC Leu 2.3% CCC Pro 5 .8% CAC His 2.3% CGC Arg 5.0%
CTA Leu 1.9% CCA Pro 0.8% CAA Gin 0.4% CGA Arg 1.5%
CTG Leu 3.1% CCG Pro 2.3% CAG Gin 0.8% CGG Arg 0.8%
ATT lie 0.4% ACT Thr 0.0% AAT Asn 0.0% AGT Ser 0.4%
ATC H e 0.8% ACC Thr 2.3% AAC Asn 0.4% AGC Ser 1.2%
ATA H e 0.8% ACA Thr 0.0% AAA Lys 0.0% AGA Arg 1.5%
ATG Met 3.1% AC G Thr 1 .5% AAG Lys 0.4% AGG Arg 0.8%
GTT Val 0.896 GOT Ala 1.2% GAT Asp 0.8% GGT Gly 1.2%
GTC Val 0.4% GCC Ala 5.4% GAC Asp 3.8% GGC Gly 3.1%
GTA Val 1.5% GCA Ala 0.8% GAA Glu 1.9% GGA Gly 1.2%
GTG Val 3.5% GCG Ala 8.5% GAG Glu 3 .5% GGG Gly 3.5%
EIGUEE_5^9
Comparative data for 0RF3, HSV-1 USIO and VZV RS3
a. Hydrophobicity plots
The peaks represent the hydrophobic regions. The 
hydrophobicity values for each amino acid were summed 
over a window of nine residues which was moved along 
the sequence one residue at a time. The best 
conserved region is denoted by a filled rectangle.
b. Direct alignment of residues in the conserved
region.
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-40
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-40
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-40
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120 L I LMAYWCCLGHA VZV
159 L L F C A HWCCLGHA EHV-1
subtype 2
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all three proteins (Figure 5,8b), Of the remaining 12, 
protein 2 and VZV 1IK share 3 residues, protein 2 and HSV-1 
lOK share 2 and VZV IIK and HSV-1 lOK share 2. The EHV-1 
and HSV-1 proteins also share a hydrophobic sequence 
(LVAVL) at residues 200 to 204 and residues 74 to 78 
respectively. This sequence is not conserved in VZV IIK.
QEEa
0RF3 is transcribed leftwards from residue 3322 to 
2545. It is contained entirely within the TR^ and has a 
G+C content of 68.3%. The high G+C content is reflected in 
codon usage and in the predicted amino acid composition of 
protein 3. The protein is rich in amino acids specified by 
G+C-rich codons such as alanine^ arginine, proline and 
glycine (Table 5,3). The sequence AATAAA is located in the 
bottom strand within the codon sequence at residue 2555 
(Figure 5.4). Protein 3 is partially homologous to the 
products of HSV-1 USIO (McGeoch et gT., 1985) and VZV RS3
(Davison and Scott, 1985). The best conserved region 
(Figure 5.9b) of 13 residues contains eight residues shared 
by all three proteins. The sequence GKT at residues 57 to 
59 of the proteins 3 is conserved at residues 170 to 172 of 
the HSV-1 protein and 17 to 19 of the VZV protein.
The product of HSV USIO is a protein with an 
approximate molecular weight of 34,053 (34K) (McGeoch
al_. , 1985). The mRNA containing USIO shares a common 3'
terminus with those of two upstream genes, USl1 and US12, 
and USIO has a 110 codon out-of-frame overlap with the 
coding sequence of USl1 (Rixon and McGeoch, 1984; McGeoch
EiGUEE_5^1û
Comparative data for 0RF4 HSV-1 USl and VZV RS2.
a. Hydrophobicity plots
The peaks represent the hydrophobic regiotis. The 
hydrophobicity values for each amino acid were summed 
over a window of nine residues which was moved along 
the sequence one residue at a time. The best 
conserved region is denoted by a filled rectangle. A 
region conserved in the VZV and EHV-1 proteins but 
not in the HSV-1 protein is indicated by a cross- 
hatched rectangle.
b. Direct alignment of residues in the best conserved 
region.
c. Direct alignment of residues in the region conserved 
in the VZV and EHV-1 subtype 2 proteins but not in 
the HSV-1 protein.
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e.1. al. , 1985) . With the overlapping sequence there are
three copies of an IBbp tandem repeat sequence plus a
partial copy of 6bp (McGeoch e.t al. , 1985) . The reiterated
sequence encodes a partially repeated amino acid sequence
in 34K, composed of seven copies of the sequence PGX, where 
X is L, S or P (Rixon and McGeoch, 1984). This feature is in
the region specific to HSV-1 and is therefore not present in
the VZV or EHV-1 homologues.
QEEI
0RF4 originates from beyond the right end of Bam HI 1
and terminates at 3756. It is contained entirely within
TRg, and has a G+C content of 62.5%, The codon usage in
ORF4 and amino acid composition of the predicted protein
are shown in Table 5.4. The sequence AATAAA is positioned
in the lower strand at residue 3617, and the variant ATTAAA
is found at position 3753. The amino acid sequence of the
predicted primary translation product of 0RF4 shows
homology to that of VZV RS2 (Davison and Scott, 1985), and
somewhat less homology to HSV-1 USl (McGeoch al, 1985) .
The best conserved region is 41 residues long, within which
14 are shared by all three proteins (Figure 5.10a,b). Of
the remaining 27 residues the EHV-1 protein shares two with
the HSV-1 protein and 13 with the VZV protein. A second
sequence from residue 68-108 in the EHV-1 protein is
partially conserved in the VZV protein (residues 42 to 82)
but not in the HSV-1 protein (Figure 5.10c).
HSV-1 USl encodes the immediate early protein V IE
^ mw
68. The temporal class of the EHV-1 and VZV proteins is 
unknown. The VZV gene is not preceded by the consensus 
sequence TAATGARAT, which is present upstream from HSV-1
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and HSV-2 immediate early genes (Vhitton and Clements,
1984). The upstream sequence of the EHV-1 gene lies 
outside Eâffi HI, and so it is not known whether it is 
preceded by a TAATGARAT sequence.
Ee.ite.natad_Se.qu.enG.g.s
In EHV-1 subtype 2 Bam HI 1 the sequence GGAGGTGG is 
tandemly repeated 31 times from residue 2255 to 2508.
There is a partial copy of 6bp at the right end of the 
reiteration in Figure 5.4. Tandemly repeated DMA sequences 
are a feature of many eukaryotic genomes, and demonstrate a 
high frequency of sequence variation due to sequence 
duplication or deletion of single copies of the repeating 
unit (Farabaugh al- , 1978; Spritz, 1981 ; ' Bell at. al- ,
1982). A number of different tandem reiterations, in which 
the repeat unit ranges from lbp-37bp, have been identified 
in the HSV genome. They occur both in polypeptide-coding 
regions (McGeoch, 1984 ; Rixon and McGeoch, 1984; Rixon 
al. , 1984 ; McGeoch al- , 1985) and non-coding regions
(Davison and Vilkie, 1981 ; Mocarski and Roizman, 1981 ; 
Vatson at al- , 1981; Murchie and McGeoch, 1982 ; McGeoch,
1984 ; Rixon at al- , 1984 ; Vhitton and Clements, 1984).
Four unique G+C-rich tandemly reiterated sequences have 
been identified in the VZV genome (Davison and Scott,
1986a). Three of these are positioned in and appear to 
encode repeated amino acid sequences. The fourth, in 
TR /IR , is non-coding. The VZV reiterations are not 
related to those of HSV-1 either in location or in 
sequence. As is typical of HSV-1 and VZV reiterations, the
EiQlLEE_5.^ ii
Summary of the reiterated DNA sequences in the S
segment of HSV-1 and VZV genomes and the reiterated EHV-1
subtype 2 DNA sequence identified in this study.
In HSV-1 reiteration 1 lies within the a. sequence,
reiteration 2 and 3 lie between the a sequence and gene
RSI which codes for V 175; reiteration 4 lies within themw
common intron of the IEmRNA-5 which contains USl; 
reiteration 5 lies within the coding sequence of gene US7;
reiteration 6 lies between genes US9 and USIO;
reiteration 7 lies within the overlapping coding regions
of genes USIO and USl1 (Figure 5.12).
The VZV reiteration lies between the genes RSI and 
RS2 (Figure 5. 12) .
The EHV-1 subtype 2 reiteration lies between ORFs 2
and 3 (Figures 5.4 and 5.5).
E e lte .iia te !l_ D E A -S a qu s ji£g .£ -la -jL E ë —S-S£.gBS.nl£-Q£-HSY-l_and_YZV.
HSV-1
1 GGAGCGGGGGGA
2 GCCGGGGAGGGCTGGG
3 CGAGGGGCGGGAGGGGG
4 CCCCCTCCTCCGCGCCCGCGTC
5 CCTCCACCCCCTCGACCACCA
6 TGGGTGGGTGGGGAG
7 CCGGGGCTCCCGGGGAGA
EHVml
._2
bp coding
12 NO
16 NO
17 NO
22 NO
21 YES
15 NO
18 YES
CCCCGCCGATGGGGAGGGGGCGCGGTA 27 NO
GGAGGTGG 8 NO
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EHV-1 sequence is G+C rich. This non-coding reiteration 
occupies most of the region between ORFs 2 and3. Figure 
5.11 shows the DNA sequences of the reiterations in the 
HSV-1 and VZV S segment. Of the seven HSV-1 reiterated 
sequences four (reiterations 1-4 in Figure 5.11) lie in the 
TRg/IRg and are non-protein coding (McGeoch e£. al., 1986).
VZV has far fewer reiterations than HSV-1 and only one of 
these is located in the S segment (Davison and Scott 
1986a). Five entire copies and a partial copy of a 
tandemly repeated 27bp sequence are located between the RSI 
and RS2 of VZV (Figures 5,11 and 5.12), Of the three 
reiterated sequences in HSV-1 (Figure 5.11) two lie 
within coding regions (McGeoch si al., 1985). The third, a
15bp sequence, TGGGTGGGTGGGGAG, is located in a similar 
intergenic position to the EHV-1 subtype 2 reiteration, 
between the coding sequence for the lOK and 34K proteins.
The marked copy number variability in at least some HSV 
tandem reiterations is reflected in the heterogeneity of 
electrophoretic mobility of certain restriction 
endonuclease fragments (Lonsdale S-t. al- , 1980; Davison and
Vilkie, 1981; Murchie and McGeoch, 1982). This type of 
mobility variation in restriction enzyme fragments has also 
been observed for isolates of VZV (Straus al al-, 1983) and
EHV-1 subtype 1 (Allen at. al- , 1983). Variability in the
number of repeated units in the coding sequence of V^^21 is 
thought to be responsible for variation in the mobility of 
protein in different strains of HSV-1 (Rixon and McGeoch,
1984).
The significance of reiterations in herpesvirus
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genomes is unknown. Several HSV-1 reiterations have no 
counterparts in HSV-2 or VZV (Davison and Vilkie, 1981; 
Rixon g.t ai. , 1984; Davison and Scott, 1986a). This would
suggest that they encode no essential functions, but are 
simply regions of the genome which are readily amplified in
random unequal crossover (Smith, 1976), It is likely that
non-coding reiterations accumulate at locations in 
herpesvirus genomes which are not subject to rigorous 
selective pressure. Protein-coding reiterations are 
obviously constrained by requirements for protein function 
but it is not known if they have a functional role. The 
carboxy terminal portion of the HSV-1 protein V^^21 
contains 24 repeats of the tripeptide XPR which extend well 
beyond the reiterated DNA sequence. This suggests that, in 
this case, the repeated amino acid sequence is of
functional importance and that it, rather than the
nucleotide sequence, is under selective pressure (Rixon and 
McGeoch, 1984).
QQisparlsQH-.Q£_Ge.iie._Arraiigem£.iit._ln_£HVn.3 SuEi.ype._2.4 HSV-1
and. - VZV
The DNA sequences of the S segments of HSV-1 (Davison 
and Vilkie, 1981 ; Murchie and McGeoch, 1982; McGeoch &£ 
al. , 1985, 1986a) and VZV (Davison, 1983; Davison and
Scott, 1985) have been determined. HSV-1 contains ten 
entire genes plus major parts of two others. Each inverted 
repeat contains one entire gene and the 5' portion of one 
other. VZV contains two entire genes plus the major 
parts of two more, and each inverted repeat contains three
ElûHEE_5u_ia
Comparison of gene layout in the S segments of HSV-1 and 
VZV. Relationships are indicated for only one copy of 
genes in the inverted repeats (Davison and McGeoch, 1986)
HSV-1
RSI US1 US2 US3 US4 US5 US6 US7 US8 US9 US11 US12
^-USIO
RS1
RS2 RS3 USl US2 US3 US4 RS3 RS2 RSI
VZV
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entire genes. The relationships between genes in the S 
segments of HSV-1 and VZV are illustrated in Figure 5,12 
(Davison and McGeoch, 1986). The seven genes in the VZV S 
segment all have homologues in the HSV-1 S segment (Davison 
and McGeoch, 1986). Homology was detected at the level of 
predicted amino acid sequence, and was not apparent in 
hybridization studies, except for the large gene in TR^/IR^ 
(Davison and Vilkie, 1983). The HSV-1 S segment contains 
six genes which have no VZV homologues (Davison and 
McGeoch, 1986). The S segment of EHV-1 subtype 2 is 
considerably larger than that of VZV and HSV-1 (Figure 5.1) 
suggesting that the EHV-1 S segment may contain more genes 
than the equivalent regions of HSV-1 and VZV. If this is 
so, these genes are not contained in B&m HI 1. All four 
ORFs identified in this fragment have HSV-1 and VZV 
counterparts.
The relationships between genes in the S segments of
HSV-1 and VZV and Bam HI 1 of EHV-1 subtype 2 is shown in
Figure 5.13. EHV-1 subtype 2 has a gene arrangement in Baa
HI 1 intermediate between that of the corresponding regions
of the HSV and VZV genomes. EHV-1 ORFs 3 and 4 are larger
than their VZV homologues, RS3 and RS2, but smaller than
their HSV-1 counterparts, USIO and USl. These EHV-1 genes
are more closely related in location to the VZV genes than
to the HSV genes. EHV-1 0RF3 and 4 are positioned in the
same tandem arrangement as VZV RS3 and RS2 in TR^/
IRg (Figure 5.13). The HSV-1 homologue of 0RF4, the gene
encoding V IE 68 is positioned across the IR^/U^ junction mw ^ S S
(Marsden e.t. al. , 1978; McGeoch at al. , 1985), and the
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coding sequence is contained entirely within (Rixon and 
Clements, 1982; Vatson and Vande Voude, 1982 ;
Murchie and McGeoch, 1982). The HSV-1 homologue of 0RF3 is 
also located in U^. While the EHV-1 genes and the two VZV 
homologues are adjacent and transcribed in the same 
direction the HSV-1 genes are at opposite ends of Ug and 
transcribed in the opposite directions (Figure 5.13). A 
reiterated sequence is located between HSV-1 US9 and USIO. 
Unlike VZV, EHV-1 subtype 2 also possesses a tandem 
reiteration between the counterparts of these HSV-1 genes. 
However, apart from their equivalent location and typically 
high G+C content, the two reiterated sequences show little 
homology in length, copy number or nucleotide sequence.
EHV-1 ORFl and 0RF2 bear closer resemblance to their 
HSV-1 than their VZV counterparts in position and 
orientation (Figure 5.13). Like HSV-1 US8 and US9, they 
are positioned tandemly in the right half of Ug and are 
transcribed rightwards. The sequence between ORFl and 2 
lacks a significantly large ORF and is considerably longer 
than that between HSV-1 US8 and US9. EHV-1 0RF2 
differs from the HSV-1 homologue in that the 3' coding end 
of the sequence apparently extends into the TRg. In VZV, 
the homologue of ORFl (US4) contains the Ug/TRg junction 
(Figure 5.13); the stop codon is located within TRg. The 
VZV homologue of 0RF2 (USl) is located at the other end of 
Ug (Figure 5.13) and the stop codon spans the junction 
between Ug and IRg. In HSV-1, the Ug/Rg junctions are 
located 8 and 40 nucleotides, respectively, from the 
initiator ATG codons of US12 and USl (Murchie and McGeoch,
E1GURE_^12
Relationships between genes in the S segments of HSV-1 and 
VZV and in Bam HI 1 of EHV-1 subtype 2. For clarity only 
one copy of genes in the inverted repeats is illustrated.
Gene orientation in the S segments of HSV-1, VZV and EHV-1 subtype 2
EHV-1 subtype 2
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1982). The junctions in HSV-2 are located 1 and 33bp from 
the corresponding ATG codons (Vhitton and Clements, 1984). 
Vhitton and Clements (1984) suggested from the HSV-1 and 
HSV-2 results that the TR^/IRg are capable of expansion 
during evolution to include sequences from the U^, but that 
the extent of expansion is limited by adjacent coding 
sequences. Thus, the location of IRg in EHV-1 subtype 2 is 
likely to be defined by a gene at the other end of the U^. 
Comparison of gene organisation in thê S segments of HSV-1 
and VZV indicate that not only can TR^/IRg expand to 
include short sequences of Ug (Vhitton and Clements, 1984) 
but they can include or expel entire genes (Davison and 
McGeoch, 1986). Davison and McGeoch (1986) have proposed 
an evolutionary model for the descent of the S segments of 
HSV-1 and VZV from a common ancestor by a series of 
recombinational events involving expansion or contraction 
of TRg/IRg. The homology of the predicted EHV-1 subtype 2 
proteins to HSV-1 and VZV proteins specified by genes in Ug 
and TRg/IRg suggests that EHV-1 subtype 2 is also a product 
of this evolutionary pathway. Elucidation of the full 
extent of divergence of EHV-1 subtype 2 from HSV-1 and VZV 
awaits the determination of the complete DNA sequence of 
the S segment.
CHAPTER 6 
GENERAL DISCUSSION
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APPLICATION OF MOLECULAR ANALYSIS TO THE UNDERSTANDING AND
Although the genome structures of the two subtypes of 
EHV-1 are similar, and the cross-hybridization data 
indicate that they share a common gene arrangement, the 
restriction endonuclease maps are quite different. This is 
in accord with the existing body of evidence that EHV-1 is 
not a single entity but two genetically distinct viruses, 
one of which could be renamed EHV-4 as suggested by 
Studdert ei. al. (1981). The recognition of two subtypes, 
only one of which, despite their overlapping disease 
potential, appears to be associated with epizootic abortion 
and neurological disease, is altering the thinking on EHV-1 
disease throughout the horse industry. Dogmas unchallenged 
since the 1960s are currently under renewed investigation. 
The long-accepted hypothesis that annual outbreaks of EHV-1 
respiratory disease in yearlings in Kentucky are the usual 
source of virus which induces abortion in mares (Doll and 
Bryans, 1963b) is questionable in the light of molecular 
epizootiological studies conducted in the same area which 
have demonstrated the relative paucity of subtype 1 virus 
isolated from cases of upper respiratory tract disease 
(Allen et aT. , 1983a). Also, virus challenge studies in
seronegative foals showed intersubtypic cross-protection. 
Animals experimentally infected at 6-monthly intervals with 
EHV-1 subtype 2 were resistant to challenge with subtype 1 
(Allen and Bryans, 1986). This confirms the hypothesis 
originally put forward by Doll and Bryans (1963b) that
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repeated EHV-1 respiratory infections stimulate protective 
immunity against abortigenic EHV-1. This hypothesis arose 
from the observation that the most devastating abortion 
storms tended to occur on studs which had been free of EHV- 
1 respiratory disease in their young stock for an extended 
period or where mares were separated from younger animals.
At present there is no safe effective vaccine against 
EHV-1. The existence of two distinct virus subtypes, both 
capable of causing abortion and epizootics of respiratory 
disease, and their ability to cross-protect would suggest 
that the EHV-1 disease complex would be best controlled by 
a bivalent vaccine containing both virus subtypes 
(Fitzpatrick and Studdert, 1984). All the currently 
available vaccines, whether live attenuated or killed, 
consist only of EHV-1 subtype 1 (Mumford and Bates, 1984). 
According to the manufacturers, one live attenuated vaccine 
on sale in the U.K. cannot be guaranteed to protect against 
abortion, but is claimed to protect against respiratory 
disease. However, this vaccine contains no subtype 2 
virus. Several vaccines have been developed against EHV-1, 
ranging from the "planned infection" program with a live 
virus adapted to hamsters (Doll and Bryans, 1963a), to the 
use of an adjuvanted chemically-inactivated virus (Moore 
and Koonse, 1977). All these vaccines were ineffective to 
a greater or lesser extent, and many were dangerous. For 
example, use of an inactivated virus vaccine derived from 
the tissues of equine foetuses increased the incidence of 
haemolytic icterus of new-born foals (Doll si aL., 1952).
Also, hamstei— adapted live virus caused abortion in a
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percentage of its recipients (Doll and Bryans, 1963a), and 
a chemically inactivated vaccine produced from virus 
propagated in hamsters lacked immunogenic potency and gave 
rise to anaphylactoid reactions (Doll edt aX., 1956; Doll
and Bryans, 1963a). In the molecular epizootiological 
surveys in Kentucky (Allen al. , 1983a), several viruses
isolated from aborted foetuses had the distinctive 
electropherotype of vaccine strains. Pneumabort-K is an 
inactivated adjuvanted EHV-1 vaccine Initially developed by 
Bryans in Kentucky and now available in Great Britain. The 
vaccine was shown to protect against abortion in challenge 
studies in America (Bryans, 1978; Moore and Koonse, 1977) 
and to elicit a satisfactory immune response in field 
trials in France, Ireland and Kentucky (Bryans, 1980). The 
vaccine received a manufacturing license in the United 
States in 1980, and the results of its use have been 
closely monitored in Kentucky. Allen and Bryans (1986) 
reported a decrease of more than 50% in the incidence of 
EHV-1 abortion during the first four years after the 
vaccine was licensed. However, trials in Great Britain 
have not shown this vaccine to be efficacious in the 
control of either subtype of EHV-1 (Burrows et. * 1984;
Mumford and Bates, 1984).
Much of the current thinking in vaccine development 
centres on the virus glycoproteins, which stimulate 
protective immunity (Mertz at aX., 1984), Very little is
known about EHV-1 glycoproteins, but the existence of HSV 
glycoproteins gB, gC, gD, (Spear, 1976), gE (Baucke and 
Spear, 1979), gH (Buckmaster at aX. , 1984) and gG (Marsden
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ai. a l*  » 1978, 1984; Roizinan a t  a l*  » 1984; Richman a t  a l*  •
1986; McGeoch a t  a l * ,  submitted) has been established.
The existence of additional glycoproteins has been 
predicted from the DNA sequence analysis of HSV-1 Ug 
(McGeoch a t  a l*  , 1985). HSV gB plays an important role in
virus penetration and cell fusion (Manservigi a t  a l * , 1977;
Sarmiento a t  a l * , 1979); gC, a non-essential component of
the virion, has an inhibitory effect upon cell fusion and 
acts as a receptor for a complement Component, C3b, 
following infection (Friedman a t  a l * » 1984; Manservigi a t
a l*  , 1977; Ruyechan a t  a l*  , 1979); gD is thought to play 
a role in the fusion of infected cells (Nobel a t  a l * ,
1983); gE acts as an Fc receptor for ^-globulin (Baucke 
and Spear, 1979; Para a t  a l * , 1980; Machtiger a t  a l * ,
1980); gH may have a role in virus maturation or egress, 
as anti-gH antibodies can block plaque formation 
(Buckmaster a t  a l*  , 1984), HSV glycoproteins stimulate the
production of neutralizing antibodies (Powell a t  a l * , 1974;
Cohen a t  a l * , 1978; Norrild, 1980; Para a t  a l * , 1982), 
are implicated in both antibody-dependent complement- 
mediated cytotoxicity and antibody-dependent cellular 
cytotoxicity (Glorioso a t  a l * , 1978; Norrild a t  a l * ,
1979), and may function as targets for T cell-mediated 
lysis of HSV-infected cell (Carter a t  a l * , 1981; Eberle a t
a l*  , 1981). Antisera (Honess and Vatson, 1974; Powell a t
a l*  , 1974; Norrild, 1980) or monoclonal antibodies
(Showalter a t  a l * , 1981; Pereira a t  a l * , 1982; Rector a t
a l*  , 1982; Cranage a t  a l*  , 1983) to individual
glycoproteins neutralize virus In vitro■ Specific
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monoclonal antibodies have been used to purify individual 
HSV glycoproteins by immunoadsorption chromatography, and 
purified gD (Eisenberg at al., 1982a; Chan, 1983; Long a t
a l*  , 1984), gC (Schrier a t  a l*  ♦ 1983; Roberts a t  a l*  ,
1985) and gB (Chan, 1983; Roberts a t  a l * , 1985) were able
to immunize mice against challenge with virulent HSV-1.
Similarly, EHV-1 envelope glycoproteins serve as 
target antigens against which the host's immune response is 
mounted (Papp-Vid and Derbyshire, 1978, 1979). Six major
and six minor glycoproteins have been identified within the 
envelope of both subtypes of EHV-1 (Turtinen and Allen,
1982; Turtinen, 1983), but it is possible that some of 
these proteins may differ only in their carbohydrate 
moieties or be related by modification of a primary 
translation product, as has been shown for some HSV 
glycoproteins (Spear and Roizman, 1980; Cohen et. &1. ,
1980; Pereira et aT., 1982). Convalescent horse sera were
found to be immunoreactive with five of the six major 
glycoproteins using the Western blot technique, and studies 
using hyperimmune rabbit serum demonstrated that four of 
these glycoproteins contained subtype cross-reactive 
antigenic determinants (Turtinen, 1983).
No information has been published on the location or 
DNA sequence of genes coding for EHV-1 glycoproteins. The 
colinearity of the genomes of HSV-1 and the two subtypes of 
EHV-1 discussed in Chapter 4 makes it possible to predict 
the location of glycoprotein genes in the EHV-1 genome.
This is particularly true for glycoprotein genes present in 
the L segment. Genes for gB and gH, or their counterparts,
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have been located in the genomes of two members of the 
Alphaherpesvirinae (HSV and VZV), one member of the 
Betaherpesvirinae (CMV) and one member of the 
Garamah e .r:p fi^v lrlna e . (EBV) (Pellet at a l .  , 1985; Davison and
Scott, 1986a; McGeoch and Davison 1986; Davison and 
Taylor, 1986; Tony Kouzarides, personal communication) by 
DNA sequence analysis. Similarly, a counterpart of the HSV 
gC gene has been identified in an equivalent location in 
the VZV genome (Davison and Scott, 1986a). However, the 
predictive value of genome colinearity is far less in the S 
segment, the least homologous region of the 
Alphaherpesvirinae. Ug has been shown to contain 
glycoprotein genes in several members of the 
Alphaherpesvirinae (Mettenleiter ei a l .  ♦ 1985; Rea at a l .  ,
1985; Ellis a t  al-, 1985; Davison a t  a l * , 1985; McGeoch 
a t  al., 1985). These include HSV gD, for which no
counterpart is present in the VZV genome (Davison and
McGeoch, 1986). Thus the location or even the presence of 
an EHV-1 homologue to HSV gD cannot be predicted with any 
degree of certainty. In Chapter 5, the observation that 
the EHV-1 S segment is larger than that of HSV and VZV led
to the suggestion that it may contain more genes than the
latter. The HSV-1 S segment contains 6 genes with no 
counterparts in the VZV S segment (Davison and McGeoch,
1986). One encodes the HSV-1 equivalent of HSV-2 gG 
(Frame ei al.» 1986a; McGeoch al*, submitted), and the
amino acid sequences of the predicted products of two 
others suggest that they also encode glycoproteins (McGeoch 
et al. , 1985). It is thus, possible that the EHV-1 S
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sequence may contain genes encoding glycoproteins which 
have no homologues in either HSV-1 or VZV. However, the 
glycoprotein gene identified by DNA sequence analysis of 
Bam HI 1 (Chapter 5) encodes the EHV-1 homologue of HSV gE 
and VZV gpl. This homology was detected by comparisons of 
predicted amino acid sequence, and was not indicated by 
comparative hybridization experiments.
Genetically engineered vaccines may offer a safer and 
more effective approach to the control of EHV-1 disease 
than the more conventional methods of vaccine development. 
The present orientation of research on subunit vaccines is 
based on the idea that immunogenic glycoproteins can be 
prepared in limitless quantities at a relatively low cost 
by cloning and expression in a number of vector systene 
including mammalian cells, bacteria and yeast. It is 
possible that a very concentrated preparation of the 
appropriate antigens might stimulate an immune response 
which would offer as much, if not more, protection than 
that elicited by a natural infection. Subunit vaccines are 
free of risks associated with the presence of residual live 
virus, potentially harmful cellular products or infectious 
contaminants. In HSV much of the earlier work on subunit 
vaccine development concentrated on gD, which elicits 
formation of potent cross-reactive neutralizing antibodies 
(Sim and Vatson 1973; Honess and Vatson, 1974; Cohen 
al. , 1978; Eisenberg si gJL. , 1982a). HSV-1 gD has been
successfully expressed in Ex. S2QÜ (Vatson at aJL. , 1983;
Veis at at., 1983) and as a non-glycosylated fusion protein
stimulates development of neutralizing antibodies in
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rabbits (Veis et aJL. , 1983). It has also been expressed in
mammalian cells (Berman e t  a t . , 1983) where the protein is
correctly processed and incorporated into the cell membrane 
(Gething and Sambrook, 1981). Deletion of the hydrophobic 
membrane-anchor region at the carboxy terminus of gD 
allowed the expressed glycoprotein to be secreted into the 
medium. This product protected mice against lethal 
challenge with the homologous virus (Lasky at. a t . ,  1984). 
The synthesis and assembly in yeast of a model hybrid 
particle containing both hepatitis B surface antigen and 
HSV-1 gD is an interesting approach to polyvalent vaccine 
development described by Valenzuela at. a t .  (1985). Another 
approach to subunit vaccine development utilises chemically 
synthesized peptides representing amino acid sequences for 
the immunogenic domains of the glycoprotein (Bittle at. a t .  , 
1982; Shinnick at. a t*  , 1983) . The immunologically
important domains of gD were mapped using monoclonal 
antibodies (Eisenberg a t  a t . , 1982b, 1985). Cohen a t  a t .
(1984) described the localisation and synthesis of an 
antigenic determinant of gD that induces type-common 
neutralizing antibodies. Immunisation with this synthetic 
peptide protected mice against virus challenge (Eisenberg 
a t  a t . , 1985).
Live vaccines are often superior to inactivated or 
subunit vaccines because they are able to replicate and 
stimulate a stronger and longer-lasting humoral and cell- 
mediated immune response. However, the pathogenesis of 
EHV-1 is still poorly understood, and the inherent risk of 
live vaccines has resulted in a reluctance to use such
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prophylactic measures in the U.K., where the problem of 
EHV-1 abortion has never been as severe as in the United 
States and some European countries. An approach to live 
vaccination which circumvents the risk of inducing EHV-1 
abortion is to insert EHV-1 glycoprotein genes into the DNA 
of a non-pathogenic vector virus such as vaccinia (Mackett 
et al., 1982, 1984; Panicali and Paoletti, 1982; Smith at
al.,1984; Smith and Moss, 1984). Expression of the HSV-1 
gD gene by a vaccinia vector has been achieved (Paoletti a t  
al.. 1984), and the recombinant virus protected mice
against lethal challenge with HSV-1. Vaccinia has a large 
capacity for foreign genes. More than 20kbp of exogenous 
DNA has been inserted into vaccinia without affecting virus 
viability (Smith at. a l . , 1984). It should be possible not
only to express a number of different glycoproteins in one 
vector but also to engineer a vaccinia recombinant which 
would act as a vehicle for the immunogenic components of 
several viruses. Paoletti a t  a l .  (1985) have described a 
vaccinia recombinant which expresses the influenza virus 
haemagglutinin, the hepatitis-B virus surface antigen and 
HSV-1 gD. This virus elicited the appropriate 
immunological responses on injection into laboratory 
animals. Thus, the potential exists to develop a vaccinia 
vector vaccine offering protection against both subtypes of 
EHV-1 and equine influenza virus.
The characterization of the genome of EHV-1 subtype 2 
discussed in Chapters 3 and 4 allows one to make 
predictions of the possible locations of suitable 
glycoprotein genes for expression in the vector systems
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mentioned above. EHV-1 subtype 2 Baffi HI c, c and f, and g 
are predicted to contain sequences coding for the 
homologues of HSV-1 gB, gH and gC respectively. HSV-1 gH 
is an essential glycoprotein (Weller at al. , 1983; McGeoch
and Davison, 1986) and a monoclonal antibody against it, 
neutralizes virus infectivity (Buckmaster at al., 1984).
HSV-1 gB is an essential glycoprotein which appears to play 
an important role in the stimulation of cell mediated 
immunity. Human HSV-specific T cells' can be activated by 
gB (Yasukawa and Zarling, 1985), and lysis of HSV-1- 
infected target cells by human natural killer cells appears 
to correlate with the expression of gB and gC on the cell 
membranes (Bishop et. al., 1983, 1984). HSV-1 gB expressed
in mammalian cells has been shown to protect guinea pigs 
against initial HSV-2 infection (Stanberry et. al. , 1985a).
The conservation of gB and gH in the Alphaherpesvirinae,
conservation of some essential functions in the 
herpesviruses. The EHV-1 homologue of HSV gC might also be 
a candidate for the development of an EHV-1 vaccine but, 
although the HSV glycoprotein elicits a neutralizing 
antibody response, it does not appear to be an essential 
component of the virion (Heine at al., 1974; Zezulak and
Spear, 1984; Centifanto-Fitzgerald at al., 1982). There
is some evidence that gD is the most important protective 
HSV immunogen (Holland at al., 1983; Showalter at al.,
1981; Para at al., 1985). gpl, the homologue of HSV gE,
is the most abundant and most immunogenic of the VZV 
glycoproteins (Veigle and Grose 1983; Keller et al.,
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1984. The genes encoding these proteins are positioned in 
the Ug, and thus the location of their EHV-1 counterpart is 
difficult to predict confidently. However, protein 1 
specified by EHV-1 subtype 2 EaiD HI 1 (Chapter 5) shows 
similarities to the predicted amino acid sequences of VZV 
gpl and HSV gE. This EHV-1 subtype 2 homologue of HSV gE 
is another potentially useful candidate for vaccine 
development.
Over the last two decades, significant advances have 
been made in the development of antiviral agents. The 
short-lived protective immunity induced by natural 
infection with EHV-1 suggests that antiviral chemotherapy 
may be a useful alternative or adjunct to a vaccination 
programme. Three of the genes located on the EHV-1 subtype 
2 genome by comparative hybridization encode the DNA 
polymerase and the two subunits of the ribonucleotide 
reductase. The HSV-1 DNA polymerase is a target for 
nucleoside analogues such as acyclovir (ACV; 9 -(2- 
hydroxyethoxymethyl> guanine), the triphosphate derivative 
of which acts as a competitive inhibitor with dGTP for 
viral DNA polymerase (Elion ei al*, 1977). ACV has proven
activity against a number of human herpesviruses (Schaeffer 
et al. , 1978; Collins and Bauer, 1979; Brigden s.t aX. ,
1981; Prober at at., 1982; Balfour et at., 1983), and has
been licensed for use in man since 1981, ACV is active 
against EHV-1 in Syrian hamsters (Rollinson and White,
1983), but the pharmacokinetics of this drug in the horse 
indicate that it is unlikely to be suitable for use in the 
treatment of EHV-1 disease (Elizabeth Rollinson, personal
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communication). However, a close analogue of ACV, DHPG, (9 
- C2-hydroxy - 1 (hydroxymethyl) ethoxymethyl] guanine), 
appears to be far more potent than ACV against EHV-1 in 
plaque reduction experiments and in the hamster disease 
model (Rollinson and White, 1983), DHPG also appears to be 
less cytotoxic than ACV (Smith at at*, 1983), Neither the
bioactivation of these two drugs nor the reasons for the 
greater antiviral effect of DHPG compared with ACV are 
fully understood. The localization of the DNA polymerase 
gene is a first step in its further characterization and 
the elucidation of drug action and resistance (Coen at at. , 
1985).
Concern exists about the likelihood of nucleoside 
analogues causing damage to host cell DNA, DHPG has been 
tentatively associated with testicular atrophy in rats, a 
side-effect which would be totally unacceptable in a 
thoroughbred stallion. In view of this, the recent 
identification by Dutia at at. (1986) of a synthetic 
peptide which specifically inhibits the activity of 
herpesvirus-induced ribonucleotide reductase may offer an 
exciting alternative in the field of antiherpetic agents. 
The mechanism of inhibition probably involves interference 
with the normal interaction between the two HSV-1 
ribonucleotide reductase subunits. Nothing is yet known 
about the components of EHV-1 ribonucleotide reductase or 
their interactions. Antisera raised against the carboxy- 
terminal 7 amino acids of the small ribonucleotide 
reductase subunit of HSV-1 and HSV-2, a proposed site of 
interaction between the two subunits and a target for
- 136 -
inhibitory oligopeptides, failed to precipitate the EHV-1 
ribonucleotide reductase. However, the approximate 
localisation of the genes encoding this EHV-1 enzyme is a 
first step towards fine mapping and DNA sequencing studies. 
It is likely that a modified synthetic peptide will have an 
inhibitory effect on the EHV-1 ribonucleotide reductase 
similar to that reported for HSV-1.
Many questions relating to the pathogenicity and 
interrelationships of the two subtype's of EHV-1 remain to 
be answered. The recently proven ability of the virus to 
establish a latent infection (Edington &1_. , 1985)
increases the difficulties anticipated in the control of 
the disease by vaccination or anti-viral therapy. An 
understanding of latency and reactivation is a prerequisite 
for a logical approach to the control of the disease. It 
is not known whether latent infection with one subtype 
precludes the establishment of latency with the second 
(Gerdes and Smith 1983; Nettleton et a]^ . , 1984), or whether
superinfection with one subtype may induce reactivation of 
the other latent subtype, as is possibly the case for HSV-1 
and HSV-2 (Thomas ei aX- , 1985). The site of latency of
EHV-1 has not yet been identified. Much speculation 
surrounds the role of leukocytes in EHV-1 infection. EHV-1 
is isolated only from intact leukocytes (Gleeson and 
Coggins, 1980; Scott e.t. al-, 1983), suggesting that the 
virus may persist in these cells in a latent state (Gleeson 
and Coggins, 1980). Leukocytes have recently been 
implicated as a site of latency for another member of the 
Alphaherpesvirinae, PRV (Rziha et al., 1984). It has been
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suggested that in an abortigenic EHV-1 infection the 
lymphocytes harbour the virus until the infected cells or 
the released virus cross the placenta (Gleeson and Coggins, 
1980). However, virus has not been isolated from 
leukocytes beyond the 24th day after inoculation (Bryans 
and Prickett, 1969), and other sites for the virus during 
the period between the nasopharyngeal infection and 
abortion have been suggested (Kendrick, 1969). Jackson el. 
al. 1977 suggested that in the neurological form of the 
disease the virus spreads directly from leukocytes to 
vascular endothelial cells, where it induces a 
characteristic vasculitis.
DNA hybridization techniques have a major role to play 
in an investigation of the pathogenesis of EHV-1. The 
cloned DNA fragments of EHV-1 subtype 2 may be used as 
specific probes to identify virus-specific DNA of both EHV- 
1 subtypes in equine tissues. Probes of superior 
specificity and sensitivity may be obtained by 
radiolabelling M13 clones used in the DNA sequence analysis 
of Bam HI 1 of EHV-1 subtype 2. Efstathiou êi âl* (1986) 
used an 800bp fragment of the HSV-1 thymidine-kinase coding 
region to detect HSV-specific DNA sequences at 
concentrations as low as 0.01 copy per cell in human 
trigeminal ganglia. DNA hybridization also permits the 
identification of integrated, non-replicating or subvirion 
DNA which is not detectable by other means. Little is 
known about the molecular state of latent herpesviruses.
It has been suggested that the latent HSV genome persists 
in a static non-infectious form rather than as a low-level
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chronic infection. Virus cannot be isolated from 
homogenized latently infected tissue, but may be detected 
only after a long lag phase by explant cocultivation.
Also, treatment with inhibitors of viral DNA replication 
did not affecb the rate of virus reactivation from latently 
infected ganglia (Field gjL &1. , 1979; Blyth al», 1980).
However, although Puga et a_l. (1978) observed no viral RNA 
in latently infected cells, indicating that latent virus 
may not be transcribed, limited expression of viral mRNA 
has been demonstrated in the nervous system of latently 
infected humans (Galloway ei aJL. , 1982) and rabbits (Green
et al.. 1981). Moreover, HSV-1 thymidine kinase activity
was detected in latently infected mouse ganglia (Tenser and 
Dunstan, 1979), even though this enzyme may not be 
essential for establishment of latency (Stanberry oi. al., 
1985b; Sears el al., 1985).
The elucidation of the genome structure of latent 
virus is of fundamental importance to our understanding of 
the mechanisms involved in latency and reactivation. Rock 
and Fraser (1983) showed that free genome termini were not 
detectable in mouse brain and trigeminal ganglia harbouring 
latent HSV-1. These workers later concluded that the 
genome termini join to form long linear concatemers or 
circles which may or may not integrate (Rock and Fraser, 
1985). This work was substantiated by that of Efstathiou 
et al. (1986) who, in the acute phase of infection in mice,
could detect DNA fragments from the L-S joint and free 
termini but one month later could detect only the L-S joint 
fragments. Similarly, on hybridization analysis of DNA
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from latently infected human trigeminal ganglia, no free 
termini were detected, but fragments corresponding to the 
L-S joint were present (Efstathiou ei al.• 1986). Thus,
the use of cloned EHV-1 DNA fragments to screen equine 
tissues may not only throw some light on the pathogenesis 
of the virus and the role that leukocytes play in the 
disease, but also may help to elucidate the molecular state 
of latent EHV-1.
The study and control of EHV-1 disease is severely 
curtailed by the lack of quick sensitive diagnostic 
techniques. While the indirect immunofluorescence 
technique (IFT) is a satisfactory means of identifying 
cases of EHV-1 abortion (Thomson el al. » 1976), in the face
of an abortion storm it is impossible to decide 
conclusively from serological or hormonal data whether or 
not a mare is going to abort. Diagnosis of an EHV-1 
subtype 2 respiratory infection can take up to two weeks 
(Mumford, 1984). Detection of the neurological form of the 
disease is often difficult, as by the time clinical signs 
are manifest the antibody titre is rising and the peak of 
virus excretion from the upper respiratory tract is usually 
past. Virus is sometimes isolated from the blood 
leukocytes by co-cultivation (Mumford, 1984).
Seroepidemiological studies have demonstrated that EHV-1 is 
endemic in horse populations worldwide (Matumoto e± al. , 
1965), and that the majority of horses, in Great Britain at 
least, experience an infection within the first year of 
life (Thomson 1978). One might presume from this that a 
large proportion of the equine population is latently
—  lifO
infected with EHV-1. As yet there is no means of 
diagnosing latent infections nor of identifying those 
animals likely to suffer reactivation and thus be a source 
of infection to their companions.
■ Nucleic acid hybridization procedures are not used 
only in basic research, but also as an alternative tool in 
diagnostic microbiology. Spot hybridization tests can be 
used to detect viruses, for example EBV (Brandsma and 
Miller, 1980), CMV (Chou and Merrigari, 1983; Spector at. 
al., 1984) and hepatitis B virus (Brechot at al., 1985),
bacteria such as enterotoxigenic aoll (Mosley at al. , 
1982; Echeverria at al. , 1984, 1986) and parasites like
Plasmodium falciparum (Franzen at al., 1984),
Stalhandske and Pettersson (1982) were able to 
differentiate between HSV-1 and HSV-2 infected cells using 
a cloned restriction enzyme fragment of HSV-1 DNA as a 
probe.
Cloned DNA fragments from both subtypes of EHV-1 are 
now available for development as diagnostic probes. 
Molecular hybridization may offer a relatively fast and 
sensitive method of detecting virus in nasal scrapings, 
tracheal washes and leukocytes of infected horses. Also, 
in the case of a latently infected carrier, DNA probes may 
identify virus which is otherwise undetectable. The 
development of a rapid and accurate subtyping system for 
EHV-1 isolates is of primary importance. The isolation of 
a subtype 1 virus from a foal on a stud calls for far more 
stringent isolation procedures than the isolation in 
similar circumstances of a subtype 2 virus. Use of a
—  141
cloned fragment from a heterologous region of the genomes 
should enable differentiation between the two subtypes in a 
hybridization assay. Alternatively, as shown in Chapter 2, 
the hybridization pattern of the cloned fragments of 
subtype 2 to a Bam HI or an Eslq RI digest of subtype 1 is 
now known and could be utilized to type an isolate, 
although less rapidly.
Nucleic acid probes labelled with radioisotopes are 
not ideal for routine use in a diagnostic laboratory. A 
number of non-radiographic methods of hybridization 
detection have been described, many of which use 
biotinylated DNA (Langer ei al. , 1981; Renz, 1983; Tchen
et al., 1984). Polynucleotides substituted with biotin-
labelled analogues of TTP or UTP have been reported to 
exhibit similar reassociation kinetics to biotin-free 
polymers (Langer el al., 1981). Hybridization can be
detected by immunofluorescent or immunohistochemical 
techniques in the presence of antibiotin antibody or by an 
avidin-enzyme conjugate combined with a colour-producing 
substrate (Leary el al., 1983). A biotin-labelled DNA
probe kit for the rapid detection of HSV is now 
commercially available (Fung el al., 1985).
The problems of EHV-1 disease have been baffling 
horse-owners, scientists and veterinarians for decades.
The application of recombinant DNA technology to Veterinary 
Virology is still in its infancy but it is of vital 
importance to the horse industry that equine
herpesvirologists exploit the ongoing revolution in applied 
molecular genetics. The data presented in this thesis
— - 142 —
constitute the groundwork for such an approach to the study 
of EHV-1 and the prophylaxis of the diseases with which it 
is associated.
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